Athene Holding (ATH-PA) 10-Q6 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2024	Nov. 04, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-37963
Entity Registrant Name	ATHENE HOLDING LTD
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-0630022
Entity Address, Address Line One	7700 Mills Civic Pkwy
Entity Address, City or Town	West Des Moines
Entity Address, Postal Zip Code	50266
City Area Code	515
Local Phone Number	342-4678
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		203,805,432
Entity Central Index Key	0001527469
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Address, State or Province	IA
Preference Share, Series A
Document Information [Line Items]
Title of 12(b) Security	6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock, Series A
Trading Symbol	ATHPrA
Security Exchange Name	NYSE
Preference Share, Series B
Document Information [Line Items]
Title of 12(b) Security	5.625% Fixed-Rate Perpetual Non-Cumulative Preferred Stock, Series B
Trading Symbol	ATHPrB
Security Exchange Name	NYSE
Preference Share, Series C
Document Information [Line Items]
Title of 12(b) Security	6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preferred Stock, Series C
Trading Symbol	ATHPrC
Security Exchange Name	NYSE
Series D Preferred Stock
Document Information [Line Items]
Title of 12(b) Security	4.875% Fixed-Rate Perpetual Non-Cumulative Preferred Stock, Series D
Trading Symbol	ATHPrD
Security Exchange Name	NYSE
Series E Preferred Stock
Document Information [Line Items]
Title of 12(b) Security	7.75% Fixed-Rate Reset Perpetual Non-Cumulative Preferred Stock, Series E
Trading Symbol	ATHPrE
Security Exchange Name	NYSE
Junior Subordinated Debt
Document Information [Line Items]
Title of 12(b) Security	7.250% Fixed-Rate Reset Junior Subordinated Debentures due 2064
Trading Symbol	ATHS
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Investments
Available-for-sale securities	$ 182,582	$ 148,347
Investment funds	18,846	17,668
Derivative assets	7,529	5,298
Restricted cash	964
Accrued investment income (related party: 2024 – $171 and 2023 – $166)	2,695	1,933
Reinsurance recoverable (related party: 2024 – $3,372 and 2023 – $0; portion at fair value: 2024 – $1,710 and 2023 – $1,367)	7,454	4,154
Deferred acquisition costs, deferred sales inducements and value of business acquired	6,971	5,979
Goodwill	4,071	4,065
Other assets (related party: 2024 – $207 and 2023 – $189)	10,726	10,179
Total assets	354,966	300,579
Liabilities
Interest sensitive contract liabilities (related party: 2024 – $7,085 and 2023 – $8,599; portion at fair value: 2024 – $12,816 and 2023 – $9,893)	245,436	204,670
Future policy benefits	52,962	53,287
Market Risk Benefits	4,402	3,751
Debt	5,725	4,209
Derivative liabilities	2,758	1,995
Payables for collateral on derivatives and securities to repurchase	7,952	7,536
Total liabilities	327,855	279,344
Commitments and Contingencies (Note 12)
Equity
Preferred stock	0	0
Common stock	0	0
Additional paid-in capital	19,567	19,499
Retained earnings (accumulated deficit)	1,345	(92)
Accumulated other comprehensive loss (related party: 2024 – $(211) and 2023 – $(357))	(3,467)	(5,569)
Total Athene Holding Ltd. stockholders’ equity	17,445	13,838
Noncontrolling interests	9,666	7,397
Total equity	27,111	21,235
Total liabilities and equity	354,966	300,579
Consolidated Entity, excluding Affiliated Entity
Investments
Available-for-sale securities	164,685	134,338
Trading securities, at fair value	1,684	1,706
Equity securities (portion at fair value: 2024 – $1,292 and 2023 – $935)	1,292	1,293
Mortgage loans	58,587	44,115
Investment funds	107	109
Policy loans	320	334
Funds withheld at interest	21,231	24,359
Derivative assets	7,529	5,298
Short-term Investments	614	341
Other investments	1,727	1,206
Total investments	257,776	213,099
Consolidated Entity Excluding Variable Interest Entities (VIE)
Investments
Cash and cash equivalents	13,587	13,020
Liabilities
Other liabilities (related party: 2024 – $3,938 and 2023 – $774)	7,257	2,781
Related Party
Investments
Available-for-sale securities	17,897	14,009
Trading securities, at fair value	619	838
Equity securities, at fair value	257	318
Mortgage loans	1,345	1,281
Investment funds	1,604	1,632
Funds withheld at interest	5,444	6,474
Short-term Investments	812	947
Other investments	348	343
Accrued investment income (related party: 2024 – $171 and 2023 – $166)	171	166
Reinsurance recoverable (related party: 2024 – $3,372 and 2023 – $0; portion at fair value: 2024 – $1,710 and 2023 – $1,367)	3,372	0
Other assets (related party: 2024 – $207 and 2023 – $189)	207	189
Liabilities
Interest sensitive contract liabilities (related party: 2024 – $7,085 and 2023 – $8,599; portion at fair value: 2024 – $12,816 and 2023 – $9,893)	7,085	8,599
Future policy benefits	23	9
Market Risk Benefits	257	227
Other liabilities (related party: 2024 – $3,938 and 2023 – $774)	3,938	774
Equity
Accumulated other comprehensive loss (related party: 2024 – $(211) and 2023 – $(357))	(211)	(357)
Variable Interest Entities
Investments
Trading securities, at fair value	2,379	2,136
Mortgage loans	2,226	2,173
Investment funds	17,135	15,927
Other investments	159	103
Cash and cash equivalents	305	98
Restricted cash	10	0
Other assets (related party: 2024 – $207 and 2023 – $189)	192	110
Liabilities
Other liabilities (related party: 2024 – $3,938 and 2023 – $774)	$ 1,363	$ 1,115

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Available-for-sale securities	$ 192,382	$ 162,016
AFS securities allowance for credit losses	678	591
Restricted cash	964
Accrued investment income	2,695	1,933
Reinsurance recoverable	7,454	4,154
Other assets	10,726	10,179
Investment funds	18,846	17,668
Liabilities and Equity
Interest sensitive contract liabilities	245,436	204,670
Future policy benefits	52,962	53,287
Liability	4,402	3,751
Accumulated other comprehensive loss (related party: 2024 – $(211) and 2023 – $(357))	(3,467)	(5,569)
Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	174,252	147,561
AFS securities allowance for credit losses	677	590
Short-term Investments	614	341
Other investments	1,727	1,206
Trading securities, at fair value	1,684	1,706
Mortgage loans, net of allowances	58,587	44,115
Investment funds	107	109
Related Party
Assets
Available-for-sale securities	18,130	14,455
AFS securities allowance for credit losses	1	1
Equity securities, at fair value	257	318
Short-term Investments	812	947
Other investments	348	343
Investment funds	1,106	1,082
Accrued investment income	171	166
Reinsurance recoverable	3,372	0
Other assets	207	189
Trading securities, at fair value	619	838
Mortgage loans, net of allowances	1,345	1,281
Investment funds	1,604	1,632
Liabilities and Equity
Interest sensitive contract liabilities	7,085	8,599
Future policy benefits	23	9
Liability	257	227
Other liabilities	3,938	774
Accumulated other comprehensive loss (related party: 2024 – $(211) and 2023 – $(357))	(211)	(357)
Consolidated Entity, Affiliated Entity and VIE Primary Beneficiary
Assets
Other investments	101	80
Trading securities, at fair value	687	644
Mortgage loans, net of allowances	412	358
Investment funds	16,357	15,425
Liabilities and Equity
Other liabilities	461	513
Variable Interest Entities
Assets
Other investments	159	103
Restricted cash	10	0
Other assets	192	110
Trading securities, at fair value	2,379	2,136
Mortgage loans, net of allowances	2,226	2,173
Investment funds	17,135	15,927
Liabilities and Equity
Other liabilities	1,363	1,115
Fair Value
Liabilities and Equity
Interest sensitive contract liabilities	187,554	146,038
Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Short-term Investments	205
Other investments	28	52
Investment funds	107	109
Fair Value \| Related Party
Assets
Short-term Investments	812	947
Investment funds	498	550
Recurring \| Fair Value
Assets
Restricted cash	964	1,761
Reinsurance recoverable	1,710	1,367
Other assets	313	378
Liabilities and Equity
Interest sensitive contract liabilities	12,816	9,893
Future policy benefits	1,711	1,700
Liability	4,402	3,751
Recurring \| Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Equity securities, at fair value	1,292	935
Embedded derivative assets, fair value	(2,581)	(3,379)
Short-term Investments	409	341
Other investments	1,507	943
Trading securities, at fair value	1,684	1,706
Mortgage loans, net of allowances	58,587	44,115
Recurring \| Fair Value \| Related Party
Assets
Equity securities, at fair value	257	318
Embedded derivative assets, fair value	(530)	(721)
Other investments	348	343
Reinsurance recoverable		1,367
Trading securities, at fair value	619	838
Mortgage loans, net of allowances	1,345	1,281
Investment funds	1,106	1,082
Recurring \| Fair Value \| Variable Interest Entities
Assets
Other investments	159	103
Trading securities, at fair value	2,379	2,136
Mortgage loans, net of allowances	2,226	2,173
Investment funds	$ 17,135	$ 15,927

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues
Premiums Earned, Net	$ 389	$ 26	$ 1,163	$ 9,163
Insurance Commissions and Fees	267	217	756	622
Other revenues	4	564	9	584
Total revenues	6,522	1,436	16,907	18,182
Benefits and expenses
Interest Sensitive Contract Benefits Expense	2,599	333	7,307	3,634
Future policy and other policy benefits	793	368	2,431	10,346
Market risk benefits remeasurement (gains) losses	524	(441)	354	(166)
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired	244	211	678	502
Policy and other operating expenses	687	472	1,653	1,359
Total benefits and expenses	4,847	943	12,423	15,675
Income before income taxes	1,675	493	4,484	2,507
Income tax expense	191	162	659	458
Net income	1,484	331	3,825	2,049
Less: Net income (loss) attributable to noncontrolling interests	859	(155)	1,379	354
Net income attributable to Athene Holding Ltd. stockholders	625	486	2,446	1,695
Less: Preferred stock dividends	45	44	136	136
Net income available to Athene Holding Ltd. common stockholder	580	442	2,310	1,559
Consolidated Entity Excluding Variable Interest Entities (VIE)
Revenues
Net Investment Income	3,777	2,928	10,578	8,052
Investment related gains (losses)	1,539	(2,624)	3,082	(1,193)
Variable Interest Entities
Revenues
Net Investment Income	77	75	210	210
Investment related gains (losses)	$ 469	$ 250	$ 1,109	$ 744

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Premiums earned	$ 389	$ 26	$ 1,163	$ 9,163
Product charges	267	217	756	622
Other revenues	4	564	9	584
Interest Sensitive Contract Benefits Expense	2,599	333	7,307	3,634
Future policy and other policy benefits	793	368	2,431	10,346
Remeasurement (gains) losses	(111)	(30)	(104)	(36)
Market risk benefits remeasurement (gains) losses	524	(441)	354	(166)
Policy and other operating expenses	687	472	1,653	1,359
Related Party
Premiums earned	4	3	16	11
Product charges	7	10	23	30
Net Investment Income	482	405	1,295	1,195
Investment expense	327	249	920	703
Investment gains (losses), net of offsets	144	(187)	78	(168)
Other revenues	5	5	563	563
Interest Sensitive Contract Benefits Expense	(52)	14	(44)	118
Future policy and other policy benefits	5	4	19	39
Market risk benefits remeasurement (gains) losses	12	(47)	(3)	(17)
Policy and other operating expenses	15	34	16	95
Consolidated Entity, Affiliated Entity and VIE Primary Beneficiary
Net Investment Income	(5)	18	13	45
Investment gains (losses), net of offsets	$ 421	$ 305	$ 1,118	$ 840

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 1,484	$ 331	$ 3,825	$ 2,049
Other comprehensive income (loss), before tax
Unrealized investment gains (losses) on available-for-sale securities	5,476	(3,155)	3,760	(1,767)
Unrealized gains (losses) on hedging instruments	221	(213)	229	(280)
Remeasurement gains (losses) on future policy benefits related to discount rate	(2,263)	1,317	(832)	1,328
Remeasurement gains (losses) on market risk benefits related to credit risk	(93)	(254)	(87)	(220)
Foreign currency translation and other adjustments	36	(21)	15	6
Other comprehensive income (loss), before tax	3,377	(2,326)	3,085	(933)
Income tax expense (benefit) related to other comprehensive income (loss)	680	(476)	632	(175)
Other comprehensive income (loss)	2,697	(1,850)	2,453	(758)
Comprehensive income (loss)	4,181	(1,519)	6,278	1,291
Less: Comprehensive income (loss) attributable to noncontrolling interests	1,214	(299)	1,730	357
Comprehensive income (loss) attributable to Athene Holding Ltd. stockholders	$ 2,967	$ (1,220)	$ 4,548	$ 934

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Equity - USD ($) $ in Millions	Total	Total Athene Holding Ltd. stockholders’ equity	Preferred Stock	Common Stock	Additional paid-in capital	Retained earnings (accumulated deficit)	Accumulated other comprehensive income (loss)	Noncontrolling interests
Beginning Balance at Dec. 31, 2022	$ 10,549	$ 7,158	$ 0	$ 0	$ 18,119	$ (3,640)	$ (7,321)	$ 3,391
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,049	1,695				1,695		354
Other comprehensive income (loss)	(758)	(761)					(761)	3
Stock-based compensation allocation from parent	36	36			36
Preferred stock dividends	(136)	(136)				(136)
Common stock dividends	(750)	(750)				(750)
Contributions from parent	1,282	1,282			1,282
Contributions from noncontrolling interests	325							325
Distributions to noncontrolling interests	(381)							(381)
Contributions from noncontrolling interests of consolidated variable interest entities, net of distributions and other	1,215							1,215
Subsidiary issuance of equity interests and other	598	13			10		3	585
Ending Balance at Sep. 30, 2023	14,029	8,537	0	0	19,447	(2,831)	(8,079)	5,492
Beginning Balance at Jun. 30, 2023	13,234	8,701	0	0	18,162	(3,085)	(6,376)	4,533
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	331	486				486		(155)
Other comprehensive income (loss)	(1,850)	(1,706)					(1,706)	(144)
Stock-based compensation allocation from parent	13	13			13
Preferred stock dividends	(44)	(44)				(44)
Common stock dividends	(188)	(188)				(188)
Contributions from parent	1,262	1,262			1,262
Contributions from noncontrolling interests	325							325
Distributions to noncontrolling interests	(254)							(254)
Contributions from noncontrolling interests of consolidated variable interest entities, net of distributions and other	602							602
Subsidiary issuance of equity interests and other	598	13			10		3	585
Ending Balance at Sep. 30, 2023	14,029	8,537	0	0	19,447	(2,831)	(8,079)	5,492
Beginning Balance at Dec. 31, 2023	21,235	13,838	0	0	19,499	(92)	(5,569)	7,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,825	2,446				2,446		1,379
Other comprehensive income (loss)	2,453	2,102					2,102	351
Stock-based compensation allocation from parent	32	32			32
Preferred stock dividends	(136)	(136)				(136)
Common stock dividends	(873)	(873)				(873)
Contributions from parent	36	36			36
Contributions from noncontrolling interests	831							831
Distributions to noncontrolling interests	(603)							(603)
Contributions from noncontrolling interests of consolidated variable interest entities, net of distributions and other	305							305
Subsidiary issuance of equity interests and other	6	0			0		0	6
Ending Balance at Sep. 30, 2024	27,111	17,445	0	0	19,567	1,345	(3,467)	9,666
Beginning Balance at Jun. 30, 2024	24,332	14,998	0	0	19,543	1,264	(5,809)	9,334
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,484	625				625		859
Other comprehensive income (loss)	2,697	2,342					2,342	355
Stock-based compensation allocation from parent	11	11			11
Preferred stock dividends	(45)	(45)				(45)
Common stock dividends	(499)	(499)				(499)
Contributions from parent	13	13			13
Contributions from noncontrolling interests	126							126
Distributions to noncontrolling interests	(95)							(95)
Contributions from noncontrolling interests of consolidated variable interest entities, net of distributions and other	(919)							(919)
Subsidiary issuance of equity interests and other	6							6
Ending Balance at Sep. 30, 2024	$ 27,111	$ 17,445	$ 0	$ 0	$ 19,567	$ 1,345	$ (3,467)	$ 9,666

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net income		$ 3,825	$ 2,049
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on recapture of reinsurance agreements, net of cash received		0	489
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired		678	502
Net amortization (accretion) of net investment premiums, discounts and other		(47)	70
Net investment income (related party: 2024 – $(22) and 2023 – $(51))		(100)	(76)
Net recognized (gains) losses on investments and derivatives (related party: 2024 – $(1,194) and 2023 – $(767))		(3,558)	325
Policy acquisition costs deferred		(1,191)	(1,040)
Changes in operating assets and liabilities:
Accrued investment income (related party: 2024 – $(5) and 2023 – $(59))		(762)	(436)
Interest sensitive contract liabilities (related party: 2024 – $68 and 2023 – $88)		4,948	1,485
Future policy benefits, market risk benefits and reinsurance recoverable (related party: 2024 – $(125) and 2023 – $(338))		(1,135)	2,917
Funds withheld assets (related party: 2024 – $(290) and 2023 – $(114))		(1,933)	(1,990)
Other assets and liabilities		765	387
Net cash provided by operating activities		1,490	3,704
Cash flows from investing activities
Consolidation of new variable interest entities		0	3
Sales, maturities and repayments of:
Available-for-sale securities (related party: 2024 – $4,778 and 2023 – $1,153)		33,603	9,145
Trading securities (related party: 2024 – $266 and 2023 – $21)		482	234
Equity securities (related party: 2024 – $62 and 2023 – $0)		394	110
Mortgage loans (related party: 2024 – $63 and 2023 – $24)		5,691	3,093
Investment funds (related party: 2024 – $93 and 2023 – $285)		109	339
Derivative instruments and other investments		2,533	4,221
Short-term investments (related party: 2024 – $1,281 and 2023 – $967)		2,240	3,195
Purchases of:
Available-for-sale securities (related party: 2024 – $(8,156) and 2023 – $(4,102))		(63,102)	(24,568)
Trading securities (related party: 2024 – $(80) and 2023 – $(827))		(417)	(1,053)
Equity securities		(625)	(70)
Mortgage loans (related party: 2024 – $(27) and 2023 – $0)		(19,319)	(14,398)
Investment funds (related party: 2024 – $(1,452) and 2023 – $(1,884))		(1,745)	(2,009)
Derivative instruments and other investments (related party: 2024 – $(16) and 2023 – $(46))		(2,845)	(5,242)
Short-term investments (related party: 2024 – $(1,144) and 2023 – $(1,858))		(2,360)	(2,392)
Deconsolidation of previously consolidated entities		(1)	(51)
Other investing activities, net		(46)	443
Net cash used in investing activities		(45,408)	(29,000)
Cash flows from financing activities
Proceeds from Contributions from Parent		0	1,250
Proceeds from debt		1,569	0
Deposits on investment-type policies and contracts		57,013	35,168
Withdrawals on investment-type policies and contracts (related party: 2024 – $(314) and 2023 – $(304))		(16,054)	(10,229)
Payments for (Proceeds from) Derivative Instrument, Financing Activities		416	945
Payments of Ordinary Dividends, Preferred Stock and Preference Stock		(181)	(136)
Payments of Ordinary Dividends, Common Stock		374	750
Other financing activities, net		(280)	(318)
Net cash provided by financing activities		43,892	27,891
Effect of exchange rate changes on cash and cash equivalents		3	2
Net (decrease) increase in cash and cash equivalents		(23)	2,597
Cash and cash equivalents at beginning of year	[1]	14,879	8,769
Cash and cash equivalents at end of period	[1]	14,856	11,366
Non-cash transactions
Reduction in investments relating to recapture of reinsurance agreements		0	482
Deposits on investment-type policies and contracts through reinsurance agreements, net assumed (ceded) (related party: 2024 – $(3,201) and 2023 – $16)		(3,152)	78
Withdrawals on investment-type policies and contracts through reinsurance agreements, net assumed (ceded) (related party: 2024 – $1,267 and 2023 – $1,239)		6,092	10,212
Reinsurance Settlements
Non-cash transactions
Transfer to Investments		48	164
Reinsurance Settlements \| Related Party
Non-cash transactions
Transfer to Investments		48	65
Pension Risk Transfer Premiums
Non-cash transactions
Transfer to Investments		521	4,776
Distribution of Marketable Securities to Stockholders as Dividends
Cash flows from financing activities
Payments of Ordinary Dividends, Common Stock		499	0
Investments distributed to noncontrolling interests
Cash flows from financing activities
Capital distributions to noncontrolling interests		1,107	0
Related Party
Adjustments to reconcile net income to net cash provided by operating activities:
Net investment income (related party: 2024 – $(22) and 2023 – $(51))		(22)	(51)
Net recognized (gains) losses on investments and derivatives (related party: 2024 – $(1,194) and 2023 – $(767))		(1,194)	(767)
Changes in operating assets and liabilities:
Accrued investment income (related party: 2024 – $(5) and 2023 – $(59))		(5)	(59)
Interest sensitive contract liabilities (related party: 2024 – $68 and 2023 – $88)		68	88
Future policy benefits, market risk benefits and reinsurance recoverable (related party: 2024 – $(125) and 2023 – $(338))		(125)	(338)
Funds withheld assets (related party: 2024 – $(290) and 2023 – $(114))		(290)	(114)
Sales, maturities and repayments of:
Available-for-sale securities (related party: 2024 – $4,778 and 2023 – $1,153)		4,778	1,153
Trading securities (related party: 2024 – $266 and 2023 – $21)		266	21
Equity securities (related party: 2024 – $62 and 2023 – $0)		62	0
Mortgage loans (related party: 2024 – $63 and 2023 – $24)		63	24
Investment funds (related party: 2024 – $93 and 2023 – $285)		93	285
Short-term investments (related party: 2024 – $1,281 and 2023 – $967)		1,281	967
Purchases of:
Available-for-sale securities (related party: 2024 – $(8,156) and 2023 – $(4,102))		(8,156)	(4,102)
Trading securities (related party: 2024 – $(80) and 2023 – $(827))		(80)	(827)
Mortgage loans (related party: 2024 – $(27) and 2023 – $0)		(27)	0
Investment funds (related party: 2024 – $(1,452) and 2023 – $(1,884))		(1,452)	(1,884)
Derivative instruments and other investments (related party: 2024 – $(16) and 2023 – $(46))		(16)	(46)
Short-term investments (related party: 2024 – $(1,144) and 2023 – $(1,858))		(1,144)	(1,858)
Cash flows from financing activities
Withdrawals on investment-type policies and contracts (related party: 2024 – $(314) and 2023 – $(304))		(314)	(304)
Non-cash transactions
Deposits on investment-type policies and contracts through reinsurance agreements, net assumed (ceded) (related party: 2024 – $(3,201) and 2023 – $16)		(3,201)	16
Withdrawals on investment-type policies and contracts through reinsurance agreements, net assumed (ceded) (related party: 2024 – $1,267 and 2023 – $1,239)		1,267	1,239
Consolidated Entity Excluding Variable Interest Entities (VIE)
Cash flows from financing activities
Capital contributions from noncontrolling interests		831	325
Capital distributions to noncontrolling interests		603	381
Proceeds from (Payments to) Noncontrolling Interests		0	632
Variable Interest Entities
Cash flows from financing activities
Capital contributions from noncontrolling interests		$ 1,555	$ 1,385

[1] 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities.

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Net investment (income) loss	$ (100)	$ (76)
Net recognized gains on investments and derivatives	(3,558)	325
Accrued investment income	(762)	(436)
Interest sensitive contract liabilities	4,948	1,485
Future policy benefits, market risk benefits and reinsurance recoverable	(1,135)	2,917
Funds withheld assets	(1,933)	(1,990)
Sales, maturities and repayments of:
Available-for-sale securities	33,603	9,145
Trading securities	482	234
Equity securities	394	110
Mortgage loans	5,691	3,093
Investment funds	109	339
Derivative instruments and other investments	2,533	4,221
Short-term investments	2,240	3,195
Purchases of:
Available-for-sale securities	(63,102)	(24,568)
Mortgage loans	(19,319)	(14,398)
Trading securities	(417)	(1,053)
Investment funds	(1,745)	(2,009)
Derivative instruments and other investments	(2,845)	(5,242)
Short-term investments	(2,360)	(2,392)
Withdrawals on investment-type policies and contracts	(16,054)	(10,229)
Deposits on investment-type policies and contracts through reinsurance agreements	(3,152)	78
Withdrawals on investment-type policies and contracts through reinsurance agreements	6,092	10,212
Related Party
Net investment (income) loss	(22)	(51)
Net recognized gains on investments and derivatives	(1,194)	(767)
Accrued investment income	(5)	(59)
Interest sensitive contract liabilities	68	88
Future policy benefits, market risk benefits and reinsurance recoverable	(125)	(338)
Funds withheld assets	(290)	(114)
Sales, maturities and repayments of:
Available-for-sale securities	4,778	1,153
Trading securities	266	21
Equity securities	62	0
Mortgage loans	63	24
Investment funds	93	285
Short-term investments	1,281	967
Purchases of:
Available-for-sale securities	(8,156)	(4,102)
Mortgage loans	(27)	0
Trading securities	(80)	(827)
Investment funds	(1,452)	(1,884)
Derivative instruments and other investments	(16)	(46)
Short-term investments	(1,144)	(1,858)
Withdrawals on investment-type policies and contracts	(314)	(304)
Deposits on investment-type policies and contracts through reinsurance agreements	(3,201)	16
Withdrawals on investment-type policies and contracts through reinsurance agreements	$ 1,267	$ 1,239

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Business, Basis of Presentation, and Significant Accounting Policies	1. Business, Basis of Presentation and Significant Accounting Policies Athene Holding Ltd. (AHL), together with its subsidiaries (collectively, Athene, we, our, us, or the Company), is a leading financial services company that specializes in issuing, reinsuring and acquiring retirement savings products in the United States (US) and internationally. We are a direct subsidiary of Apollo Global Management, Inc. (AGM, and together with its subsidiaries other than us or our subsidiaries, Apollo). We conduct business primarily through the following consolidated subsidiaries: • Our non-US reinsurance subsidiaries, to which AHL’s other insurance subsidiaries and third-party ceding companies directly and indirectly reinsure a portion of their liabilities, including Athene Life Re Ltd. (ALRe), Athene Annuity Re Ltd. (AARe) and Athene Life Re International Ltd. (ALReI); and • Athene USA Corporation, an Iowa corporation (together with its subsidiaries, AUSA). In addition, we consolidate certain variable interest entities (VIEs) for which we have determined we are the primary beneficiary. See Note 4 – Variable Interest Entities for further information on VIEs. Consolidation and Basis of Presentation —We have prepared the accompanying condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information and the United States Securities and Exchange Commission’s rules and regulations for Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. Certain reclassifications have been made to conform with current year presentation. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year. For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements. The condensed consolidated balance sheet as of December 31, 2023 has been derived from the audited financial statements, but does not include all of the information and footnotes required by US GAAP for complete financial statements. Therefore, these condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023. The preparation of financial statements requires the use of management estimates. Actual results may differ from estimates used in preparing the condensed consolidated financial statements. Recently Issued Accounting Pronouncements Compensation – Stock Compensation (Accounting Standards Update (ASU) 2024-01) The amendments in this update clarify how an entity determines whether it is required to account for profits interest awards (and similar awards) in accordance with Accounting Standards Codification (ASC) 718 Compensation – Stock Compensation or other guidance. The ASU provides specific examples on when profits interest awards should be accounted for as a share-based payment arrangement under ASC 718 or in a manner similar to a cash bonus or profit-sharing arrangement under ASC 710 Compensation – General or other ASC topics. The guidance is effective for us on January 1, 2025, and early adoption is permitted but must be implemented as of the beginning of the fiscal year. We are currently evaluating the impact of the new pronouncement on our consolidated financial statements. Income Taxes—Improvements to Income Tax Disclosures (ASU 2023-09) The amendments in this update revise certain disclosures on income taxes including rate reconciliation, income taxes paid, and certain amendments on disaggregation by federal, state and foreign taxes. The guidance is effective for us for annual periods beginning in 2025. Early adoption is permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements. Segment Reporting – Improvements to Reporting Segment Disclosures (ASU 2023-07) The amendments in this update require disclosures of incremental segment information on an annual and interim basis for all public entities to provide analyses useful to investors for decision making. The update requires public entities, including those with a single reportable segment, to report significant segment expenses that are regularly provided to and used by the chief operating decision maker in managing the business. The guidance is effective for us for the 2024 annual period and in interim periods in 2025 on a retrospective basis. We are evaluating the impact of this guidance and plan to include updated financial statement disclosures in our consolidated financial statements for the year ended December 31, 2024. Business Combinations – Joint Venture Formations (ASU 2023-05) The amendments in this update address how a joint venture initially recognizes and measures contributions received at its formation date. The amendments require a joint venture to apply a new basis of accounting upon formation and to initially recognize its assets and liabilities at fair value. The guidance is effective prospectively for all joint ventures formed on or after January 1, 2025, while retrospective application may be elected for a joint venture formed before the effective date. Early adoption is permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements. Adopted Accounting Pronouncements Reference Rate Reform (Topic 848) (ASU 2022-06, ASU 2021-01, ASU 2020-04) We adopted ASU 2020-04 and ASU 2021-01 and elected to apply certain of the practical expedients related to contract modifications, hedge accounting relationships, and derivative modifications pertaining to discounting, margining, or contract price alignment. The main purpose of the practical expedients is to ease the administrative burden of accounting for contracts impacted by reference rate reform, and these elections did not have, and are not expected to have, a material impact on the consolidated financial statements. ASU 2022-06 amended and deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which we will no longer be permitted to apply the expedients provided in Topic 848. We will continue to evaluate the impact of reference rate reform on contract modifications and hedging relationships.

Investments

Investments	9 Months Ended
Investments	Sep. 30, 2024
Schedule of Investments [Abstract]
Investments	2. Investments AFS Securities — Our AFS investment portfolio includes bonds, collateralized loan obligations (CLO), asset-backed securities (ABS), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS) and redeemable preferred stock. Our AFS investment portfolio includes related party investments, primarily comprised of investments over which Apollo can exercise significant influence, which are presented as investments in related parties on the condensed consolidated balance sheets, and are separately disclosed below. The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type: September 30, 2024 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 7,501 $ — $ 84 $ (824) $ 6,761 US state, municipal and political subdivisions 1,175 — 2 (200) 977 Foreign governments 2,088 — 44 (374) 1,758 Corporate 95,432 (168) 1,309 (8,963) 87,610 CLO 27,362 (1) 437 (188) 27,610 ABS 22,488 (74) 500 (444) 22,470 CMBS 9,704 (57) 112 (395) 9,364 RMBS 8,502 (377) 338 (328) 8,135 Total AFS securities 174,252 (677) 2,826 (11,716) 164,685 AFS securities – related parties Corporate 1,642 — 7 (35) 1,614 CLO 5,763 — 41 (24) 5,780 ABS 10,725 (1) 40 (261) 10,503 Total AFS securities – related parties 18,130 (1) 88 (320) 17,897 Total AFS securities, including related parties $ 192,382 $ (678) $ 2,914 $ (12,036) $ 182,582 December 31, 2023 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 6,161 $ — $ 67 $ (829) $ 5,399 US state, municipal and political subdivisions 1,296 — — (250) 1,046 Foreign governments 2,083 — 71 (255) 1,899 Corporate 88,343 (129) 830 (10,798) 78,246 CLO 20,506 (2) 261 (558) 20,207 ABS 13,942 (49) 120 (630) 13,383 CMBS 7,070 (29) 52 (502) 6,591 RMBS 8,160 (381) 252 (464) 7,567 Total AFS securities 147,561 (590) 1,653 (14,286) 134,338 AFS securities – related parties Corporate 1,423 — 1 (72) 1,352 CLO 4,367 — 21 (120) 4,268 ABS 8,665 (1) 34 (309) 8,389 Total AFS securities – related parties 14,455 (1) 56 (501) 14,009 Total AFS securities, including related parties $ 162,016 $ (591) $ 1,709 $ (14,787) $ 148,347 The amortized cost and fair value of AFS securities, including related parties, are shown by contractual maturity below: September 30, 2024 (In millions) Amortized Cost Fair Value AFS securities Due in one year or less $ 2,407 $ 2,394 Due after one year through five years 19,358 19,138 Due after five years through ten years 27,393 26,016 Due after ten years 57,038 49,558 CLO, ABS, CMBS and RMBS 68,056 67,579 Total AFS securities 174,252 164,685 AFS securities – related parties Due after one year through five years 1,028 1,024 Due after five years through ten years 43 45 Due after ten years 571 545 CLO and ABS 16,488 16,283 Total AFS securities – related parties 18,130 17,897 Total AFS securities, including related parties $ 192,382 $ 182,582 Actual maturities can differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Unrealized Losses on AFS Securities — The following summarizes the fair value and gross unrealized losses for AFS securities, including related parties, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost: September 30, 2024 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 1,031 $ (6) $ 3,795 $ (818) $ 4,826 $ (824) US state, municipal and political subdivisions 22 (1) 893 (198) 915 (199) Foreign governments 886 (134) 737 (239) 1,623 (373) Corporate 7,810 (314) 45,086 (8,624) 52,896 (8,938) CLO 3,742 (7) 3,146 (131) 6,888 (138) ABS 435 (93) 4,319 (258) 4,754 (351) CMBS 918 (5) 2,074 (341) 2,992 (346) RMBS 270 (4) 1,201 (102) 1,471 (106) Total AFS securities 15,114 (564) 61,251 (10,711) 76,365 (11,275) AFS securities – related parties Corporate 211 (12) 368 (23) 579 (35) CLO 680 (1) 690 (20) 1,370 (21) ABS 2,403 (34) 3,398 (213) 5,801 (247) Total AFS securities – related parties 3,294 (47) 4,456 (256) 7,750 (303) Total AFS securities, including related parties $ 18,408 $ (611) $ 65,707 $ (10,967) $ 84,115 $ (11,578) December 31, 2023 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 2,013 $ (94) $ 2,389 $ (735) $ 4,402 $ (829) US state, municipal and political subdivisions 123 (5) 888 (245) 1,011 (250) Foreign governments 690 (13) 760 (242) 1,450 (255) Corporate 7,752 (474) 50,028 (10,311) 57,780 (10,785) CLO 689 (2) 11,579 (543) 12,268 (545) ABS 2,129 (75) 4,378 (458) 6,507 (533) CMBS 859 (12) 1,967 (406) 2,826 (418) RMBS 467 (9) 2,057 (263) 2,524 (272) Total AFS securities 14,722 (684) 74,046 (13,203) 88,768 (13,887) AFS securities – related parties Corporate 548 (35) 382 (37) 930 (72) CLO 397 (16) 2,592 (102) 2,989 (118) ABS 2,008 (66) 2,793 (225) 4,801 (291) Total AFS securities – related parties 2,953 (117) 5,767 (364) 8,720 (481) Total AFS securities, including related parties $ 17,675 $ (801) $ 79,813 $ (13,567) $ 97,488 $ (14,368) The following summarizes the number of AFS securities that were in an unrealized loss position, including related parties, for which an allowance for credit losses has not been recorded: September 30, 2024 Unrealized loss position Unrealized loss position 12 months or more AFS securities 7,058 6,167 AFS securities – related parties 139 62 The unrealized losses on AFS securities can primarily be attributed to changes in market interest rates since the application of pushdown accounting or acquisition. We did not recognize the unrealized losses in income, unless as required for hedge accounting, as we intend to hold these securities and it is not more likely than not we will be required to sell a security before the recovery of its amortized cost. Allowance for Credit Losses — The following table summarizes the activity in the allowance for credit losses for AFS securities including purchased credit deteriorated (PCD) securities by asset type: Three months ended September 30, 2024 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Corporate $ 168 $ — $ — $ — $ — $ 168 CLO — 1 — — — 1 ABS 67 13 — (14) 8 74 CMBS 57 1 — — (1) 57 RMBS 378 5 — (4) (2) 377 Total AFS securities 670 20 — (18) 5 677 AFS securities – related parties, ABS 1 — — — — 1 Total AFS securities, including related parties $ 671 $ 20 $ — $ (18) $ 5 $ 678 Three months ended September 30, 2023 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Foreign governments $ 27 $ — $ — $ — $ — $ 27 Corporate 73 67 — (2) 2 140 CLO 3 — — — — 3 ABS 35 1 — (4) (2) 30 CMBS 6 1 — — — 7 RMBS 377 4 1 (5) (6) 371 Total AFS securities 521 73 1 (11) (6) 578 AFS securities – related parties, ABS 1 — — — — 1 Total AFS securities, including related parties $ 522 $ 73 $ 1 $ (11) $ (6) $ 579 Nine months ended September 30, 2024 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Corporate $ 129 $ 48 $ — $ (8) $ (1) $ 168 CLO 2 1 — — (2) 1 ABS 49 25 — (15) 15 74 CMBS 29 27 — — 1 57 RMBS 381 10 — (14) — 377 Total AFS securities 590 111 — (37) 13 677 AFS securities – related parties, ABS 1 — — — — 1 Total AFS securities, including related parties $ 591 $ 111 $ — $ (37) $ 13 $ 678 Nine months ended September 30, 2023 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Foreign governments $ 27 $ — $ — $ — $ — $ 27 Corporate 61 88 — (8) (1) 140 CLO 7 1 — — (5) 3 ABS 29 2 — (4) 3 30 CMBS 5 4 — — (2) 7 RMBS 329 15 40 (13) — 371 Total AFS securities 458 110 40 (25) (5) 578 AFS securities – related parties CLO 1 — — — (1) — ABS — 1 — — — 1 Total AFS securities – related parties 1 1 — — (1) 1 Total AFS securities, including related parties $ 459 $ 111 $ 40 $ (25) $ (6) $ 579 Net Investment Income —Net investment income by asset class consists of the following: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 AFS securities $ 2,520 $ 1,822 $ 6,997 $ 4,940 Trading securities 40 49 125 135 Equity securities 19 14 65 54 Mortgage loans 1,007 642 2,711 1,632 Investment funds 42 (13) 36 59 Funds withheld at interest 279 486 1,001 1,368 Other 218 214 621 623 Investment revenue 4,125 3,214 11,556 8,811 Investment expenses (348) (286) (978) (759) Net investment income $ 3,777 $ 2,928 $ 10,578 $ 8,052 Investment Related Gains (Losses) —Investment related gains (losses) by asset class consists of the following: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 AFS securities 1 Gross realized gains on investment activity $ 744 $ 55 $ 936 $ 379 Gross realized losses on investment activity (237) (431) (802) (647) Net realized investment gains (losses) on AFS securities 507 (376) 134 (268) Net recognized investment gains (losses) on trading securities 119 (137) 21 (105) Net recognized investment gains (losses) on equity securities 38 (3) 65 (34) Net recognized investment gains (losses) on mortgage loans 1,139 (911) 874 (838) Derivative gains (losses) 1,608 (1,480) 2,486 (66) Provision for credit losses (14) (60) (114) (237) Other gains (losses) (1,858) 343 (384) 355 Investment related gains (losses) $ 1,539 $ (2,624) $ 3,082 $ (1,193) 1 Includes the effects of recognized gains or losses on AFS securities associated with designated hedges. Proceeds from sales of AFS securities were $8,539 million and $724 million for the three months ended September 30, 2024 and 2023, respectively, and $19,305 million and $3,918 million for the nine months ended September 30, 2024 and 2023, respectively. The following table summarizes the change in unrealized gains (losses) on trading and equity securities, including related parties, we held as of the respective period end: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 83 $ (75) $ 42 $ (35) Trading securities – related parties (1) 3 (2) 3 Equity securities 28 6 56 9 Equity securities – related parties 10 (9) 2 (16) Repurchase Agreements— The following table summarizes the remaining contractual maturities of our repurchase agreements, which are included in payables for collateral on derivatives and securities to repurchase on the condensed consolidated balance sheets: (In millions) September 30, 2024 December 31, 2023 Less than 30 days $ — $ 686 91 days to 1 year 1,097 — Greater than 1 year 1,569 3,167 Payables for repurchase agreements $ 2,666 $ 3,853 The following table summarizes the securities pledged as collateral for repurchase agreements: September 30, 2024 December 31, 2023 (In millions) Amortized Cost Fair Value Amortized Cost Fair Value AFS securities Foreign governments $ 155 $ 113 $ 137 $ 99 Corporate 1,770 1,549 2,735 2,307 CLO 587 589 580 579 ABS 597 559 1,207 1,086 Total securities pledged under repurchase agreements $ 3,109 $ 2,810 $ 4,659 $ 4,071 Reverse Repurchase Agreements —As of September 30, 2024 and December 31, 2023, amounts loaned under reverse repurchase agreements were $1,017 million and $947 million, respectively, and the fair value of the collateral, comprised primarily of asset-backed securities and commercial mortgage loans, was $2,347 million and $1,504 million, respectively. Mortgage Loans, including related parties and consolidated VIEs —Mortgage loans include both commercial and residential loans. W e have elected the fair value option on our mortgage loan portfolio. See Note 5 – Fair Value for further fair value option information. The following represents the mortgage loan portfolio, with fair value option loans presented at unpaid principal balance: (In millions) September 30, 2024 December 31, 2023 Commercial mortgage loans $ 32,066 $ 27,630 Commercial mortgage loans under development 1,722 1,228 Total commercial mortgage loans 33,788 28,858 Mark to fair value (1,926) (2,246) Commercial mortgage loans 31,862 26,612 Residential mortgage loans 30,616 21,894 Mark to fair value (320) (937) Residential mortgage loans 30,296 20,957 Mortgage loans $ 62,158 $ 47,569 We primarily invest in commercial mortgage loans on income producing properties, including office and retail buildings, apartments, hotels, and industrial properties. We diversify the commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. We evaluate mortgage loans based on relevant current information to confirm if properties are performing at a consistent and acceptable level to secure the related debt. The distribution of commercial mortgage loans, including those under development, by property type and geographic region, is as follows: September 30, 2024 December 31, 2023 (In millions, except percentages) Fair Value Percentage of Total Fair Value Percentage of Total Property type Apartment $ 11,556 36.3 % $ 9,591 36.0 % Office building 4,140 13.0 % 4,455 16.7 % Industrial 6,144 19.3 % 4,143 15.6 % Hotels 2,941 9.2 % 2,913 11.0 % Retail 2,447 7.7 % 2,158 8.1 % Other commercial 4,634 14.5 % 3,352 12.6 % Total commercial mortgage loans $ 31,862 100.0 % $ 26,612 100.0 % US region East North Central $ 1,494 4.7 % $ 1,517 5.7 % East South Central 443 1.3 % 523 2.0 % Middle Atlantic 8,497 26.7 % 7,147 26.9 % Mountain 1,335 4.2 % 1,196 4.5 % New England 1,126 3.5 % 1,295 4.9 % Pacific 5,788 18.2 % 4,860 18.3 % South Atlantic 5,504 17.3 % 4,583 17.2 % West North Central 228 0.7 % 249 0.9 % West South Central 1,965 6.2 % 1,228 4.6 % Total US region 26,380 82.8 % 22,598 85.0 % International region United Kingdom 2,638 8.3 % 2,343 8.7 % Other international 1 2,844 8.9 % 1,671 6.3 % Total international region 5,482 17.2 % 4,014 15.0 % Total commercial mortgage loans $ 31,862 100.0 % $ 26,612 100.0 % 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Our residential mortgage loan portfolio primarily consists of first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table: September 30, 2024 December 31, 2023 US States California 26.2 % 27.6 % Florida 12.6 % 12.0 % Texas 7.0 % 6.1 % New York 5.1 % 5.9 % Other 1 40.2 % 39.4 % Total US residential mortgage loan percentage 91.1 % 91.0 % International United Kingdom 5.1 % 4.0 % Other 1 3.8 % 5.0 % Total international residential mortgage loan percentage 8.9 % 9.0 % Total residential mortgage loan percentage 100.0 % 100.0 % 1 Represents all other states or countries, with each individual state or country comprising less than 5% of the portfolio. Investment Funds — Our investment fund portfolio strategy primarily focuses on core holdings of strategic origination and retirement services platforms, equity and credit funds, and other funds. Strategic origination platforms include investments sourced by affiliated platforms that originate loans to third parties and in which we gain exposure directly to the loan or indirectly through our ownership of the origination platform and/or securitizations of assets originated by the origination platform. Retirement services platforms include investments in equity of financial services companies. Our credit strategy comprises direct origination, asset-backed, multi credit and opportunistic credit funds focused on generating returns through high-quality credit underwriting and origination. Our equity strategy comprises private equity, hybrid value, secondaries equity, real estate equity, impact investing platform, infrastructure and clean transition equity funds that raise capital from investors to pursue control-oriented investments across the universe of private assets. Our investment funds can meet the definition of a VIE, which are discussed further in Note 4 – Variable Interest Entities . Our investment funds do not specify timing of distributions on the funds’ underlying assets. The following summarizes our investment funds, including related parties and consolidated VIEs: September 30, 2024 December 31, 2023 1 (In millions, except percentages) Carrying value Percent of total Carrying value Percent of total Investment funds Equity $ 107 0.6 % $ 109 0.6 % Investment funds – related parties Strategic origination platforms 28 0.2 % 32 0.2 % Retirement services platforms 1,287 6.8 % 1,300 7.3 % Equity 264 1.4 % 267 1.5 % Credit 16 0.1 % 20 0.1 % Other 9 0.0 % 13 0.1 % Total investment funds – related parties 1,604 8.5 % 1,632 9.2 % Investment funds – consolidated VIEs Strategic origination platforms 5,519 29.3 % 4,987 28.2 % Retirement services platforms — — % 483 2.7 % Equity 7,837 41.6 % 7,032 39.8 % Credit 3,077 16.3 % 2,852 16.2 % Other 702 3.7 % 573 3.3 % Total investment funds – consolidated VIEs 17,135 90.9 % 15,927 90.2 % Total investment funds, including related parties and funds owned by consolidated VIEs $ 18,846 100.0 % $ 17,668 100.0 % 1 Prior period amounts have been reclassified to conform with the current year presentation as a result of aligning our investment fund categories to reflect our updated investment strategies. Non-Consolidated Securities and Investment Funds Fixed maturity securities – We invest in securitization entities as a debt holder or an investor in the residual interest of the securitization vehicle. These entities are deemed VIEs due to insufficient equity within the structure and lack of control by the equity investors over the activities that significantly impact the economics of the entity. In general, we are a debt investor within these entities and, as such, hold a variable interest; however, due to the debt holders’ lack of ability to control the decisions within the trust that significantly impact the entity, and the fact the debt holders are protected from losses due to the subordination of the equity tranche, the debt holders are not deemed the primary beneficiary. Securitization vehicles in which we hold the residual tranche are not consolidated because we do not unilaterally have substantive rights to remove the general partner, or when assessing related party interests, we are not under common control, as defined by US GAAP, with the related parties, nor are substantially all of the activities conducted on our behalf; therefore, we are not deemed the primary beneficiary. Debt investments and investments in the residual tranche of securitization entities are considered debt instruments and are held at fair value and classified as AFS or trading securities on the condensed consolidated balance sheets. Investment funds – Investment funds include non-fixed income, alternative investments in the form of limited partnerships or similar legal structures. Equity securities – We invest in preferred equity securities issued by entities deemed to be VIEs due to insufficient equity within the structure. Our risk of loss associated with our non-consolidated investments depends on the investment. Investment funds, equity securities and trading securities are limited to the carrying value plus unfunded commitments. AFS securities are limited to amortized cost plus unfunded commitments. The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: September 30, 2024 December 31, 2023 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 107 $ 862 $ 109 $ 876 Investment in related parties – investment funds 1,604 2,659 1,632 2,377 Assets of consolidated VIEs – investment funds 17,135 23,698 15,927 22,240 Investment in fixed maturity securities 67,990 69,290 48,155 50,623 Investment in related parties – fixed maturity securities 16,902 20,764 13,495 15,608 Investment in related parties – equity securities 257 257 318 318 Total non-consolidated investments $ 103,995 $ 117,530 $ 79,636 $ 92,042 Concentrations —The following table represents our investment concentrations in excess of 10% of AHL stockholders’ equity: (In millions) September 30, 2024 AP Grange Holdings, LLC $ 4,626 Atlas 1 3,240 Fox Hedge L.P. 3,050 December 31, 2023 Wheels 1 $ 1,591 AT&T Inc. 1,526 1 Related party amounts are representative of single issuer risk and may only include a portion of the total investments associated with a related party. See further discussion of these related parties in Note 11 – Related Parties.

Derivative Instruments

Derivative Instruments	9 Months Ended
Derivative Instruments	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	3. Derivative Instruments We use a variety of derivative instruments to manage risks, primarily equity, interest rate, credit, foreign currency and market volatility. See Note 5 – Fair Value for information about the fair value hierarchy for derivatives. The following table presents the notional amount and fair value of derivative instruments: September 30, 2024 December 31, 2023 Notional Amount Fair Value Notional Amount Fair Value (In millions) Assets Liabilities Assets Liabilities Derivatives designated as hedges Foreign currency hedges Swaps 15,119 $ 503 $ 345 9,034 $ 477 $ 230 Forwards 3,691 195 36 6,294 275 102 Interest rate swaps 4,506 56 418 4,468 — 521 Forwards on net investments 218 — 3 219 — 6 Interest rate swaps 21,079 131 40 10,031 29 95 Total derivatives designated as hedges 885 842 781 954 Derivatives not designated as hedges Equity options 82,762 5,820 127 73,881 3,809 102 Futures 44 119 — 35 72 — Foreign currency swaps 13,706 223 354 8,072 230 244 Interest rate swaps 1,870 76 1 3,499 81 9 Other swaps 2,591 12 1 2,588 39 1 Foreign currency forwards 40,174 394 1,433 28,236 286 685 Embedded derivatives Funds withheld including related parties (3,111) 80 (4,100) (64) Interest sensitive contract liabilities — 11,996 — 9,059 Total derivatives not designated as hedges 3,533 13,992 417 10,036 Total derivatives $ 4,418 $ 14,834 $ 1,198 $ 10,990 Derivatives Designated as Hedges Cash Flow Hedges – We use interest rate swaps to convert floating-rate interest payments to fixed-rate interest payments to reduce exposure to interest rate changes. The interest rate swaps will expire by July 2031. During the three months ended September 30, 2024 and 2023, we recognized gains of $152 million and $91 million, respectively, in other comprehensive income (OCI) associated with these hedges. During the nine months ended September 30, 2024 and 2023, we recognized gains of $149 million and losses of $35 million, respectively, in OCI associated with these hedges. There were no amounts deemed ineffective during the three and nine months ended September 30, 2024 and 2023. As of September 30, 2024, no amounts were expected to be reclassified to income within the next 12 months. Fair Value Hedges – We use foreign currency forward contracts, foreign currency swaps, foreign currency interest rate swaps and interest rate swaps that are designated and accounted for as fair value hedges to hedge certain exposures to foreign currency risk and interest rate risk. The foreign currency forward price is agreed upon at the time of the contract and payment is made at a specified future date. The following represents the carrying amount and the cumulative fair value hedging adjustments included in the hedged assets or liabilities: September 30, 2024 December 31, 2023 (In millions) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) AFS securities Foreign currency forwards $ 3,851 $ (13) $ 4,883 $ (15) Foreign currency swaps 11,588 71 6,820 (141) Interest sensitive contract liabilities Foreign currency swaps 2,507 (44) 1,438 19 Foreign currency interest rate swaps 4,220 205 4,010 363 Interest rate swaps 17,483 (121) 6,910 189 1 The carrying amount disclosed for AFS securities is amortized cost. The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships: Amounts excluded (In millions) Derivatives Hedged items Net Recognized in income through amortization approach Recognized in income through changes in fair value Three months ended September 30, 2024 Investment related gains (losses) Foreign currency forwards $ (180) $ 184 $ 4 $ 4 $ 8 Foreign currency swaps (313) 282 (31) — — Foreign currency interest rate swaps 255 (258) (3) — — Interest rate swaps 382 (386) (4) — — Interest sensitive contract benefits Foreign currency interest rate swaps 26 (25) 1 — — Three months ended September 30, 2023 Investment related gains (losses) Foreign currency forwards $ 179 $ (187) $ (8) $ 21 $ 5 Foreign currency swaps 161 (166) (5) — — Foreign currency interest rate swaps (90) 95 5 — — Interest rate swaps (74) 63 (11) — — Interest sensitive contract benefits Foreign currency interest rate swaps 16 (14) 2 — — Amounts excluded (In millions) Derivatives Hedged items Net Recognized in income through amortization approach Recognized in income through changes in fair value Nine months ended September 30, 2024 Investment related gains (losses) Foreign currency forwards $ (1) $ 1 $ — $ 35 $ 14 Foreign currency swaps (158) 144 (14) — — Foreign currency interest rate swaps 132 (135) (3) — — Interest rate swaps 267 (310) (43) — — Interest sensitive contract benefits Foreign currency interest rate swaps 66 (64) 2 — — Nine months ended September 30, 2023 Investment related gains (losses) Foreign currency forwards $ 74 $ (77) $ (3) $ 66 $ 12 Foreign currency swaps 59 (57) 2 — — Foreign currency interest rate swaps (5) 15 10 — — Interest rate swaps (92) 79 (13) — — Interest sensitive contract benefits Foreign currency interest rate swaps 44 (44) — — — The following is a summary of the gains (losses) excluded from the assessment of hedge effectiveness that were recognized in OCI : Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Foreign currency forwards $ 13 $ (65) $ (2) $ (63) Foreign currency swaps 56 (239) 82 (182) Net Investment Hedges – We use foreign currency forwards to hedge the foreign currency exchange rate risk of our investments in subsidiaries that have a reporting currency other than the US dollar. We assess hedge effectiveness based on the changes in forward rates. During the three months ended September 30, 2024 and 2023, these derivatives had losses of $14 million and gains of $13 million, respectively. During the nine months ended September 30, 2024 and 2023 , these derivatives had losses of $11 million and gains of $5 million, respectively. These derivatives are included in foreign currency translation and other adjustments on the condensed consolidated statements of comprehensive income (loss). As of September 30, 2024 and December 31, 2023, the cumulative foreign currency translations recorded in AOCI related to these net investment hedges were gains of $15 million and $26 million, respectively. During the three and nine months ended September 30, 2024 and 2023 , there were no amounts deemed ineffective. Derivatives Not Designated as Hedges Equity options – We use equity indexed options to economically hedge fixed indexed annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index, primarily the S&P 500. To hedge against adverse changes in equity indices, we enter into contracts to buy equity indexed options. The contracts are net settled in cash based on differentials in the indices at the time of exercise and the strike price. Futures – Futures contracts are purchased to hedge the growth in interest credited to the customer as a direct result of increases in the related indices. We enter into exchange-traded futures with regulated futures commission clearing brokers who are members of a trading exchange. Under exchange-traded futures contracts, we agree to purchase a specified number of contracts with other parties and to post variation margin on a daily basis in an amount equal to the difference in the daily fair values of those contracts. Interest rate swaps – We use interest rate swaps to reduce market risks from interest rate changes and to alter interest rate exposure arising from duration mismatches between assets and liabilities. With an interest rate swap, we agree with another party to exchange the difference between fixed-rate and floating-rate interest amounts tied to an agreed-upon notional principal amount at specified intervals. Other swaps – Other swaps include total return swaps, credit default swaps and swaptions. We purchase total rate of return swaps to gain exposure and benefit from a reference asset or index without ownership. Credit default swaps provide a measure of protection against the default of an issuer or allow us to gain credit exposure to an issuer or traded index. We use credit default swaps coupled with a bond to synthetically create the characteristics of a reference bond. Swaptions provide an option to enter into an interest rate swap and are used to hedge against interest rate exposure. Embedded derivatives – We have embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Host contracts include reinsurance agreements structured on a modco or funds withheld basis and indexed annuity products. The following is a summary of the gains (losses) related to derivatives not designated as hedges: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Equity options $ 596 $ (951) $ 2,298 $ 390 Futures 26 (73) 152 22 Swaps (126) (24) (156) 38 Foreign currency forwards 209 146 (657) (191) Embedded derivatives on funds withheld 747 (780) 560 (439) Amounts recognized in investment related gains (losses) 1,452 (1,682) 2,197 (180) Embedded derivatives in indexed annuity products 1 (275) 1,251 (1,270) (277) Total gains (losses) on derivatives not designated as hedges $ 1,177 $ (431) $ 927 $ (457) 1 Included in interest sensitive contract benefits on the condensed consolidated statements of income. Credit Risk —We may be exposed to credit-related losses in the event of counterparty nonperformance on derivative financial instruments. Generally, the current credit exposure of our derivative contracts is the fair value at the reporting date less any collateral received from the counterparty. We manage credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties. Where possible, we maintain collateral arrangements and use master netting agreements that provide for a single net payment from one counterparty to another at each due date and upon termination. We have also established counterparty exposure limits, where possible, in order to evaluate if there is sufficient collateral to support the net exposure. Collateral arrangements typically require the posting of collateral in connection with its derivative instruments. Collateral agreements often contain posting thresholds, some of which may vary depending on the posting party’s financial strength ratings. Additionally, a decrease in our financial strength rating to a specified level can result in settlement of the derivative position. The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the condensed consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral September 30, 2024 Derivative assets $ 7,529 $ (1,739) $ (5,272) $ 518 $ — $ 518 Derivative liabilities (2,758) 1,739 1,091 72 1 73 December 31, 2023 Derivative assets $ 5,298 $ (1,497) $ (3,676) $ 125 $ — $ 125 Derivative liabilities (1,995) 1,497 848 350 — 350 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of September 30, 2024 and December 31, 2023, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.

Variable Interest Entities

Variable Interest Entities	9 Months Ended
Variable Interest Entities	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	4. Variable Interest Entities We determined that we are required to consolidate certain Apollo-managed investment funds and other Apollo-managed structures. Since the criteria for the primary beneficiary are satisfied by our related party group, we are deemed the primary beneficiary. In addition, we consolidate certain securitization entities where we are deemed the primary beneficiary. No arrangement exists requiring us to provide additional funding in excess of our committed capital investment, liquidity, or the funding of losses or an increase to our loss exposure in excess of our investment in any of the consolidated VIEs. The following summarizes the income statement activity of the consolidated VIEs: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 39 $ 28 $ 104 $ 79 Mortgage loans 30 29 91 83 Investment funds 22 20 43 55 Other (14) (2) (28) (7) Net investment income $ 77 $ 75 $ 210 $ 210 Net recognized investment gains (losses) on trading securities $ 29 $ (16) $ 21 $ (15) Net recognized investment gains (losses) on mortgage loans 24 (25) (4) (45) Net recognized investment gains on investment funds 414 292 1,099 833 Other gains (losses) 2 (1) (7) (29) Investment related gains (losses) $ 469 $ 250 $ 1,109 $ 744

Fair Value

Fair Value	9 Months Ended
Fair Value	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value	5. Fair Value Fair value is the price we would receive to sell an asset or pay to transfer a liability (exit price) in an orderly transaction between market participants. We determine fair value based on the following fair value hierarchy: Level 1 – Unadjusted quoted prices for identical assets or liabilities in an active market. Level 2 – Quoted prices for inactive markets or valuation techniques that require observable direct or indirect inputs for substantially the full term of the asset or liability. Level 2 inputs include the following: • Quoted prices for similar assets or liabilities in active markets, • Observable inputs other than quoted market prices, and • Observable inputs derived principally from market data through correlation or other means. Level 3 – Prices or valuation techniques with unobservable inputs significant to the overall fair value estimate. These valuations use critical assumptions not readily available to market participants. Level 3 valuations are based on market standard valuation methodologies, including discounted cash flows, matrix pricing or other similar techniques. Net Asset Value (NAV) – Investment funds are typically measured using NAV as a practical expedient in determining fair value and are not classified in the fair value hierarchy. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the investment fund financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the investment funds may have significant unobservable inputs, which may include but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the instrument’s fair value measurement. We use a number of valuation sources to determine fair values. Valuation sources can include quoted market prices; third-party commercial pricing services; third-party brokers; industry-standard, vendor modeling software that uses market observable inputs; and other internal modeling techniques based on projected cash flows. We periodically review the assumptions and inputs of third-party commercial pricing services through internal valuation price variance reviews, comparisons to internal pricing models, back testing to recent trades, or monitoring trading volumes. The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis: September 30, 2024 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 6,761 $ — $ 6,759 $ 2 $ — US state, municipal and political subdivisions 977 — — 977 — Foreign governments 1,758 — 756 967 35 Corporate 87,610 — 12 83,423 4,175 CLO 27,610 — — 27,610 — ABS 22,470 — — 6,855 15,615 CMBS 9,364 — — 9,347 17 RMBS 8,135 — — 7,792 343 Total AFS securities 164,685 — 7,527 136,973 20,185 Trading securities 1,684 — 24 1,623 37 Equity securities 1,292 — 207 1,059 26 Mortgage loans 58,587 — — — 58,587 Funds withheld at interest – embedded derivative (2,581) — — — (2,581) Derivative assets 7,529 — 143 7,385 1 Short-term investments 409 — 202 39 168 Other investments 1,507 — — 603 904 Cash and cash equivalents 13,587 — 13,587 — — Restricted cash 964 — 964 — — Investments in related parties AFS securities Corporate 1,614 — — 233 1,381 CLO 5,780 — — 5,215 565 ABS 10,503 — — 694 9,809 Total AFS securities – related parties 17,897 — — 6,142 11,755 Trading securities 619 — — — 619 Equity securities 257 — — — 257 Mortgage loans 1,345 — — — 1,345 Investment funds 1,106 — — — 1,106 Funds withheld at interest – embedded derivative (530) — — — (530) Other investments 348 — — — 348 Reinsurance recoverable 1,710 — — — 1,710 Other assets 313 — — — 313 Assets of consolidated VIEs Trading securities 2,379 — — 441 1,938 Mortgage loans 2,226 — — — 2,226 Investment funds 17,135 16,317 — — 818 Other investments 159 — 5 — 154 Cash and cash equivalents 305 — 305 — — Total assets measured at fair value $ 292,932 $ 16,317 $ 22,964 $ 154,265 $ 99,386 Liabilities Interest sensitive contract liabilities Embedded derivative $ 11,996 $ — $ — $ — $ 11,996 Universal life benefits 820 — — — 820 Future policy benefits AmerUs Life Insurance Company (AmerUs) Closed Block 1,166 — — — 1,166 Indianapolis Life Insurance Company (ILICO) Closed Block and life benefits 545 — — — 545 Market risk benefits 4,402 — — — 4,402 Derivative liabilities 2,758 — 1 2,756 1 Other liabilities 337 — — — 337 Total liabilities measured at fair value $ 22,024 $ — $ 1 $ 2,756 $ 19,267 December 31, 2023 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 5,399 $ — $ 5,392 $ 7 $ — US state, municipal and political subdivisions 1,046 — — 1,046 — Foreign governments 1,899 — 895 964 40 Corporate 78,246 — 10 75,711 2,525 CLO 20,207 — — 20,207 — ABS 13,383 — — 6,440 6,943 CMBS 6,591 — — 6,570 21 RMBS 7,567 — — 7,302 265 Total AFS securities 134,338 — 6,297 118,247 9,794 Trading securities 1,706 — 24 1,654 28 Equity securities 935 — 210 699 26 Mortgage loans 44,115 — — — 44,115 Funds withheld at interest – embedded derivative (3,379) — — — (3,379) Derivative assets 5,298 — 108 5,190 — Short-term investments 341 — — 236 105 Other investments 943 — — 313 630 Cash and cash equivalents 13,020 — 13,020 — — Restricted cash 1,761 — 1,761 — — Investments in related parties AFS securities Corporate 1,352 — — 181 1,171 CLO 4,268 — — 3,762 506 ABS 8,389 — — 563 7,826 Total AFS securities – related parties 14,009 — — 4,506 9,503 Trading securities 838 — — — 838 Equity securities 318 — 63 — 255 Mortgage loans 1,281 — — — 1,281 Investment funds 1,082 — — — 1,082 Funds withheld at interest – embedded derivative (721) — — — (721) Other investments 343 — — — 343 Reinsurance recoverable 1,367 — — — 1,367 Other assets 378 — — — 378 Assets of consolidated VIEs Trading securities 2,136 — — 284 1,852 Mortgage loans 2,173 — — — 2,173 Investment funds 15,927 14,950 — — 977 Other investments 103 — — 2 101 Cash and cash equivalents 98 — 98 — — Total assets measured at fair value $ 238,410 $ 14,950 $ 21,581 $ 131,131 $ 70,748 Liabilities Interest sensitive contract liabilities Embedded derivative $ 9,059 $ — $ — $ — $ 9,059 Universal life benefits 834 — — — 834 Future policy benefits AmerUs Closed Block 1,178 — — — 1,178 ILICO Closed Block and life benefits 522 — — — 522 Market risk benefits 3,751 — — — 3,751 Derivative liabilities 1,995 — 17 1,977 1 Other liabilities 266 — — (64) 330 Total liabilities measured at fair value $ 17,605 $ — $ 17 $ 1,913 $ 15,675 Fair Value Valuation Methods —We used the following valuation methods and assumptions to estimate fair value: AFS and trading securities – We obtain the fair value for most marketable securities without an active market from several commercial pricing services. These are classified as Level 2 assets. The pricing services incorporate a variety of market observable information in their valuation techniques, including benchmark yields, trading activity, credit quality, issuer spreads, bids, offers and other reference data. This category typically includes US and non-US corporate bonds, US agency and government guaranteed securities, CLO, ABS, CMBS and RMBS. We also have fixed maturity securities priced based on indicative broker quotes or by employing market accepted valuation models. For certain fixed maturity securities, the valuation model uses significant unobservable inputs and these are included in Level 3 in our fair value hierarchy. Significant unobservable inputs used include: discount rates, issue-specific credit adjustments, material non-public financial information, estimation of future earnings and cash flows, default rate assumptions, liquidity assumptions and indicative quotes from market makers. These inputs are usually considered unobservable, as not all market participants have access to this data. We value privately placed fixed maturity securities based on the credit quality and duration of comparable marketable securities, which may be securities of another issuer with similar characteristics. In some instances, we use a matrix-based pricing model. These models consider the current level of risk-free interest rates, corporate spreads, credit quality of the issuer and cash flow characteristics of the security. We also consider additional factors such as net worth of the borrower, value of collateral, capital structure of the borrower, presence of guarantees and our evaluation of the borrower’s ability to compete in its relevant market. Privately placed fixed maturity securities are classified as Level 2 or 3. Equity securities – Fair values of publicly traded equity securities are based on quoted market prices and classified as Level 1. Other equity securities, typically private equities or equity securities not traded on an exchange, we value based on other sources, such as commercial pricing services or brokers, and are classified as Level 2 or 3. Mortgage loans – We estimate fair value on a monthly basis using discounted cash flow analysis and rates being offered for similar loans to borrowers with similar credit ratings. Loans with similar characteristics are aggregated for purposes of the calculations. The discounted cash flow model uses unobservable inputs, including estimates of discount rates and loan prepayments. Mortgage loans are classified as Level 3. Investment funds – Certain investment funds for which we elected the fair value option are included in Level 3 and are priced based on market accepted valuation models. The valuation models use significant unobservable inputs, which include material non-public financial information, estimation of future distributable earnings and demographic assumptions. These inputs are usually considered unobservable, as not all market participants have access to this data. Other investments – The fair values of other investments are primarily determined using a discounted cash flow model using discount rates for similar investments. Funds withheld at interest embedded derivatives – Funds withheld at interest embedded derivatives represent the right to receive or obligation to pay the total return on the assets supporting the funds withheld at interest or funds withheld liability, respectively, and are analogous to a total return swap with a floating rate leg. The fair value of embedded derivatives on funds withheld and modco agreements is measured as the unrealized gain (loss) on the underlying assets and classified as Level 3. Derivatives – Derivative contracts can be exchange traded or over-the-counter. Exchange-traded derivatives typically fall within Level 1 of the fair value hierarchy depending on trading activity. Over-the-counter derivatives are valued using valuation models or an income approach using third-party broker valuations. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, prepayment rates and correlation of the inputs. We consider and incorporate counterparty credit risk in the valuation process through counterparty credit rating requirements and monitoring of overall exposure. We also evaluate and include our own nonperformance risk in valuing derivatives. The majority of our derivatives trade in liquid markets; therefore, we can verify model inputs and model selection does not involve significant management judgment. These are typically classified within Level 2 of the fair value hierarchy. Cash and cash equivalents, including restricted cash – The carrying amount for cash equals fair value. We estimate the fair value for cash equivalents based on quoted market prices. These assets are classified as Level 1. Other assets and market risk benefits liability – Other assets at fair value consist of market risk benefit assets. See Note 7 – Long-duration Contracts for additional information on market risk benefits valuation methodology and additional fair value disclosures. The estimates are classified as Level 3. Interest sensitive contract liabilities embedded derivatives – Embedded derivatives related to interest sensitive contract liabilities with fixed indexed annuity products are classified as Level 3. The valuations include significant unobservable inputs associated with economic assumptions and actuarial assumptions for policyholder behavior. AmerUs Closed Block – We elected the fair value option for the future policy benefits liability in the AmerUs Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component is the present value of the projected release of required capital and future earnings before income taxes on required capital supporting the AmerUs Closed Block, discounted at a rate which represents a market participant’s required rate of return, less the initial required capital. Unobservable inputs include estimates for these items. The AmerUs Closed Block policyholder liabilities and any corresponding reinsurance recoverable are classified as Level 3. ILICO Closed Block – We elected the fair value option for the ILICO Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component uses the present value of future cash flows which include commissions, administrative expenses, reinsurance premiums and benefits, and an explicit cost of capital. The discount rate includes a margin to reflect the business and nonperformance risk. Unobservable inputs include estimates for these items. The ILICO Closed Block policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3. Universal life liabilities and other life benefits – We elected the fair value option for certain blocks of universal and other life business ceded to Global Atlantic. We use a present value of liability cash flows. Unobservable inputs include estimates of mortality, persistency, expenses, premium payments and a risk margin used in the discount rates that reflect the riskiness of the business. These universal life policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3. Other liabilities – Other liabilities include funds withheld liability embedded derivatives, as described above in funds withheld at interest embedded derivatives, and a ceded modco agreement of certain inforce funding agreement contracts for which we elected the fair value option. We estimate the fair value of the ceded modco agreement by discounting projected cash flows for net settlements and certain periodic and non-periodic payments. Unobservable inputs include estimates for asset portfolio returns and economic inputs used in the discount rate, including risk margin. Depending on the projected cash flows and other assumptions, the contract may be recorded as an asset or liability. The estimate is classified as Level 3. Fair Value Option — The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties and consolidated VIEs: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 131 $ (137) $ 31 $ (105) Mortgage loans 1,186 (984) 868 (909) Investment funds 37 (66) 18 25 Future policy benefits (46) 59 12 64 Other 5 (4) 9 (71) Total gains (losses) $ 1,313 $ (1,132) $ 938 $ (996) Gains and losses on trading securities, mortgage loans, investments of consolidated VIEs, and other are recorded in investment related gains (losses) on the condensed consolidated statements of income . Gains and losses related to investment funds are recorded in net investment income on the condensed consolidated statements of income. We record the change in fair value of future policy benefits to future policy and other policy benefits on the condensed consolidated statements of income. The following summarizes information for fair value option mortgage loans, including related parties and consolidated VIEs: (In millions) September 30, 2024 December 31, 2023 Unpaid principal balance $ 64,404 $ 50,752 Mark to fair value (2,246) (3,183) Fair value $ 62,158 $ 47,569 The following represents our commercial mortgage loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) September 30, 2024 December 31, 2023 Unpaid principal balance of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 507 $ 221 Mark to fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status (191) (74) Fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 316 $ 147 Fair value of commercial mortgage loans 90 days or more past due $ 254 $ 64 Fair value of commercial mortgage loans in non-accrual status 316 147 The following represents our residential mortgage loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) September 30, 2024 December 31, 2023 Unpaid principal balance of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 850 $ 528 Mark to fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status (74) (49) Fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 776 $ 479 Fair value of residential mortgage loans 90 days or more past due 1 $ 776 $ 479 Fair value of residential mortgage loans in non-accrual status 679 355 1 As of September 30, 2024 and December 31, 2023 includes $97 million and $124 million, respectively, of residential mortgage loans that are guaranteed by US government-sponsored agencies. The following is the estimated amount of gains (losses) included in earnings during the period attributable to changes in instrument-specific credit risk on our mortgage loan portfolio: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Mortgage loans $ (19) $ (20) $ (49) $ (31) We estimated the portion of gains and losses attributable to changes in instrument-specific credit risk by identifying commercial mortgage loans with loan-to-value ratios meeting credit quality criteria, and residential mortgage loans with delinquency status meeting credit quality criteria. Level 3 Financial Instruments — The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. Transfers in and out of Level 3 are primarily based on changes in the availability of pricing sources, as described in the valuation methods above. Three months ended September 30, 2024 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 34 $ — $ 1 $ — $ — $ 35 $ — $ — Corporate 8,114 6 80 775 (4,800) 4,175 2 98 ABS 8,420 1 313 2,202 4,679 15,615 — 301 CMBS 20 2 (5) — — 17 — (3) RMBS 261 2 2 78 — 343 — 2 Trading securities 37 1 — (1) — 37 1 — Equity securities 36 (1) — — (9) 26 — — Mortgage loans 52,645 1,096 — 4,846 — 58,587 1,236 — Funds withheld at interest – embedded derivative (3,283) 702 — — — (2,581) — — Derivative assets 1 — — — — 1 — — Short-term investments 80 — — 166 (78) 168 — — Other investments 904 — — — — 904 (1) — Investments in related parties AFS securities Corporate 1,194 (3) 12 (23) 201 1,381 — 9 CLO 521 — 2 42 — 565 — 2 ABS 10,580 28 75 (874) — 9,809 7 73 Trading securities 719 — — (100) — 619 (1) — Equity securities 247 10 — — — 257 10 — Mortgage loans 1,320 39 — (14) — 1,345 (43) — Investment funds 1,066 40 — — — 1,106 40 — Funds withheld at interest – embedded derivative (717) 187 — — — (530) — — Other investments 335 13 — — — 348 13 — Reinsurance recoverable 1,518 99 — 93 — 1,710 — — Assets of consolidated VIEs Trading securities 1,876 82 — 34 (54) 1,938 82 — Mortgage loans 2,120 51 — 55 — 2,226 51 — Investment funds 913 (1) — 338 (432) 818 (1) — Other investments 113 4 — 37 — 154 4 — Total Level 3 assets $ 89,074 $ 2,358 $ 480 $ 7,654 $ (493) $ 99,073 $ 1,400 $ 482 Liabilities Interest sensitive contract liabilities Embedded derivative $ (11,234) $ (275) $ — $ (487) $ — $ (11,996) $ — $ — Universal life benefits (769) (51) — — — (820) — — Future policy benefits AmerUs Closed Block (1,120) (46) — — — (1,166) — — ILICO Closed Block and life benefits (529) (16) — — — (545) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (253) (86) — 2 — (337) — — Total Level 3 liabilities $ (13,906) $ (474) $ — $ (485) $ — $ (14,865) $ — $ — 1 Related to instruments held at end of period. Three months ended September 30, 2023 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 48 $ — $ (2) $ — $ — $ 46 $ — $ (2) Corporate 2,460 (8) (25) (26) (20) 2,381 — (27) ABS 5,305 — 14 (255) (438) 4,626 — 4 CMBS 12 — — — — 12 — — RMBS 6 — — 261 (4) 263 — — Trading securities 38 (1) — (5) — 32 (1) — Equity securities 67 7 — — — 74 7 — Mortgage loans 34,668 (850) — 4,160 — 37,978 (850) — Funds withheld at interest – embedded derivative (4,356) (625) — — — (4,981) — — Short-term investments 30 — (1) 100 — 129 — (1) Other investments 337 (5) — 145 — 477 (5) — Investments in related parties AFS securities Corporate 1,171 1 (10) 24 — 1,186 — (10) CLO 495 — 8 — — 503 — 8 ABS 7,742 (2) (11) 110 — 7,839 (6) (14) Trading securities 867 4 — — — 871 3 — Equity securities 252 (7) — — — 245 (7) — Mortgage loans 1,296 (61) — (1) — 1,234 (61) — Investment funds 1,061 (18) — — — 1,043 (18) — Funds withheld at interest – embedded derivative (1,297) 325 — — — (972) — — Other investments 343 (16) — — — 327 (16) — Reinsurance recoverable 1,436 (135) — — — 1,301 — — Assets of consolidated VIEs Trading securities 1,425 (48) — (45) 526 1,858 (48) — Mortgage loans 2,113 (73) — 2 — 2,042 (73) — Investment funds 1,351 (30) — 81 — 1,402 (30) — Other investments 99 5 — (12) — 92 5 — Total Level 3 assets $ 56,969 $ (1,537) $ (27) $ 4,539 $ 64 $ 60,008 $ (1,100) $ (42) Liabilities Interest sensitive contract liabilities Embedded derivative $ (8,198) $ 1,251 $ — $ (398) $ — $ (7,345) $ — $ — Universal life benefits (854) 115 — — — (739) — — Future policy benefits AmerUs Closed Block (1,159) 59 — — — (1,100) — — ILICO Closed Block and life benefits (571) 20 — — — (551) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (209) (4) — — — (213) — — Total Level 3 liabilities $ (10,992) $ 1,441 $ — $ (398) $ — $ (9,949) $ — $ — 1 Related to instruments held at end of period. Nine months ended September 30, 2024 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 40 $ — $ 1 $ (6) $ — $ 35 $ — $ 1 Corporate 2,525 3 87 2,387 (827) 4,175 — 110 ABS 6,943 (14) 314 8,371 1 15,615 — 298 CMBS 21 1 (5) — — 17 — (3) RMBS 265 5 3 72 (2) 343 — 2 Trading securities 28 1 — (6) 14 37 — — Equity securities 26 (1) — 1 — 26 — — Mortgage loans 44,115 825 — 13,647 — 58,587 965 — Funds withheld at interest – embedded derivative (3,379) 798 — — — (2,581) — — Derivative assets — — — — 1 1 — — Short-term investments 105 — — 142 (79) 168 — — Other investments 630 (6) — 280 — 904 (7) — Investments in related parties AFS securities Corporate 1,171 (2) 33 (22) 201 1,381 — 31 CLO 506 — 17 42 — 565 — 18 ABS 7,826 46 22 1,915 — 9,809 2 20 Trading securities 838 (1) — (218) — 619 (2) — Equity securities 255 2 — — — 257 2 — Mortgage loans 1,281 41 — 23 — 1,345 (41) — Investment funds 1,082 24 — — — 1,106 24 — Funds withheld at interest – embedded derivative (721) 191 — — — (530) — — Other investments 343 5 — — — 348 5 — Reinsurance recoverable 1,367 51 — 292 — 1,710 — — Assets of consolidated VIEs Trading securities 1,852 31 — 103 (48) 1,938 30 — Mortgage loans 2,173 2 — 51 — 2,226 2 — Investment funds 977 (66) — 339 (432) 818 (66) — Other investments 101 — — 53 — 154 1 — Total Level 3 assets $ 70,370 $ 1,936 $ 472 $ 27,466 $ (1,171) $ 99,073 $ 915 $ 477 Liabilities Interest sensitive contract liabilities Embedded derivative $ (9,059) $ (1,270) $ — $ (1,667) $ — $ (11,996) $ — $ — Universal life benefits (834) 14 — — — (820) — — Future policy benefits AmerUs Closed Block (1,178) 12 — — — (1,166) — — ILICO Closed Block and life benefits (522) (23) — — — (545) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (330) (123) — 52 64 (337) — — Total Level 3 liabilities $ (11,924) $ (1,390) $ — $ (1,615) $ 64 $ (14,865) $ — $ — 1 Related to instruments held at end of period. Nine months ended September 30, 2023 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 1 $ — $ (2) $ 47 $ — $ 46 $ — $ (2) Corporate 1,665 (9) (1) 1,170 (444) 2,381 — (7) ABS 4,867 — (36) 794 (999) 4,626 — (49) CMBS — — — — 12 12 — (1) RMBS 232 6 2 258 (235) 263 — — Trading securities 53 2 — (12) (11) 32 — — Equity securities 92 (5) — — (13) 74 (5) — Mortgage loans 27,454 (794) — 11,318 — 37,978 (792) — Funds withheld at interest – embedded derivative (4,847) (134) — — — (4,981) — — Short-term investments 36 — (3) 70 26 129 — (1) Other investments 441 (5) — 41 — 477 (7) — Investments in related parties AFS securities Corporate 812 2 (18) 175 215 1,186 — (18) CLO 303 — 15 185 — 503 — 15 ABS 5,542 7 38 1,968 284 7,839 (2) 32 Trading securities 878 6 — (13) — 871 3 — Equity securities 279 (2) — (32) — 245 (3) — Mortgage loans 1,302 (44) — (24) — 1,234 (44) — Investment funds 959 52 — 32 — 1,043 53 — Funds withheld at interest – embedded derivative (1,425) 453 — — — (972) — — Other investments 303 (18) — 42 — 327 (19) — Reinsurance recoverable 1,388 (87) — — — 1,301 — — Assets of consolidated VIEs Trading securities 622 (40) — (55) 1,331 1,858 (40) — Mortgage loans 2,055 (71) — 58 — 2,042 (71) — Investment funds 2,471 (7) — 73 (1,135) 1,402 (7) — Other investments 99 7 — (14) — 92 7 — Total Level 3 assets $ 45,582 $ (681) $ (5) $ 16,081 $ (969) $ 60,008 $ (927) $ (31) Liabilities Interest sensitive contract liabilities Embedded derivative $ (5,841) $ (277) $ — $ (1,227) $ — $ (7,345) $ — $ — Universal life benefits (829) 90 — — — (739) — — Future policy benefits AmerUs Closed Block (1,164) 64 — — — (1,100) — — ILICO Closed Block and life benefits (548) (3) — — — (551) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (142) (71) — — — (213) — — Total Level 3 liabilities $ (8,525) $ (197) $ — $ (1,227) $ — $ (9,949) $ — $ — 1 Related to instruments held at end of period. The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above: Three months ended September 30, 2024 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Corporate $ 912 $ — $ (16) $ (121) $ 775 $ 68 $ (4,868) $ (4,800) ABS 3,004 — (351) (451) 2,202 4,897 (218) 4,679 RMBS 81 — — (3) 78 — — — Trading securities — — — (1) (1) — — — Equity securities — — — — — — (9) (9) Mortgage loans 7,518 — — (2,672) 4,846 — — — Short-term investments 168 — — (2) 166 — (78) (78) Investments in related parties AFS securities Corporate 45 — (65) (3) (23) 201 — 201 CLO 42 — — — 42 — — — ABS 1,193 — — (2,067) (874) — — — Trading securities — — — (100) (100) — — — Mortgage loans — — — (14) (14) — — — Reinsurance recoverable — 94 — (1) 93 — — — Assets of consolidated VIEs Trading securities 38 — (4) — 34 34 (88) (54) Mortgage loans 70 — — (15) 55 — — — Investment funds 338 — — — 338 — (432) (432) Other investments 37 — — — 37 — — — Total Level 3 assets $ 13,446 $ 94 $ (436) $ (5,450) $ 7,654 $ 5,200 $ (5,693) $ (493) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (750) $ — $ 263 $ (487) $ — $ — $ — Other liabilities — — — 2 2 — — — Total Level 3 liabilities $ — $ (750) $ — $ 265 $ (485) $ — $ — $ — Three months ended September 30, 2023 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Corporate $ 26 $ — $ — $ (52) $ (26) $ — $ (20) $ (20) ABS 221 — (13) (463) (255) 357 (795) (438) RMBS 261 — — — 261 — (4) (4) Trading securities — — — (5) (5) — — — Mortgage loans 5,696 — (285) (1,251) 4,160 — — — Short-term investments 100 — — — 100 — — — Other investments 145 — — — 145 — — — Investments in related parties AFS securities Corporate 27 — — (3) 24 — — — ABS 426 — — (316) 110 — — — Trading securities 1 — (1) — — — — — Mortgage loans — — — (1) (1) — — — Assets of consolidated VIEs Trading securities 6 — (51) — (45) 526 — 526 Mortgage loans 4 — — (2) 2 — — — Investment funds 113 — (32) — 81 — — — Other investments 2 — (14) — (12) — — — Total Level 3 assets $ 7,028 $ — $ (396) $ (2,093) $ 4,539 $ 883 $ (819) $ 64 Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (573) $ — $ 175 $ (398) $ — $ — $ — Total Level 3 liabilities $ — $ (573) $ — $ 175 $ (398) $ — $ — $ — Nine months ended September 30, 2024 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Foreign governments $ — $ — $ — $ (6) $ (6) $ — $ — $ — Corporate 2,623 — (18) (218) 2,387 166 (993) (827) ABS 9,635 — (423) (841) 8,371 748 (747) 1 RMBS 81 — — (9) 72 — (2) (2) Trading securities — — — (6) (6) 14 — 14 Equity securities 2 — (1) — 1 9 (9) — Mortgage loans 19,226 — (26) (5,553) 13,647 — — — Derivative assets — — — — — 1 — 1 Short-term investments 171 — (6) (23) 142 — (79) (79) Other investments 280 — — — 280 — — — Investments in related parties AFS securities Corporate 51 — (66) (7) (22) 201 — 201 CLO 42 — — — 42 — — — ABS 5,780 — (504) (3,361) 1,915 — — — Trading securities 4 — — (222) (218) — — — Mortgage loans 87 — — (64) 23 — — — Reinsurance recoverable — 294 — (2) 292 — — — Assets of consolidated VIEs Trading securities 201 — (91) (7) 103 40 (88) (48) Mortgage loans 125 — — (74) 51 — — — Investment funds 339 — — — 339 — (432) (432) Other investments 56 — (3) — 53 — — — Total Level 3 assets $ 38,703 $ 294 $ (1,138) $ (10,393) $ 27,466 $ 1,179 $ (2,350) $ (1,171) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (2,408) $ — $ 741 $ (1,667) $ — $ — $ — Other liabilities — — — 52 52 64 — 64 Total Level 3 liabilities $ — $ (2,408) $ — $ 793 $ (1,615) $ 64 $ — $ 64 Nine months ended September 30, 2023 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Foreign governments $ 53 $ — $ — $ (6) $ 47 $ — $ — $ — Corporate 1,338 — — (168) 1,170 29 (473) (444) ABS 1,552 — (33) (725) 794 695 (1,694) (999) CMBS — — — — — 12 — 12 RMBS 262 — — (4) 258 5 (240) (235) Trading securities 8 — — (20) (12) 5 (16) (11) Equity securities — — — — — — (13) (13) Mortgage loans 14,361 — (348) (2,695) 11,318 — — — Short-term investments 100 — — (30) 70 26 — 26 Other investments 472 — — (431) 41 — — — Investments in related parties AFS securities Co

Deferred Acquisition Costs, Def

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired	6. Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 7 – Long-duration Contracts for more information on our products. Nine months ended September 30, 2024 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2023 $ 890 $ 1,517 $ 10 $ 11 $ 970 $ 2,581 $ 5,979 Additions 404 751 36 — 479 — 1,670 Amortization (176) (131) (8) (1) (88) (274) (678) Balance at September 30, 2024 $ 1,118 $ 2,137 $ 38 $ 10 $ 1,361 $ 2,307 $ 6,971 Nine months ended September 30, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 426 609 2 3 447 — 1,487 Amortization (74) (69) (3) (1) (40) (315) (502) Other — — — — — (3) (3) Balance at September 30, 2023 $ 656 $ 1,295 $ 10 $ 11 $ 806 $ 2,670 $ 5,448 Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds, including traditional deferred annuities and indexed annuities, are amortized on a constant-level basis for a cohort of contracts using initial premium or deposit. Significant inputs and assumptions are required for determining the expected duration of the cohort and involves using accepted actuarial methods to determine decrement rates related to policyholder behavior for lapses, withdrawals (surrenders) and mortality. The assumptions used to determine the amortization of DAC and DSI are consistent with those used to estimate the related liability balance. Deferred costs related to investment contracts without significant revenue streams from sources other than investment of policyholder funds are amortized using the effective interest method, which primarily includes funding agreements. The effective interest method requires inputs to project future cash flows, which for funding agreements includes contractual terms of notional value, periodic interest payments based on either fixed or floating interest rates, and duration. For other investment-type contracts which include immediate annuities and assumed endowments without significant mortality risks, assumptions are required related to policyholder behavior for lapses and withdrawals (surrenders).

Long-duration Contracts

Long-duration Contracts	9 Months Ended
Long-duration Contracts	Sep. 30, 2024
Insurance [Abstract]
Long-duration Contracts	7. Long-duration Contracts Interest sensitive contract liabilities – Interest sensitive contract liabilities primarily include: ▪ traditional deferred annuities, ▪ indexed annuities consisting of fixed indexed and index-linked variable annuities, ▪ funding agreements, and ▪ other investment-type contracts comprising of immediate annuities without significant mortality risk (which includes pension group annuities without life contingencies) and assumed endowments without significant mortality risks. The following represents a rollforward of the policyholder account balance by product within interest sensitive contract liabilities. Where explicit policyholder account balances do not exist, the disaggregated rollforward represents the recorded reserve. Nine months ended September 30, 2024 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at December 31, 2023 $ 64,763 $ 93,147 $ 32,350 $ 7,629 $ 197,889 Deposits 19,786 12,761 24,083 933 57,563 Policy charges (2) (522) — — (524) Surrenders and withdrawals (3,691) (9,724) — (63) (13,478) Benefit payments (830) (1,204) (7,746) (173) (9,953) Interest credited 2,323 2,313 1,173 152 5,961 Foreign exchange (1) 1 116 (56) 60 Other — — 421 (74) 347 Balance at September 30, 2024 $ 82,348 $ 96,772 $ 50,397 $ 8,348 $ 237,865 Weighted average crediting rate 4.3 % 2.6 % 4.5 % 2.6 % Net amount at risk $ 427 $ 15,221 $ — $ 65 Cash surrender value 78,049 89,378 — 7,112 Nine months ended September 30, 2023 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at December 31, 2022 $ 43,518 $ 92,660 $ 27,439 $ 4,722 $ 168,339 Deposits 18,011 8,960 4,893 3,760 35,624 Policy charges (2) (481) — — (483) Surrenders and withdrawals (8,207) (8,292) (110) (25) (16,634) Benefit payments (738) (1,216) (2,264) (223) (4,441) Interest credited 1,284 802 628 110 2,824 Foreign exchange (77) (1) (26) (344) (448) Other 1 63 77 (46) (1,419) (1,325) Balance at September 30, 2023 $ 53,852 $ 92,509 $ 30,514 $ 6,581 $ 183,456 Weighted average crediting rate 3.7 % 2.3 % 3.1 % 2.7 % Net amount at risk $ 425 $ 14,438 $ — $ 104 Cash surrender value 50,352 84,052 — 5,335 1 Other includes $1,371 million reduction of reserves related to the Venerable Insurance and Annuity Company (VIAC) recapture agreement. See Note 11 – Related Parties for further information. The following is a reconciliation of interest sensitive contract liabilities to the condensed consolidated balance sheets: September 30, (In millions) 2024 2023 Traditional deferred annuities $ 82,348 $ 53,852 Indexed annuities 96,772 92,509 Funding agreements 50,397 30,514 Other investment-type 8,348 6,581 Reconciling items 1 7,571 5,609 Interest sensitive contract liabilities $ 245,436 $ 189,065 1 Reconciling items primarily include embedded derivatives in indexed annuities, unaccreted host contract adjustments on indexed annuities, negative VOBA, sales inducement liabilities, and wholly ceded universal life insurance contracts. The following represents policyholder account balances by range of guaranteed minimum crediting rates, as well as the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums: September 30, 2024 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 28,488 $ 15,531 $ 126,352 $ 170,371 2.0% – < 4.0% 23,576 1,787 1,927 27,290 4.0% – < 6.0% 28,764 75 1 28,840 6.0% and greater 11,364 — — 11,364 Total $ 92,192 $ 17,393 $ 128,280 $ 237,865 September 30, 2023 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 28,564 $ 19,709 $ 90,121 $ 138,394 2.0% – < 4.0% 28,838 1,128 541 30,507 4.0% – < 6.0% 11,433 9 1 11,443 6.0% and greater 3,112 — — 3,112 Total $ 71,947 $ 20,846 $ 90,663 $ 183,456 Future policy benefits – Future policy benefits consist primarily of payout annuities, including single premium immediate annuities with life contingencies (which include pension group annuities with life contingencies), and whole life insurance contracts. The following is a rollforward by product within future policy benefits: Nine months ended September 30, 2024 (In millions, except percentages and years) Payout annuities with life contingencies Whole life Total Present value of expected net premiums Beginning balance $ — $ 1,182 $ 1,182 Effect of changes in discount rate assumptions — (45) (45) Effect of foreign exchange on the change in discount rate assumptions — (2) (2) Beginning balance at original discount rate — 1,135 1,135 Effect of actual to expected experience — (4) (4) Adjusted balance — 1,131 1,131 Interest accrual — 17 17 Net premium collected — (144) (144) Foreign exchange — (28) (28) Ending balance at original discount rate — 976 976 Effect of changes in discount rate assumptions — 41 41 Effect of foreign exchange on the change in discount rate assumptions — 1 1 Ending balance $ — $ 1,018 $ 1,018 Present value of expected future policy benefits Beginning balance $ 45,001 $ 3,371 $ 48,372 Effect of changes in discount rate assumptions 6,233 (89) 6,144 Effect of foreign exchange on the change in discount rate assumptions 1 (6) (5) Beginning balance at original discount rate 51,235 3,276 54,511 Effect of changes in cash flow assumptions (104) — (104) Effect of actual to expected experience (89) (4) (93) Adjusted balance 51,042 3,272 54,314 Issuances 1,010 — 1,010 Interest accrual 1,353 52 1,405 Benefit payments (3,355) (66) (3,421) Foreign exchange 33 (64) (31) Ending balance at original discount rate 50,083 3,194 53,277 Effect of changes in discount rate assumptions (5,362) 46 (5,316) Effect of foreign exchange on the change in discount rate assumptions (16) (3) (19) Ending balance $ 44,705 $ 3,237 $ 47,942 Net future policy benefits $ 44,705 $ 2,219 $ 46,924 Weighted-average liability duration (in years) 9.4 31.3 Weighted-average interest accretion rate 3.7 % 4.8 % Weighted-average current discount rate 5.0 % 4.0 % Expected future gross premiums, undiscounted $ — $ 1,255 Expected future gross premiums, discounted 1 — 1,064 Expected future benefit payments, undiscounted 73,523 10,235 1 Discounted at the original discount rate. Nine months ended September 30, 2023 (In millions, except percentages and years) Payout annuities with life contingencies Whole life Total Present value of expected future policy benefits Beginning balance $ 36,422 $ — $ 36,422 Effect of changes in discount rate assumptions 8,425 — 8,425 Effect of foreign exchange on the change in discount rate assumptions (13) — (13) Beginning balance at original discount rate 44,834 — 44,834 Effect of changes in cash flow assumptions (297) — (297) Effect of actual to expected experience (36) — (36) Adjusted balance 44,501 — 44,501 Issuances 9,120 — 9,120 Interest accrual 1,194 — 1,194 Benefit payments (2,731) — (2,731) Foreign exchange 6 — 6 Other 1 (1,509) — (1,509) Ending balance at original discount rate 50,581 — 50,581 Effect of changes in discount rate assumptions (9,753) — (9,753) Effect of foreign exchange on the change in discount rate assumptions 12 — 12 Ending balance $ 40,840 $ — $ 40,840 Net future policy benefits $ 40,840 $ — $ 40,840 Weighted-average liability duration (in years) 9.6 0.0 Weighted-average interest accretion rate 3.6 % — % Weighted-average current discount rate 6.1 % — % Expected future benefit payments, undiscounted $ 73,933 $ — 1 Other includes $1,509 million reduction of reserves related to the VIAC recapture agreement. See Note 11 – Related Parties for further information. The following is a reconciliation of future policy benefits to the condensed consolidated balance sheets: September 30, (In millions) 2024 2023 Payout annuities with life contingencies $ 44,705 $ 40,840 Whole life 2,219 — Reconciling items 1 6,038 5,832 Future policy benefits $ 52,962 $ 46,672 1 Reconciling items primarily include the deferred profit liability and negative VOBA associated with the liability for future policy benefits. Additionally, it includes term life reserves, fully ceded whole life reserves, and reserves for immaterial lines of business including accident and health and disability, as well as other insurance benefit reserves for no-lapse guarantees with universal life contracts, all of which are fully ceded. The following is a reconciliation of premiums and interest expense relating to future policy benefits to the condensed consolidated statements of income: Premiums Interest expense Nine months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Payout annuities with life contingencies $ 985 $ 9,142 $ 1,353 $ 1,194 Whole life 154 — 35 — Reconciling items 1 24 21 — — Total $ 1,163 $ 9,163 $ 1,388 $ 1,194 1 Reconciling items primarily relate to immaterial lines of business including term life, fully ceded whole life, and accident and health and disability. Significant assumptions and inputs to the calculation of future policy benefits for payout annuities with life contingencies include policyholder demographic data, assumptions for policyholder longevity and policyholder utilization for contracts with deferred lives, and discount rates. For whole life products, significant assumptions and inputs include policyholder demographic data, assumptions for mortality, morbidity, and lapse and discount rates. We base certain key assumptions related to policyholder behavior on industry standard data adjusted to align with actual company experience, if necessary. At least annually, we review all significant cash flow assumptions and update as necessary, unless emerging experience indicates a more frequent review is necessary. The discount rate reflects market observable inputs from upper-medium grade fixed income instrument yields and is interpolated, where necessary, to conform to the duration of our liabilities. During the nine months ended September 30, 2024, the present value of expected future policy benefits decreased by $430 million, which was driven by $3,421 million of benefit payments and $104 million of favorable unlocking of assumptions, offset by $1,405 million of interest accruals, $1,010 million of issuances, primarily pension group annuities, and an $832 million change in discount rate assumptions related to a decrease in market observable rates. During the nine months ended September 30, 2023, the present value of expected future policy benefits increased by $4,418 million, which was driven by $9,120 million of issuances, primarily pension group annuities, and $1,194 million of interest accrual, partially offset by $2,731 million of benefit payments, a $1,509 million reduction in reserve related to recapture, a $1,328 million change in discount rate assumptions related to an increase in rates, and $297 million resulting from favorable unlocking of assumptions, primarily related to higher interest rates and favorable mortality experience lowering future benefit payments. The following is a summary of remeasurement gains (losses) included within future policy and other policy benefits on the condensed consolidated statements of income: Nine months ended September 30, (In millions) 2024 2023 Reserves $ 193 $ 333 Deferred profit liability (37) (243) Negative VOBA (52) (54) Total remeasurement gains (losses) $ 104 $ 36 During the nine months ended September 30, 2024 and 2023, we recorded reserve increases of $15 million and $110 million, respectively, on the condensed consolidated statements of income as a result of the present value of benefits and expenses exceeding the present value of gross premiums. Market risk benefits – We issue and reinsure traditional deferred and indexed annuity products that contain guaranteed lifetime withdrawal benefit (GLWB) and guaranteed minimum death benefit (GMDB) riders that meet the criteria to be classified as market risk benefits. The following is a rollfoward of net market risk benefit liabilities by product: Nine months ended September 30, 2024 (In millions, except years) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2023 $ 192 $ 3,181 $ 3,373 Effect of changes in instrument-specific credit risk 2 (10) (8) Balance, beginning of period, before changes in instrument-specific credit risk 194 3,171 3,365 Issuances — 270 270 Interest accrual 8 143 151 Attributed fees collected 1 265 266 Benefit payments (3) (39) (42) Effect of changes in interest rates (2) (34) (36) Effect of changes in equity — (115) (115) Effect of actual policyholder behavior compared to expected behavior 5 64 69 Effect of changes in future expected policyholder behavior (3) 88 85 Effect of changes in other future expected assumptions — (19) (19) Balance, end of period, before changes in instrument-specific credit risk 200 3,794 3,994 Effect of changes in instrument-specific credit risk 1 94 95 Balance at September 30, 2024 201 3,888 4,089 Less: Reinsurance recoverable — (40) (40) Balance at September 30, 2024, net of reinsurance $ 201 $ 3,848 $ 4,049 Net amount at risk $ 427 $ 15,221 Weighted-average attained age of contract holders (in years) 76 69 Nine months ended September 30, 2023 (In millions, except years) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2022 $ 170 $ 2,319 $ 2,489 Effect of changes in instrument-specific credit risk 13 353 366 Balance, beginning of period, before changes in instrument specific credit risk 183 2,672 2,855 Issuances — 47 47 Interest accrual 7 108 115 Attributed fees collected 2 250 252 Benefit payments (1) (24) (25) Effect of changes in interest rates (18) (591) (609) Effect of changes in equity — (26) (26) Effect of actual policyholder behavior compared to expected behavior 4 42 46 Effect of changes in future expected policyholder behavior (3) 78 75 Effect of changes in other future expected assumptions — 6 6 Balance, end of period, before changes in instrument-specific credit risk 174 2,562 2,736 Effect of changes in instrument-specific credit risk (7) (139) (146) Balance at September 30, 2023 $ 167 $ 2,423 $ 2,590 Net amount at risk $ 425 $ 14,438 Weighted-average attained age of contract holders (in years) 75 69 The following is a reconciliation of market risk benefits to the condensed consolidated balance sheets. Market risk benefit assets are included in other assets on the condensed consolidated balance sheets. September 30, 2024 September 30, 2023 (In millions) Asset Liability Net liability Asset Liability Net liability Traditional deferred annuities $ — $ 201 $ 201 $ — $ 167 $ 167 Indexed annuities 313 4,201 3,888 431 2,854 2,423 Total $ 313 $ 4,402 $ 4,089 $ 431 $ 3,021 $ 2,590 During the nine months ended September 30, 2024, net market risk benefit liabilities increased by $716 million, which was primarily driven by $270 million of issuances, $266 million in fees collected from policyholders, and $151 million of interest accrual. During the nine months ended September 30, 2023, net market risk benefit liabilities increased by $101 million, which was primarily driven by $252 million in fees collected from policyholders, a $220 million change in instrument-specific credit risk related to tightening of credit spreads and $115 million of interest accrual, partially offset by a decrease of $609 million related to changes in the risk-free discount rate across the curve. The determination of the fair value of market risk benefits requires the use of inputs related to fees and assessments and assumptions in determining the projected benefits in excess of the projected account balance. Judgment is required for both economic and actuarial assumptions, which can be either observable or unobservable, that impact future policyholder account growth. Economic assumptions include interest rates and implied volatilities throughout the duration of the liability. For indexed annuities, assumptions also include projected equity returns which impact cash flows attributable to indexed strategies, implied equity volatilities, expected index credits on the next policy anniversary date and future equity option costs. Assumptions related to the level of option budgets used for determining the future equity option costs and the impact on future policyholder account value growth are considered unobservable inputs. Policyholder behavior assumptions are unobservable inputs and are established using accepted actuarial valuation methods to estimate withdrawals (surrender rate) and income rider utilization. Assumptions are generally based on industry data and pricing assumptions which are updated for actual experience, if necessary. Actual experience may be limited for recently issued products. All inputs are used to project excess benefits and fees over a range of risk-neutral, stochastic interest rate scenarios. For indexed annuities, stochastic equity return scenarios are also included within the range. A risk margin is incorporated within the discount rate to reflect uncertainty in the projected cash flows such as variations in policyholder behavior, as well as a credit spread to reflect nonperformance risk, which is considered an unobservable input. We use our public credit rating relative to the US Treasury curve as of the valuation date to reflect our nonperformance risk in the fair value estimate of market risk benefits. The following summarizes the unobservable inputs for market risk benefits: September 30, 2024 (In millions, except percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 4,089 Discounted cash flow Nonperformance risk 0.5 % 1.2 % 1.1 % 1 Decrease Option budget 0.5 % 6.0 % 2.2 % 2 Decrease Surrender rate 3.3 % 7.0 % 4.5 % 2 Decrease Utilization rate 28.6 % 95.0 % 84.7 % 3 Increase September 30, 2023 (In millions, except percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 2,590 Discounted cash flow Nonperformance risk 0.6 % 1.6 % 1.4 % 1 Decrease Option budget 0.5 % 5.9 % 1.9 % 2 Decrease Surrender rate 3.4 % 6.5 % 4.6 % 2 Decrease Utilization rate 28.6 % 95.0 % 83.2 % 3 Increase 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. 2 The option budget and surrender rate weighted averages are calculated based on projected account values. 3 The utilization of GLWB withdrawals represents the estimated percentage of policyholders that are expected to use their income rider over the duration of the contract, with the weighted average based on current account values.

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2024
Debt Disclosure [Abstract]
Debt	8. Debt Liquidity Facility —On June 28, 2024, AHL and ALRe entered into a new revolving credit agreement with a syndicate of banks and Wells Fargo Bank, National Association, as administrative agent (Liquidity Facility), which replaced our previous revolving credit agreement dated as of June 30, 2023. The previous credit agreement, and the commitments under it, expired on June 28, 2024. The Liquidity Facility is unsecured and has a commitment termination date of June 27, 2025, subject to any extensions of additional 364-day periods with consent of extending lenders and/or “term-out” of outstanding loans (by which, at our election, the outstanding loans may be converted to term loans which shall have a maturity of up to one year after the original maturity date), in each case in accordance with the terms of the Liquidity Facility. In connection with the Liquidity Facility, ALRe guaranteed all of the obligations of AHL under the Liquidity Facility and the related loan documents. The Liquidity Facility will be used for liquidity and working capital needs to meet short-term cash flow and investment timing differences. The borrowing capacity under the Liquidity Facility is $2.6 billion, subject to being increased up to $3.1 billion in total on the terms described in the Liquidity Facility. The Liquidity Facility contains various standard covenants with which we must comply, including the following: 1. ALRe minimum consolidated net worth of no less than $10.2 billion; and 2. Restrictions on our ability to incur liens, with certain exceptions. Interest accrues on outstanding borrowings at either the adjusted term secured overnight financing rate plus a margin or the base rate plus a margin, with applicable margin varying based on ALRe’s financial strength rating. Rates and terms are as defined in the Liquidity Facility. As of September 30, 2024 and December 31, 2023, we had no amounts outstanding under the current or previous liquidity facilities and were in compliance with all financial covenants under the facilities. Senior Notes —During the first quarter of 2024, we issued $1.0 billion of 6.250% Senior Notes due April 1, 2054 (2054 Senior Notes). We will pay interest on the 2054 Senior Notes semi-annually, commencing on October 1, 2024. Subordinated Notes —During the first quarter of 2024, we issued $575 million of 7.250% Fixed-Rate Reset Junior Subordinated Debentures due March 30, 2064 (2064 Subordinated Notes). We will pay interest at an annual fixed rate of 7.250% on the 2064 Subordinated Notes quarterly, commencing on June 30, 2024 until March 30, 2029. On March 30, 2029, and every fifth annual anniversary thereafter, the interest rate will reset to the Five-Year US Treasury Rate (as defined in the applicable prospectus supplement) plus 2.986%. We may defer interest payments for up to five During the fourth quarter of 2024, we issued $600 million of 6.625% Fixed-Rate Reset Junior Subordinated Debentures due October 15, 2054 (2054 Subordinated Notes). We will pay interest at an annual fixed rate of 6.625% on the 2054 Subordinated Notes semi-annually, commencing on April 15, 2025 until October 15, 2034. On October 15, 2034, and every fifth annual anniversary thereafter, the interest rate will reset to the Five-Year US Treasury Rate (as defined in the applicable prospectus supplement) plus 2.607%. We may defer interest payments for up to five consecutive years. The following is a summary of our debt: Outstanding Balance (In millions, except percentages) Issue Date Maturity Date Principal Balance September 30, 2024 December 31, 2023 4.125% 2028 Senior Notes January 12, 2018 January 12, 2028 $ 1,000 $ 1,054 $ 1,066 6.150% 2030 Senior Notes April 3, 2020 April 3, 2030 500 582 593 3.500% 2031 Senior Notes October 8, 2020 January 15, 2031 500 521 523 6.650% 2033 Senior Notes November 21, 2022 February 1, 2033 400 395 395 5.875% 2034 Senior Notes December 12, 2023 January 15, 2034 600 584 583 3.950% 2051 Senior Notes May 25, 2021 May 25, 2051 500 545 545 3.450% 2052 Senior Notes December 13, 2021 May 15, 2052 500 504 504 6.250% 2054 Senior Notes March 22, 2024 April 1, 2054 1,000 982 — 7.250% 2064 Subordinated Notes March 7, 2024 March 30, 2064 575 558 — Total debt $ 5,575 $ 5,725 $ 4,209

Equity

Equity	9 Months Ended
Equity	Sep. 30, 2024
Equity [Abstract]
Equity	9. Equity Common Dividends — During the three months ended September 30, 2024 , we declared and distributed $499 million of dividends to AGM, which were provided in the form of assets in kind. Additionally, we declared and paid $374 million of common stock cash dividends during the nine months ended September 30, 2024. Acc umulated Other Comprehensive Income (Loss)— The following provides the details and changes in AOCI: (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at June 30, 2024 $ (9,670) $ (277) $ (83) $ 4,218 $ 5 $ (2) $ (5,809) Other comprehensive income (loss) before reclassifications 5,142 (22) 225 (2,263) (93) 36 3,025 Less: Reclassification adjustments for gains (losses) realized in net income 1 (348) (8) 4 — — — (352) Less: Income tax expense (benefit) 1,122 (3) 47 (472) (20) 6 680 Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax 886 7 60 (596) (9) 7 355 Balance at September 30, 2024 $ (6,188) $ (295) $ 31 $ 3,023 $ (59) $ 21 $ (3,467) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at June 30, 2023 $ (11,049) $ (378) $ 26 $ 4,708 $ 312 $ 5 $ (6,376) Other comprehensive income (loss) before reclassifications (3,199) 33 (192) 1,317 (254) (21) (2,316) Less: Reclassification adjustments for gains (losses) realized in net income 1 (11) — 21 — — — 10 Less: Income tax expense (benefit) (654) 6 (46) 273 (52) (3) (476) Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax (577) (3) (26) 471 (8) (4) (147) Balance at September 30, 2023 $ (13,006) $ (348) $ (115) $ 5,281 $ 118 $ (9) $ (8,079) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2023 $ (8,672) $ (289) $ (82) $ 3,458 $ 3 $ 13 $ (5,569) Other comprehensive income (loss) before reclassifications 3,528 (19) 264 (832) (87) 15 2,869 Less: Reclassification adjustments for gains (losses) realized in net income 1 (237) (14) 35 — — — (216) Less: Income tax expense (benefit) 776 (1) 49 (176) (18) 2 632 Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax 505 2 67 (221) (7) 5 351 Balance at September 30, 2024 $ (6,188) $ (295) $ 31 $ 3,023 $ (59) $ 21 $ (3,467) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2022 $ (12,565) $ (334) $ 47 $ 5,256 $ 285 $ (10) $ (7,321) Other comprehensive income (loss) before reclassifications (1,841) (31) (214) 1,328 (220) 6 (972) Less: Reclassification adjustments for gains (losses) realized in net income 1 (105) — 66 — — — (39) Less: Income tax expense (benefit) (828) (12) (68) 777 (46) 2 (175) Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax (467) (5) (50) 526 (7) 3 — Balance at September 30, 2023 $ (13,006) $ (348) $ (115) $ 5,281 $ 118 $ (9) $ (8,079) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The income tax expense was $191 million and $162 million for the three months ended September 30, 2024 and 2023, respectively. Our effective tax rate was 11% and 33% for the three months ended September 30, 2024 and 2023, respectively. The income tax expense was $659 million and $458 million for the nine months ended September 30, 2024 and 2023, respectively. Our effective tax rate was 15% and 18% for the nine months ended September 30, 2024 and 2023, respectively. The UK enacted legislation in July 2023 implementing certain provisions of the Organisation for Economic Cooperation and Development’s “Pillar Two” global minimum tax initiative (Pillar Two) that will apply to multinational enterprises for accounting periods beginning on or after December 31, 2023. On February 22, 2024, the UK enacted certain amendments to its Pillar Two legislation which similarly take effect for accounting periods beginning on or after December 31, 2023. We are continuing to evaluate the potential impact on future periods of Pillar Two, pending legislative adoption by individual countries, as such legislative changes could result in changes to our effective tax rate. The Company evaluated the enacted legislation and concluded there was no material impact to the effective tax rate for the three and nine months ended September 30, 2024. On December 27, 2023, the Government of Bermuda enacted the Corporate Income Tax Act of 2023 (Bermuda CIT). Commencing on January 1, 2025, the Bermuda CIT will generally impose a 15% corporate income tax on in-scope entities that are resident in Bermuda or have a Bermuda permanent establishment, without regard to any assurances that have been given pursuant to the Exempted Undertakings Tax Protection Act 1966. We recorded material deferred tax assets as of December 31, 2023 as a result of the passage of the Bermuda CIT, primarily related to an estimated opening tax loss carryforward under Bermuda CIT. Throughout 2024, we will evaluate and record any applicable adjustments to these deferred tax assets. We evaluated the existing deferred tax assets and determined that no adjustments were necessary as of September 30, 2024.

Related Parties

Related Parties	9 Months Ended
Related Parties	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Parties	11. Related Parties Apollo Fee structure – Substantially all of our investments are managed by Apollo. Apollo provides us with a full suite of services for our investment portfolio, including direct investment management, asset allocation, mergers and acquisitions asset diligence and certain operational support services, including investment compliance, tax, legal and risk management support. Apollo has extensive experience managing our investment portfolio and its knowledge of our liability profile enables it to tailor an asset management strategy to fit our specific needs. This strategy has proven responsive to changing market conditions and focuses on earning incremental yield by taking measured liquidity risk and complexity risk, rather than assuming incremental credit risk. Our partnership has enabled us to take advantage of investment opportunities that would likely not otherwise have been available to us. Under our fee agreement with Apollo, we pay Apollo a base management fee of (1) 0.225% per year on a monthly basis equal to the lesser of (A) $103.4 billion, which represents the aggregate fair market value of substantially all of the assets in substantially all of the accounts of or relating to us (collectively, the Accounts) as of December 31, 2018 (Backbook Value), and (B) the aggregate book value of substantially all of the assets in the Accounts at the end of the respective month, plus (2) 0.15% per year of the amount, if any, by which the aggregate book value of substantially all of the assets in the Accounts at the end of the respective month exceeds the Backbook Value, subject to certain adjustments. Additionally, we pay a sub-allocation fee based on specified asset class tiers ranging from 0.065% to 0.70% of the book value of such assets, with the higher percentages in this range for asset classes that are designed to have more alpha generating abilities. Effective December 31, 2023, in addition to the base and sub-allocation fees specified above, we pay Apollo a target annual performance fee of $37.5 million, with the amount of the annual performance fee ranging from between 0% and 200% of such target amount, based on our spread related earnings for the year relative to our targets, beginning with the performance period for the second half of 2023. During the three months ended September 30, 2024 and 2023, we incurred management fees, inclusive of the base, sub-allocation and performance fees, of $327 million and $249 million, respectively. During the nine months ended September 30, 2024 and 2023, we incurred management fees, inclusive of the base, sub-allocation and performance fees, of $920 million and $703 million, respectively. Management fees are included within net investment income on the condensed consolidated statements of income. As of September 30, 2024 and December 31, 2023, management fees payable were $142 million and $101 million, respectively, and are included in other liabilities on the condensed consolidated balance sheets. Such amounts include fees incurred attributable to Athene Co-Invest Reinsurance Affiliate Holding Ltd. (together with its subsidiaries, ACRA 1) and Athene Co-Invest Reinsurance Affiliate Holding 2 Ltd. (together with its subsidiaries, ACRA 2) including any noncontrolling interests associated with ACRA 1 and ACRA 2 (collectively, ACRA). In addition to the assets on our condensed consolidated balance sheets managed by Apollo, Apollo manages the assets underlying our funds withheld receivable. For these assets, the third-party cedants pay Apollo fees based upon the same fee construct we have with Apollo. Such fees directly reduce the settlement payments that we receive from the third-party cedant and, as such, we indirectly pay those fees. Finally, Apollo charges management fees and carried interest on Apollo-managed funds and other entities in which we invest. Neither the fees paid by such third-party cedants nor the fees or carried interest paid by such Apollo-managed funds or other entities are included in the investment management fee amounts noted above. Governance – We have an investment and asset liability committee, which includes members of our senior management and reports to the risk committee of our board of directors. The committee focuses on strategic decisions involving our investment portfolio, such as approving investment limits, new asset classes and our allocation strategy, reviewing large asset transactions, as well as monitoring our credit risk, and the management of our assets and liabilities. AGM owns all of our common stock and James Belardi, our Chief Executive Officer, serves as a member of the board of directors and an executive officer of AGM, and Chief Executive Officer of Apollo Insurance Solutions Group LP (ISG), which is also a subsidiary of AGM. Mr. Belardi also owns a profit interest in ISG and in connection with such interest receives quarterly distributions equal to 3.35% of base management fees and 4.5% of subadvisory fees, as such fees are defined in our fee agreement with Apollo. Additionally, five of the eleven members of our board of directors (including Mr. Belardi) are employees of or consultants to Apollo. In order to protect against potential conflicts of interest resulting from transactions into which we have entered and will continue to enter into with the Apollo Group, our bylaws require us to maintain a conflicts committee comprised solely of directors who are not general partners, directors (other than independent directors of AGM), managers, officers or employees of any member of the Apollo Group. The conflicts committee reviews and approves material transactions between us and the Apollo Group, subject to certain exceptions. Other related party transactions Apollo Aligned Alternatives Aggregator, L.P. (AAA) – We consolidate AAA as a VIE and AAA holds the majority of our alternative investments portfolio. Apollo established AAA to provide a single vehicle through which investors participate in a portfolio of alternative investments, including those managed by Apollo. Additionally, we believe AAA enhances Apollo’s ability to increase alternative assets under management (AUM) by raising capital from third parties, which allows us to achieve greater scale and diversification for alternatives. During the third quarter of 2024, AAA underwent a restructuring which resulted in a change in consolidation that reduced our noncontrolling interests by $1,107 million and does not represent a withdrawal from AAA. Athora Holding Ltd. (Athora) – We have a cooperation agreement with Athora, pursuant to which, among other things, (1) for a period of 30 days from the receipt of notice of a cession, we have the right of first refusal to reinsure (i) up to 50% of the liabilities ceded from Athora’s reinsurance subsidiaries to Athora Life Re Ltd. and (ii) up to 20% of the liabilities ceded from a third party to any of Athora’s insurance subsidiaries, subject to a limitation in the aggregate of 20% of Athora’s liabilities, (2) Athora agreed to cause its insurance subsidiaries to consider the purchase of certain funding agreements and/or other spread instruments issued by our insurance subsidiaries, subject to a limitation that the fair market value of such funding agreements purchased by any of Athora’s insurance subsidiaries may generally not exceed 3% of the fair market value of such subsidiary’s total assets, (3) we provide Athora with a right of first refusal to pursue acquisition and reinsurance transactions in Europe (other than the United Kingdom (UK)) and (4) Athora provides us and our subsidiaries with a right of first refusal to pursue acquisition and reinsurance transactions in North America and the UK. Notwithstanding the foregoing, pursuant to the cooperation agreement, Athora is only required to use its reasonable best efforts to cause its subsidiaries to adhere to the provisions set forth in the cooperation agreement and therefore Athora’s ability to cause its subsidiaries to act pursuant to the cooperation agreement may be limited by, among other things, legal prohibitions or the inability to obtain the approval of the board of directors or other applicable governing body of the applicable subsidiary, which approval is solely at the discretion of such governing body. As of September 30, 2024 , we have not exercised our right of first refusal to reinsure liabilities ceded to Athora’s insurance or reinsurance subsidiaries. We have investments in Athora’s equity, which we hold as a related party investment fund on the condensed consolidated balance sheets, and non-redeemable preferred equity securities. The following table summarizes our investments in Athora: (In millions) September 30, 2024 December 31, 2023 Investment fund $ 1,106 $ 1,082 Non-redeemable preferred equity and corporate debt securities 296 249 Total investment in Athora $ 1,402 $ 1,331 Additionally, as of September 30, 2024 and December 31, 2023, we had $61 million and $61 million, respectively, of funding agreements outstanding to Athora . We also have commitments to make additional investments in Athora of $540 million as of September 30, 2024. Atlas Securitized Products Holdings LP (Atlas) – We have an equity investment in Atlas, an asset-backed specialty lender, through our investment in AAA. A s of September 30, 2024 and December 31, 2023, we held $2,449 million and $1,008 million, respectively, of related party AFS securities issued by Atlas. Additionally, we held $792 million and $921 million of reverse repurchase agreements issued by Atlas as of September 30, 2024 and December 31, 2023, respectively, which are held as related party short-term investments on the condensed consolidated balance sheets. As of September 30, 2024, w e have commitments to make additional investments in Atlas of $2,973 million . Additionally, s ee Note 12 – Commitments and Contingencies for further information on assurance letters issued in support of Atlas. Catalina – We have an investment in Apollo Rose II (B) (Apollo Rose). Apollo Rose holds common and preferred equity interests in Catalina Holdings (Bermuda) Ltd. (together with its subsidiaries, Catalina). During the third quarter of 2024, we distributed $141 million of our investment in Apollo Rose representing Catalina common equity interests to AGM as a dividend. This distribution resulted in our deconsolidation of Apollo Rose as a VIE. As of September 30, 2024 , we held $201 million of redeemable preferred equity securities issued by Apollo Rose, which are held as related party AFS securities on the condensed consolidated balance sheets. We have a strategic modco reinsurance agreement with Catalina to cede certain inforce funding agreements. We elected the fair value option on this agreement and had a liability of $257 million and $330 million as of September 30, 2024 and December 31, 2023, respectively, which is included in other liabilities on the condensed consolidated balance sheets. During the first quarter of 2024, we also entered into a modco reinsurance agreement with Catalina to cede a quota share of retail deferred annuity products. As of September 30, 2024, we had a reinsurance recoverable balance of $3,372 million related to this agreement. MidCap FinCo Designated Activity Company (MidCap Financial) – We have various investments in MidCap Financial including an investment through AAA, senior unsecured notes and redeemable preferred stock. We also hold structured securities issued by MidCap Financial affiliates. As of September 30, 2024 and December 31, 2023, we held securities issued by MidCap Financial and its affiliates of $2,004 million and $1,844 million, respectively, which are included in related party AFS securities on the condensed consolidated balance sheets. PK AirFinance – We have investments in PK AirFinance (PK Air), an aviation lending business with a portfolio of loans (Aviation Loans). The Aviation Loans are generally fully secured by aircraft leases and aircraft and are securitized by a special purpose vehicle (SPV) for which Apollo acts as ABS manager (ABS-SPV). The ABS-SPV issues tranches of senior notes and subordinated notes, which are secured by the Aviation Loans. We have investments in PK Air through our investment in AAA. We also held PK Air notes of $1,633 million and $1,617 million as of September 30, 2024 and December 31, 2023, respectively, which are included in related party AFS securities on the condensed consolidated balance sheets. We have commitments to make additional investments in PK Air of $40 million as of September 30, 2024. Strategic Partnership – We have an agreement pursuant to which we may invest up to $2.875 billion in funds managed by Apollo entities (Strategic Partnership). This arrangement is intended to permit us to invest across the Apollo alternatives platform into credit-oriented, strategic and other alternative investments in a manner and size that is consistent with our existing investment strategy. Fees for such investments payable by us to Apollo would be more favorable to us than market rates, and consistent with our existing alternative investments, investments made under the Strategic Partnership require approval of ISG and remain subject to our existing governance processes, including approval by our conflicts committee where applicable. As of September 30, 2024 and December 31, 2023, we held $1,894 million and $1,725 million, respectively, of investments under the Strategic Partnership and these investments are typically included as investments of consolidated VIEs or related party investment funds on the condensed consolidated balance sheets. Venerable – VA Capital Company LLC (VA Capital) is owned by a consortium of investors, led by affiliates of Apollo, Crestview Partners III Management, LLC and Reverence Capital Partners L.P., and is the parent of Venerable Holdings, Inc. (together with its subsidiaries, Venerable). We have a minority equity investment in VA Capital, which was $180 million and $181 million as of September 30, 2024 and December 31, 2023, respectively, and is included in related party investment funds on the condensed consolidated balance sheets and accounted for as an equity method investment. We also have coinsurance and modco agreements with VIAC, which is a subsidiary of Venerable. VIAC is a related party due to our investment in VA Capital. Effective July 1, 2023, VIAC recaptured $2.7 billion of reserves, which represents a portion of their business that was subject to those coinsurance and modco agreements. We recognized a gain of $555 million, which is included in other revenues on the condensed consolidated statements of income, in the third quarter of 2023 as a result of the settlement of the recapture agreement. As a result of our intent to transfer the assets supporting this business to VIAC in connection with the recapture, we were required by US GAAP to recognize the unrealized losses on these assets of $104 million as intent-to-sell impairments in the second quarter of 2023. We also have term loans receivable from Venerable due in 2033, which are included in related party other investments on the condensed consolidated balance sheets. The loans are held at fair value and were $348 million and $343 million as of September 30, 2024 and December 31, 2023, respectively. While management views the overall transactions with Venerable as favorable to us, the stated interest rate of 6.257% on the initial term loan to Venerable represented a below-market interest rate, and management considered such rate as part of its evaluation and pricing of the reinsurance transactions. Wheels – We invest in Wheels, Inc., (Wheels) indirectly through our investment in AAA. We also own securities issued by Wheels of $928 million and $981 million as of September 30, 2024 and December 31, 2023, respectively, which are included in related party AFS securities on the condensed consolidated balance sheets. We also have commitments to make additional investments in Wheels of $81 million as of September 30, 2024. ACRA and Apollo/Athene Dedicated Investment Programs I and II (collectively, ADIP) – ACRA 1 is partially owned by Apollo/Athene Dedicated Investment Program (ADIP I), a series of funds managed by Apollo. ALRe currently holds 36.55% of the economic interests in ACRA 1 and all of ACRA 1’s voting interests, with ADIP I holding the remaining 63.45% of the economic interests. ACRA 2 is partially owned by Apollo/Athene Dedicated Investment Program II (ADIP II), a fund managed by Apollo. Effective October 1, 2024, ACRA 2 repurchased a portion of its shares held by ALRe, which increased ADIP II’s ownership of economic interests in ACRA 2 to 63%, with ALRe owning the remaining 37%. ALRe holds all of ACRA 2’s voting interests. We received capital contributions and paid distributions relating to ACRA of the following: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Contributions from ADIP $ 126 $ 325 $ 831 $ 325 Distributions to ADIP (95) (254) (603) (381) Additionally, as of September 30, 2024 and December 31, 2023 , we had $265 million and $213 million, respectively, of related party payables for contingent investment fees payable by ACRA to Apollo. ACRA is obligated to pay the contingent investment fees on behalf of ADIP and, as such, the balance is attributable to the noncontrolling interests. Unsecured Revolving Promissory Note Receivable with AGM – AHL has an unsecured revolving promissory note with AGM which allows AGM to borrow funds from AHL. The note has a borrowing capacity of $500 million. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 13, 2025, or earlier at AHL’s request. The note receivable had an outstanding balance of $143 million and $109 million as of September 30, 2024 and December 31, 2023, respectively . Unsecured Revolving Promissory Note Payable with AGM – AHL has an unsecured revolving promissory note with AGM which allows AHL to borrow funds from AGM. The note has a borrowing capacity of $500 million. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 13, 2025, or earlier at AGM’s request. There was no outstanding balance on the note payable as of September 30, 2024 and December 31, 2023.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies Contingent Commitments —We had commitments to make investments, primarily capital contributions to investment funds, inclusive of related party commitments discussed previously and those of consolidated VIEs, of $27.2 billion as of September 30, 2024. We expect most of our current commitments will be invested over the next five years; however, these commitments could become due any time upon counterparty request. Funding Agreements —We are a member of the Federal Home Loan Bank of Des Moines (FHLB) and, through membership, we have issued funding agreements to the FHLB in exchange for cash advances. As of September 30, 2024 and December 31, 2023, we had $13.0 billion and $6.5 billion, respectively, of FHLB funding agreements outstanding. We are required to provide collateral in excess of the funding agreement amounts outstanding, considering any discounts to the securities posted and prepayment penalties. We have a funding agreement backed notes (FABN) program, which allows Athene Global Funding, a special-purpose, unaffiliated statutory trust, to offer its senior secured medium-term notes. Athene Global Funding uses the net proceeds from each sale to purchase one or more funding agreements from us. As of September 30, 2024 and December 31, 2023, we had $23.0 billion and $19.9 billion, respectively, of FABN f unding agreements outstanding . We had $11.9 billion of board-authorized FABN capacity remaining as of September 30, 2024. We also issue secured and other funding agreements. Secured funding agreements involve special-purpose, unaffiliated entities entering into repurchase agreements with a third party, the proceeds of which are used by the special-purpose entities to purchase funding agreements from us. As of September 30, 2024 and December 31, 2023, we had $14.1 billion and $6.0 billion, respectively, of secured and other funding agreements outstanding. Pledged Assets and Funds in Trust (Restricted Assets)— The total restricted assets included on the condensed consolidated balance sheets are as follows: (In millions) September 30, 2024 December 31, 2023 AFS securities $ 42,446 $ 32,458 Trading securities 1,777 139 Equity securities 304 80 Mortgage loans 23,171 14,257 Investment funds 777 409 Derivative assets 68 73 Short-term investments 14 153 Other investments 623 313 Restricted cash 974 1,761 Total restricted assets $ 70,154 $ 49,643 The restricted assets are primarily related to reinsurance trusts established in accordance with coinsurance agreements and the FHLB and secured funding agreements described above. Letters of Credit— We have undrawn letters of credit totaling $1,306 million as of September 30, 2024. These letters of credit were issued for our reinsurance program and have expirations through May 22, 2028. Assurance Letter —In connection with our, Apollo and Credit Suisse AG’s (CS) previously announced transaction, Atlas acquired certain assets of the CS Securitized Products Group and agreed to pay CS $3.3 billion, of which $0.4 billion is deferred until February 8, 2026, and $2.9 billion is deferred until February 8, 2028. In March 2024, in connection with Atlas concluding its investment management agreement with CS, the deferred purchase obligation amount was reduced to $2.5 billion. In addition, certain strategic investors have made equity commitments to Atlas which therefore obligates these investors for a portion of the deferred purchase obligation. This deferred purchase price is an obligation first of Atlas, and (as a result of additional guarantees provided by AAA, Apollo Asset Management, Inc. (AAM) and AHL) second of AAA, third of AAM, fourth of AHL and fifth of AARe. AARe and AAM have each issued an assurance letter to CS to guarantee the full amount. Our guarantees are not probable of payment, hence there are no liabilities recorded for the guarantees on the condensed consolidated financial statements. Guaranty Association Assessments —Guaranty associations may subject member insurers, including us, to assessments that require the insurers to pay funds to cover contractual obligations under insurance policies issued by insurance companies that become impaired or insolvent. The assessments are based on an insurer’s proportionate share of premiums written in that state during a specified one-year or three-year period for lines of business in which the impaired or insolvent insurer engaged, subject to prescribed limits. On December 30, 2022, the North Carolina Wake County Superior Court entered an Order of Liquidation (Liquidation Order) against Bankers Life Insurance Company (BLIC) and Colorado Bankers Life Insurance Company (CBLIC), which was affirmed by the North Carolina Court of Appeals on March 5, 2024. On April 9, 2024, GBIG Holdings, LLC (GBIG), the sole shareholder of BLIC and CBLIC, filed a Petition for Discretionary Review requesting the North Carolina Supreme Court review the decision by the North Carolina Court of Appeals to affirm the Liquidation Order. On July 11, 2024, GBIG filed a Motion to Withdraw its Petition for Discretionary Review. We are not a party to this litigation. The North Carolina Supreme Court granted the Motion to Withdraw on August 23, 2024, which makes the Liquidation Order effective on November 30, 2024. Shortly thereafter, guaranty associations began levying assessments and we expect those assessments to continue for the foreseeable future. As of September 30, 2024, we have recorded a liability of $177 million, based on our current best estimate of these assessments. The actual amount of assessments levied against us during the year ended December 31, 2024 or in future years in connection with the BLIC and CBLIC insolvencies may vary from this estimate. We expect to recover $5 million of assessments paid through future premium tax credits.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 625	$ 486	$ 2,446	$ 1,695

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation —We have prepared the accompanying condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information and the United States Securities and Exchange Commission’s rules and regulations for Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. Certain reclassifications have been made to conform with current year presentation. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year. For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements.
Consolidation	The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. Certain reclassifications have been made to conform with current year presentation. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year. For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements.
Use of Estimates	The preparation of financial statements requires the use of management estimates. Actual results may differ from estimates used in preparing the condensed consolidated financial statements.
Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Compensation – Stock Compensation (Accounting Standards Update (ASU) 2024-01) The amendments in this update clarify how an entity determines whether it is required to account for profits interest awards (and similar awards) in accordance with Accounting Standards Codification (ASC) 718 Compensation – Stock Compensation or other guidance. The ASU provides specific examples on when profits interest awards should be accounted for as a share-based payment arrangement under ASC 718 or in a manner similar to a cash bonus or profit-sharing arrangement under ASC 710 Compensation – General or other ASC topics. The guidance is effective for us on January 1, 2025, and early adoption is permitted but must be implemented as of the beginning of the fiscal year. We are currently evaluating the impact of the new pronouncement on our consolidated financial statements. Income Taxes—Improvements to Income Tax Disclosures (ASU 2023-09) The amendments in this update revise certain disclosures on income taxes including rate reconciliation, income taxes paid, and certain amendments on disaggregation by federal, state and foreign taxes. The guidance is effective for us for annual periods beginning in 2025. Early adoption is permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements. Segment Reporting – Improvements to Reporting Segment Disclosures (ASU 2023-07) The amendments in this update require disclosures of incremental segment information on an annual and interim basis for all public entities to provide analyses useful to investors for decision making. The update requires public entities, including those with a single reportable segment, to report significant segment expenses that are regularly provided to and used by the chief operating decision maker in managing the business. The guidance is effective for us for the 2024 annual period and in interim periods in 2025 on a retrospective basis. We are evaluating the impact of this guidance and plan to include updated financial statement disclosures in our consolidated financial statements for the year ended December 31, 2024. Business Combinations – Joint Venture Formations (ASU 2023-05) The amendments in this update address how a joint venture initially recognizes and measures contributions received at its formation date. The amendments require a joint venture to apply a new basis of accounting upon formation and to initially recognize its assets and liabilities at fair value. The guidance is effective prospectively for all joint ventures formed on or after January 1, 2025, while retrospective application may be elected for a joint venture formed before the effective date. Early adoption is permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements. Adopted Accounting Pronouncements Reference Rate Reform (Topic 848) (ASU 2022-06, ASU 2021-01, ASU 2020-04) We adopted ASU 2020-04 and ASU 2021-01 and elected to apply certain of the practical expedients related to contract modifications, hedge accounting relationships, and derivative modifications pertaining to discounting, margining, or contract price alignment. The main purpose of the practical expedients is to ease the administrative burden of accounting for contracts impacted by reference rate reform, and these elections did not have, and are not expected to have, a material impact on the consolidated financial statements. ASU 2022-06 amended and deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which we will no longer be permitted to apply the expedients provided in Topic 848. We will continue to evaluate the impact of reference rate reform on contract modifications and hedging relationships.

Investments (Tables)

Investments (Tables)	9 Months Ended
Investments (Tables)	Sep. 30, 2024
Schedule of Investments [Abstract]
Available-for-sale Securities	The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type: September 30, 2024 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 7,501 $ — $ 84 $ (824) $ 6,761 US state, municipal and political subdivisions 1,175 — 2 (200) 977 Foreign governments 2,088 — 44 (374) 1,758 Corporate 95,432 (168) 1,309 (8,963) 87,610 CLO 27,362 (1) 437 (188) 27,610 ABS 22,488 (74) 500 (444) 22,470 CMBS 9,704 (57) 112 (395) 9,364 RMBS 8,502 (377) 338 (328) 8,135 Total AFS securities 174,252 (677) 2,826 (11,716) 164,685 AFS securities – related parties Corporate 1,642 — 7 (35) 1,614 CLO 5,763 — 41 (24) 5,780 ABS 10,725 (1) 40 (261) 10,503 Total AFS securities – related parties 18,130 (1) 88 (320) 17,897 Total AFS securities, including related parties $ 192,382 $ (678) $ 2,914 $ (12,036) $ 182,582 December 31, 2023 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 6,161 $ — $ 67 $ (829) $ 5,399 US state, municipal and political subdivisions 1,296 — — (250) 1,046 Foreign governments 2,083 — 71 (255) 1,899 Corporate 88,343 (129) 830 (10,798) 78,246 CLO 20,506 (2) 261 (558) 20,207 ABS 13,942 (49) 120 (630) 13,383 CMBS 7,070 (29) 52 (502) 6,591 RMBS 8,160 (381) 252 (464) 7,567 Total AFS securities 147,561 (590) 1,653 (14,286) 134,338 AFS securities – related parties Corporate 1,423 — 1 (72) 1,352 CLO 4,367 — 21 (120) 4,268 ABS 8,665 (1) 34 (309) 8,389 Total AFS securities – related parties 14,455 (1) 56 (501) 14,009 Total AFS securities, including related parties $ 162,016 $ (591) $ 1,709 $ (14,787) $ 148,347 The following summarizes the number of AFS securities that were in an unrealized loss position, including related parties, for which an allowance for credit losses has not been recorded: September 30, 2024 Unrealized loss position Unrealized loss position 12 months or more AFS securities 7,058 6,167 AFS securities – related parties 139 62
Debt Securities, Available-for-sale, Allowance for Credit Loss	The following table summarizes the activity in the allowance for credit losses for AFS securities including purchased credit deteriorated (PCD) securities by asset type: Three months ended September 30, 2024 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Corporate $ 168 $ — $ — $ — $ — $ 168 CLO — 1 — — — 1 ABS 67 13 — (14) 8 74 CMBS 57 1 — — (1) 57 RMBS 378 5 — (4) (2) 377 Total AFS securities 670 20 — (18) 5 677 AFS securities – related parties, ABS 1 — — — — 1 Total AFS securities, including related parties $ 671 $ 20 $ — $ (18) $ 5 $ 678 Three months ended September 30, 2023 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Foreign governments $ 27 $ — $ — $ — $ — $ 27 Corporate 73 67 — (2) 2 140 CLO 3 — — — — 3 ABS 35 1 — (4) (2) 30 CMBS 6 1 — — — 7 RMBS 377 4 1 (5) (6) 371 Total AFS securities 521 73 1 (11) (6) 578 AFS securities – related parties, ABS 1 — — — — 1 Total AFS securities, including related parties $ 522 $ 73 $ 1 $ (11) $ (6) $ 579 Nine months ended September 30, 2024 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Corporate $ 129 $ 48 $ — $ (8) $ (1) $ 168 CLO 2 1 — — (2) 1 ABS 49 25 — (15) 15 74 CMBS 29 27 — — 1 57 RMBS 381 10 — (14) — 377 Total AFS securities 590 111 — (37) 13 677 AFS securities – related parties, ABS 1 — — — — 1 Total AFS securities, including related parties $ 591 $ 111 $ — $ (37) $ 13 $ 678 Nine months ended September 30, 2023 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending balance AFS securities Foreign governments $ 27 $ — $ — $ — $ — $ 27 Corporate 61 88 — (8) (1) 140 CLO 7 1 — — (5) 3 ABS 29 2 — (4) 3 30 CMBS 5 4 — — (2) 7 RMBS 329 15 40 (13) — 371 Total AFS securities 458 110 40 (25) (5) 578 AFS securities – related parties CLO 1 — — — (1) — ABS — 1 — — — 1 Total AFS securities – related parties 1 1 — — (1) 1 Total AFS securities, including related parties $ 459 $ 111 $ 40 $ (25) $ (6) $ 579
Available-for-sale Securities by Contractual Maturity	The amortized cost and fair value of AFS securities, including related parties, are shown by contractual maturity below: September 30, 2024 (In millions) Amortized Cost Fair Value AFS securities Due in one year or less $ 2,407 $ 2,394 Due after one year through five years 19,358 19,138 Due after five years through ten years 27,393 26,016 Due after ten years 57,038 49,558 CLO, ABS, CMBS and RMBS 68,056 67,579 Total AFS securities 174,252 164,685 AFS securities – related parties Due after one year through five years 1,028 1,024 Due after five years through ten years 43 45 Due after ten years 571 545 CLO and ABS 16,488 16,283 Total AFS securities – related parties 18,130 17,897 Total AFS securities, including related parties $ 192,382 $ 182,582
Fair Values and Unrealized Losses on Available-for-sale Securities	The following summarizes the fair value and gross unrealized losses for AFS securities, including related parties, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost: September 30, 2024 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 1,031 $ (6) $ 3,795 $ (818) $ 4,826 $ (824) US state, municipal and political subdivisions 22 (1) 893 (198) 915 (199) Foreign governments 886 (134) 737 (239) 1,623 (373) Corporate 7,810 (314) 45,086 (8,624) 52,896 (8,938) CLO 3,742 (7) 3,146 (131) 6,888 (138) ABS 435 (93) 4,319 (258) 4,754 (351) CMBS 918 (5) 2,074 (341) 2,992 (346) RMBS 270 (4) 1,201 (102) 1,471 (106) Total AFS securities 15,114 (564) 61,251 (10,711) 76,365 (11,275) AFS securities – related parties Corporate 211 (12) 368 (23) 579 (35) CLO 680 (1) 690 (20) 1,370 (21) ABS 2,403 (34) 3,398 (213) 5,801 (247) Total AFS securities – related parties 3,294 (47) 4,456 (256) 7,750 (303) Total AFS securities, including related parties $ 18,408 $ (611) $ 65,707 $ (10,967) $ 84,115 $ (11,578) December 31, 2023 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 2,013 $ (94) $ 2,389 $ (735) $ 4,402 $ (829) US state, municipal and political subdivisions 123 (5) 888 (245) 1,011 (250) Foreign governments 690 (13) 760 (242) 1,450 (255) Corporate 7,752 (474) 50,028 (10,311) 57,780 (10,785) CLO 689 (2) 11,579 (543) 12,268 (545) ABS 2,129 (75) 4,378 (458) 6,507 (533) CMBS 859 (12) 1,967 (406) 2,826 (418) RMBS 467 (9) 2,057 (263) 2,524 (272) Total AFS securities 14,722 (684) 74,046 (13,203) 88,768 (13,887) AFS securities – related parties Corporate 548 (35) 382 (37) 930 (72) CLO 397 (16) 2,592 (102) 2,989 (118) ABS 2,008 (66) 2,793 (225) 4,801 (291) Total AFS securities – related parties 2,953 (117) 5,767 (364) 8,720 (481) Total AFS securities, including related parties $ 17,675 $ (801) $ 79,813 $ (13,567) $ 97,488 $ (14,368)
Net Investment Income	Net investment income by asset class consists of the following: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 AFS securities $ 2,520 $ 1,822 $ 6,997 $ 4,940 Trading securities 40 49 125 135 Equity securities 19 14 65 54 Mortgage loans 1,007 642 2,711 1,632 Investment funds 42 (13) 36 59 Funds withheld at interest 279 486 1,001 1,368 Other 218 214 621 623 Investment revenue 4,125 3,214 11,556 8,811 Investment expenses (348) (286) (978) (759) Net investment income $ 3,777 $ 2,928 $ 10,578 $ 8,052
Investment Related Gains (Losses)	Investment related gains (losses) by asset class consists of the following: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 AFS securities 1 Gross realized gains on investment activity $ 744 $ 55 $ 936 $ 379 Gross realized losses on investment activity (237) (431) (802) (647) Net realized investment gains (losses) on AFS securities 507 (376) 134 (268) Net recognized investment gains (losses) on trading securities 119 (137) 21 (105) Net recognized investment gains (losses) on equity securities 38 (3) 65 (34) Net recognized investment gains (losses) on mortgage loans 1,139 (911) 874 (838) Derivative gains (losses) 1,608 (1,480) 2,486 (66) Provision for credit losses (14) (60) (114) (237) Other gains (losses) (1,858) 343 (384) 355 Investment related gains (losses) $ 1,539 $ (2,624) $ 3,082 $ (1,193) 1 Includes the effects of recognized gains or losses on AFS securities associated with designated hedges. The following table summarizes the change in unrealized gains (losses) on trading and equity securities, including related parties, we held as of the respective period end: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 83 $ (75) $ 42 $ (35) Trading securities – related parties (1) 3 (2) 3 Equity securities 28 6 56 9 Equity securities – related parties 10 (9) 2 (16)
Mortgage Loans, Net	Mortgage loans include both commercial and residential loans. W e have elected the fair value option on our mortgage loan portfolio. See Note 5 – Fair Value for further fair value option information. The following represents the mortgage loan portfolio, with fair value option loans presented at unpaid principal balance: (In millions) September 30, 2024 December 31, 2023 Commercial mortgage loans $ 32,066 $ 27,630 Commercial mortgage loans under development 1,722 1,228 Total commercial mortgage loans 33,788 28,858 Mark to fair value (1,926) (2,246) Commercial mortgage loans 31,862 26,612 Residential mortgage loans 30,616 21,894 Mark to fair value (320) (937) Residential mortgage loans 30,296 20,957 Mortgage loans $ 62,158 $ 47,569 The distribution of commercial mortgage loans, including those under development, by property type and geographic region, is as follows: September 30, 2024 December 31, 2023 (In millions, except percentages) Fair Value Percentage of Total Fair Value Percentage of Total Property type Apartment $ 11,556 36.3 % $ 9,591 36.0 % Office building 4,140 13.0 % 4,455 16.7 % Industrial 6,144 19.3 % 4,143 15.6 % Hotels 2,941 9.2 % 2,913 11.0 % Retail 2,447 7.7 % 2,158 8.1 % Other commercial 4,634 14.5 % 3,352 12.6 % Total commercial mortgage loans $ 31,862 100.0 % $ 26,612 100.0 % US region East North Central $ 1,494 4.7 % $ 1,517 5.7 % East South Central 443 1.3 % 523 2.0 % Middle Atlantic 8,497 26.7 % 7,147 26.9 % Mountain 1,335 4.2 % 1,196 4.5 % New England 1,126 3.5 % 1,295 4.9 % Pacific 5,788 18.2 % 4,860 18.3 % South Atlantic 5,504 17.3 % 4,583 17.2 % West North Central 228 0.7 % 249 0.9 % West South Central 1,965 6.2 % 1,228 4.6 % Total US region 26,380 82.8 % 22,598 85.0 % International region United Kingdom 2,638 8.3 % 2,343 8.7 % Other international 1 2,844 8.9 % 1,671 6.3 % Total international region 5,482 17.2 % 4,014 15.0 % Total commercial mortgage loans $ 31,862 100.0 % $ 26,612 100.0 % 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Our residential mortgage loan portfolio primarily consists of first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table: September 30, 2024 December 31, 2023 US States California 26.2 % 27.6 % Florida 12.6 % 12.0 % Texas 7.0 % 6.1 % New York 5.1 % 5.9 % Other 1 40.2 % 39.4 % Total US residential mortgage loan percentage 91.1 % 91.0 % International United Kingdom 5.1 % 4.0 % Other 1 3.8 % 5.0 % Total international residential mortgage loan percentage 8.9 % 9.0 % Total residential mortgage loan percentage 100.0 % 100.0 % 1 Represents all other states or countries, with each individual state or country comprising less than 5% of the portfolio.
Investment Funds	The following summarizes our investment funds, including related parties and consolidated VIEs: September 30, 2024 December 31, 2023 1 (In millions, except percentages) Carrying value Percent of total Carrying value Percent of total Investment funds Equity $ 107 0.6 % $ 109 0.6 % Investment funds – related parties Strategic origination platforms 28 0.2 % 32 0.2 % Retirement services platforms 1,287 6.8 % 1,300 7.3 % Equity 264 1.4 % 267 1.5 % Credit 16 0.1 % 20 0.1 % Other 9 0.0 % 13 0.1 % Total investment funds – related parties 1,604 8.5 % 1,632 9.2 % Investment funds – consolidated VIEs Strategic origination platforms 5,519 29.3 % 4,987 28.2 % Retirement services platforms — — % 483 2.7 % Equity 7,837 41.6 % 7,032 39.8 % Credit 3,077 16.3 % 2,852 16.2 % Other 702 3.7 % 573 3.3 % Total investment funds – consolidated VIEs 17,135 90.9 % 15,927 90.2 % Total investment funds, including related parties and funds owned by consolidated VIEs $ 18,846 100.0 % $ 17,668 100.0 % 1 Prior period amounts have been reclassified to conform with the current year presentation as a result of aligning our investment fund categories to reflect our updated investment strategies.
Schedule of Variable Interest Entities	The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: September 30, 2024 December 31, 2023 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 107 $ 862 $ 109 $ 876 Investment in related parties – investment funds 1,604 2,659 1,632 2,377 Assets of consolidated VIEs – investment funds 17,135 23,698 15,927 22,240 Investment in fixed maturity securities 67,990 69,290 48,155 50,623 Investment in related parties – fixed maturity securities 16,902 20,764 13,495 15,608 Investment in related parties – equity securities 257 257 318 318 Total non-consolidated investments $ 103,995 $ 117,530 $ 79,636 $ 92,042 The following summarizes the income statement activity of the consolidated VIEs: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 39 $ 28 $ 104 $ 79 Mortgage loans 30 29 91 83 Investment funds 22 20 43 55 Other (14) (2) (28) (7) Net investment income $ 77 $ 75 $ 210 $ 210 Net recognized investment gains (losses) on trading securities $ 29 $ (16) $ 21 $ (15) Net recognized investment gains (losses) on mortgage loans 24 (25) (4) (45) Net recognized investment gains on investment funds 414 292 1,099 833 Other gains (losses) 2 (1) (7) (29) Investment related gains (losses) $ 469 $ 250 $ 1,109 $ 744
Schedule of Repurchase Agreements	The following table summarizes the remaining contractual maturities of our repurchase agreements, which are included in payables for collateral on derivatives and securities to repurchase on the condensed consolidated balance sheets: (In millions) September 30, 2024 December 31, 2023 Less than 30 days $ — $ 686 91 days to 1 year 1,097 — Greater than 1 year 1,569 3,167 Payables for repurchase agreements $ 2,666 $ 3,853 The following table summarizes the securities pledged as collateral for repurchase agreements: September 30, 2024 December 31, 2023 (In millions) Amortized Cost Fair Value Amortized Cost Fair Value AFS securities Foreign governments $ 155 $ 113 $ 137 $ 99 Corporate 1,770 1,549 2,735 2,307 CLO 587 589 580 579 ABS 597 559 1,207 1,086 Total securities pledged under repurchase agreements $ 3,109 $ 2,810 $ 4,659 $ 4,071
Schedules of Concentration of Risk, by Risk Factor	The following table represents our investment concentrations in excess of 10% of AHL stockholders’ equity: (In millions) September 30, 2024 AP Grange Holdings, LLC $ 4,626 Atlas 1 3,240 Fox Hedge L.P. 3,050 December 31, 2023 Wheels 1 $ 1,591 AT&T Inc. 1,526 1 Related party amounts are representative of single issuer risk and may only include a portion of the total investments associated with a related party. See further discussion of these related parties in Note 11 – Related Parties.

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
Derivative Instruments (Tables)	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Notional Amount and Fair Value of Derivative Instruments	The following table presents the notional amount and fair value of derivative instruments: September 30, 2024 December 31, 2023 Notional Amount Fair Value Notional Amount Fair Value (In millions) Assets Liabilities Assets Liabilities Derivatives designated as hedges Foreign currency hedges Swaps 15,119 $ 503 $ 345 9,034 $ 477 $ 230 Forwards 3,691 195 36 6,294 275 102 Interest rate swaps 4,506 56 418 4,468 — 521 Forwards on net investments 218 — 3 219 — 6 Interest rate swaps 21,079 131 40 10,031 29 95 Total derivatives designated as hedges 885 842 781 954 Derivatives not designated as hedges Equity options 82,762 5,820 127 73,881 3,809 102 Futures 44 119 — 35 72 — Foreign currency swaps 13,706 223 354 8,072 230 244 Interest rate swaps 1,870 76 1 3,499 81 9 Other swaps 2,591 12 1 2,588 39 1 Foreign currency forwards 40,174 394 1,433 28,236 286 685 Embedded derivatives Funds withheld including related parties (3,111) 80 (4,100) (64) Interest sensitive contract liabilities — 11,996 — 9,059 Total derivatives not designated as hedges 3,533 13,992 417 10,036 Total derivatives $ 4,418 $ 14,834 $ 1,198 $ 10,990
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]	The following represents the carrying amount and the cumulative fair value hedging adjustments included in the hedged assets or liabilities: September 30, 2024 December 31, 2023 (In millions) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) AFS securities Foreign currency forwards $ 3,851 $ (13) $ 4,883 $ (15) Foreign currency swaps 11,588 71 6,820 (141) Interest sensitive contract liabilities Foreign currency swaps 2,507 (44) 1,438 19 Foreign currency interest rate swaps 4,220 205 4,010 363 Interest rate swaps 17,483 (121) 6,910 189 1 The carrying amount disclosed for AFS securities is amortized cost. The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships: Amounts excluded (In millions) Derivatives Hedged items Net Recognized in income through amortization approach Recognized in income through changes in fair value Three months ended September 30, 2024 Investment related gains (losses) Foreign currency forwards $ (180) $ 184 $ 4 $ 4 $ 8 Foreign currency swaps (313) 282 (31) — — Foreign currency interest rate swaps 255 (258) (3) — — Interest rate swaps 382 (386) (4) — — Interest sensitive contract benefits Foreign currency interest rate swaps 26 (25) 1 — — Three months ended September 30, 2023 Investment related gains (losses) Foreign currency forwards $ 179 $ (187) $ (8) $ 21 $ 5 Foreign currency swaps 161 (166) (5) — — Foreign currency interest rate swaps (90) 95 5 — — Interest rate swaps (74) 63 (11) — — Interest sensitive contract benefits Foreign currency interest rate swaps 16 (14) 2 — — Amounts excluded (In millions) Derivatives Hedged items Net Recognized in income through amortization approach Recognized in income through changes in fair value Nine months ended September 30, 2024 Investment related gains (losses) Foreign currency forwards $ (1) $ 1 $ — $ 35 $ 14 Foreign currency swaps (158) 144 (14) — — Foreign currency interest rate swaps 132 (135) (3) — — Interest rate swaps 267 (310) (43) — — Interest sensitive contract benefits Foreign currency interest rate swaps 66 (64) 2 — — Nine months ended September 30, 2023 Investment related gains (losses) Foreign currency forwards $ 74 $ (77) $ (3) $ 66 $ 12 Foreign currency swaps 59 (57) 2 — — Foreign currency interest rate swaps (5) 15 10 — — Interest rate swaps (92) 79 (13) — — Interest sensitive contract benefits Foreign currency interest rate swaps 44 (44) — — — The following is a summary of the gains (losses) excluded from the assessment of hedge effectiveness that were recognized in OCI : Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Foreign currency forwards $ 13 $ (65) $ (2) $ (63) Foreign currency swaps 56 (239) 82 (182)
Gains (Losses) Related to Derivatives Not Designated as Hedges	The following is a summary of the gains (losses) related to derivatives not designated as hedges: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Equity options $ 596 $ (951) $ 2,298 $ 390 Futures 26 (73) 152 22 Swaps (126) (24) (156) 38 Foreign currency forwards 209 146 (657) (191) Embedded derivatives on funds withheld 747 (780) 560 (439) Amounts recognized in investment related gains (losses) 1,452 (1,682) 2,197 (180) Embedded derivatives in indexed annuity products 1 (275) 1,251 (1,270) (277) Total gains (losses) on derivatives not designated as hedges $ 1,177 $ (431) $ 927 $ (457) 1 Included in interest sensitive contract benefits on the condensed consolidated statements of income.
Estimated Fair Value of Net Derivative and Other Financial Assets	The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the condensed consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral September 30, 2024 Derivative assets $ 7,529 $ (1,739) $ (5,272) $ 518 $ — $ 518 Derivative liabilities (2,758) 1,739 1,091 72 1 73 December 31, 2023 Derivative assets $ 5,298 $ (1,497) $ (3,676) $ 125 $ — $ 125 Derivative liabilities (1,995) 1,497 848 350 — 350 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of September 30, 2024 and December 31, 2023, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.
Estimated Fair Value of Net Derivative and Other Financial Liabilities	The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the condensed consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral September 30, 2024 Derivative assets $ 7,529 $ (1,739) $ (5,272) $ 518 $ — $ 518 Derivative liabilities (2,758) 1,739 1,091 72 1 73 December 31, 2023 Derivative assets $ 5,298 $ (1,497) $ (3,676) $ 125 $ — $ 125 Derivative liabilities (1,995) 1,497 848 350 — 350 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of September 30, 2024 and December 31, 2023, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	9 Months Ended
Variable Interest Entities (Tables)	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: September 30, 2024 December 31, 2023 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 107 $ 862 $ 109 $ 876 Investment in related parties – investment funds 1,604 2,659 1,632 2,377 Assets of consolidated VIEs – investment funds 17,135 23,698 15,927 22,240 Investment in fixed maturity securities 67,990 69,290 48,155 50,623 Investment in related parties – fixed maturity securities 16,902 20,764 13,495 15,608 Investment in related parties – equity securities 257 257 318 318 Total non-consolidated investments $ 103,995 $ 117,530 $ 79,636 $ 92,042 The following summarizes the income statement activity of the consolidated VIEs: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 39 $ 28 $ 104 $ 79 Mortgage loans 30 29 91 83 Investment funds 22 20 43 55 Other (14) (2) (28) (7) Net investment income $ 77 $ 75 $ 210 $ 210 Net recognized investment gains (losses) on trading securities $ 29 $ (16) $ 21 $ (15) Net recognized investment gains (losses) on mortgage loans 24 (25) (4) (45) Net recognized investment gains on investment funds 414 292 1,099 833 Other gains (losses) 2 (1) (7) (29) Investment related gains (losses) $ 469 $ 250 $ 1,109 $ 744

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
Fair Value (Tables)	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis: September 30, 2024 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 6,761 $ — $ 6,759 $ 2 $ — US state, municipal and political subdivisions 977 — — 977 — Foreign governments 1,758 — 756 967 35 Corporate 87,610 — 12 83,423 4,175 CLO 27,610 — — 27,610 — ABS 22,470 — — 6,855 15,615 CMBS 9,364 — — 9,347 17 RMBS 8,135 — — 7,792 343 Total AFS securities 164,685 — 7,527 136,973 20,185 Trading securities 1,684 — 24 1,623 37 Equity securities 1,292 — 207 1,059 26 Mortgage loans 58,587 — — — 58,587 Funds withheld at interest – embedded derivative (2,581) — — — (2,581) Derivative assets 7,529 — 143 7,385 1 Short-term investments 409 — 202 39 168 Other investments 1,507 — — 603 904 Cash and cash equivalents 13,587 — 13,587 — — Restricted cash 964 — 964 — — Investments in related parties AFS securities Corporate 1,614 — — 233 1,381 CLO 5,780 — — 5,215 565 ABS 10,503 — — 694 9,809 Total AFS securities – related parties 17,897 — — 6,142 11,755 Trading securities 619 — — — 619 Equity securities 257 — — — 257 Mortgage loans 1,345 — — — 1,345 Investment funds 1,106 — — — 1,106 Funds withheld at interest – embedded derivative (530) — — — (530) Other investments 348 — — — 348 Reinsurance recoverable 1,710 — — — 1,710 Other assets 313 — — — 313 Assets of consolidated VIEs Trading securities 2,379 — — 441 1,938 Mortgage loans 2,226 — — — 2,226 Investment funds 17,135 16,317 — — 818 Other investments 159 — 5 — 154 Cash and cash equivalents 305 — 305 — — Total assets measured at fair value $ 292,932 $ 16,317 $ 22,964 $ 154,265 $ 99,386 Liabilities Interest sensitive contract liabilities Embedded derivative $ 11,996 $ — $ — $ — $ 11,996 Universal life benefits 820 — — — 820 Future policy benefits AmerUs Life Insurance Company (AmerUs) Closed Block 1,166 — — — 1,166 Indianapolis Life Insurance Company (ILICO) Closed Block and life benefits 545 — — — 545 Market risk benefits 4,402 — — — 4,402 Derivative liabilities 2,758 — 1 2,756 1 Other liabilities 337 — — — 337 Total liabilities measured at fair value $ 22,024 $ — $ 1 $ 2,756 $ 19,267 December 31, 2023 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 5,399 $ — $ 5,392 $ 7 $ — US state, municipal and political subdivisions 1,046 — — 1,046 — Foreign governments 1,899 — 895 964 40 Corporate 78,246 — 10 75,711 2,525 CLO 20,207 — — 20,207 — ABS 13,383 — — 6,440 6,943 CMBS 6,591 — — 6,570 21 RMBS 7,567 — — 7,302 265 Total AFS securities 134,338 — 6,297 118,247 9,794 Trading securities 1,706 — 24 1,654 28 Equity securities 935 — 210 699 26 Mortgage loans 44,115 — — — 44,115 Funds withheld at interest – embedded derivative (3,379) — — — (3,379) Derivative assets 5,298 — 108 5,190 — Short-term investments 341 — — 236 105 Other investments 943 — — 313 630 Cash and cash equivalents 13,020 — 13,020 — — Restricted cash 1,761 — 1,761 — — Investments in related parties AFS securities Corporate 1,352 — — 181 1,171 CLO 4,268 — — 3,762 506 ABS 8,389 — — 563 7,826 Total AFS securities – related parties 14,009 — — 4,506 9,503 Trading securities 838 — — — 838 Equity securities 318 — 63 — 255 Mortgage loans 1,281 — — — 1,281 Investment funds 1,082 — — — 1,082 Funds withheld at interest – embedded derivative (721) — — — (721) Other investments 343 — — — 343 Reinsurance recoverable 1,367 — — — 1,367 Other assets 378 — — — 378 Assets of consolidated VIEs Trading securities 2,136 — — 284 1,852 Mortgage loans 2,173 — — — 2,173 Investment funds 15,927 14,950 — — 977 Other investments 103 — — 2 101 Cash and cash equivalents 98 — 98 — — Total assets measured at fair value $ 238,410 $ 14,950 $ 21,581 $ 131,131 $ 70,748 Liabilities Interest sensitive contract liabilities Embedded derivative $ 9,059 $ — $ — $ — $ 9,059 Universal life benefits 834 — — — 834 Future policy benefits AmerUs Closed Block 1,178 — — — 1,178 ILICO Closed Block and life benefits 522 — — — 522 Market risk benefits 3,751 — — — 3,751 Derivative liabilities 1,995 — 17 1,977 1 Other liabilities 266 — — (64) 330 Total liabilities measured at fair value $ 17,605 $ — $ 17 $ 1,913 $ 15,675
Summary of Fair Value Option	The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties and consolidated VIEs: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Trading securities $ 131 $ (137) $ 31 $ (105) Mortgage loans 1,186 (984) 868 (909) Investment funds 37 (66) 18 25 Future policy benefits (46) 59 12 64 Other 5 (4) 9 (71) Total gains (losses) $ 1,313 $ (1,132) $ 938 $ (996) The following summarizes information for fair value option mortgage loans, including related parties and consolidated VIEs: (In millions) September 30, 2024 December 31, 2023 Unpaid principal balance $ 64,404 $ 50,752 Mark to fair value (2,246) (3,183) Fair value $ 62,158 $ 47,569 The following represents our commercial mortgage loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) September 30, 2024 December 31, 2023 Unpaid principal balance of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 507 $ 221 Mark to fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status (191) (74) Fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 316 $ 147 Fair value of commercial mortgage loans 90 days or more past due $ 254 $ 64 Fair value of commercial mortgage loans in non-accrual status 316 147 The following represents our residential mortgage loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) September 30, 2024 December 31, 2023 Unpaid principal balance of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 850 $ 528 Mark to fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status (74) (49) Fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 776 $ 479 Fair value of residential mortgage loans 90 days or more past due 1 $ 776 $ 479 Fair value of residential mortgage loans in non-accrual status 679 355 1 As of September 30, 2024 and December 31, 2023 includes $97 million and $124 million, respectively, of residential mortgage loans that are guaranteed by US government-sponsored agencies. The following is the estimated amount of gains (losses) included in earnings during the period attributable to changes in instrument-specific credit risk on our mortgage loan portfolio: Three months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Mortgage loans $ (19) $ (20) $ (49) $ (31)
Reconciliation of Level 3 Assets Measured on a Recurring Basis	The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. Transfers in and out of Level 3 are primarily based on changes in the availability of pricing sources, as described in the valuation methods above. Three months ended September 30, 2024 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 34 $ — $ 1 $ — $ — $ 35 $ — $ — Corporate 8,114 6 80 775 (4,800) 4,175 2 98 ABS 8,420 1 313 2,202 4,679 15,615 — 301 CMBS 20 2 (5) — — 17 — (3) RMBS 261 2 2 78 — 343 — 2 Trading securities 37 1 — (1) — 37 1 — Equity securities 36 (1) — — (9) 26 — — Mortgage loans 52,645 1,096 — 4,846 — 58,587 1,236 — Funds withheld at interest – embedded derivative (3,283) 702 — — — (2,581) — — Derivative assets 1 — — — — 1 — — Short-term investments 80 — — 166 (78) 168 — — Other investments 904 — — — — 904 (1) — Investments in related parties AFS securities Corporate 1,194 (3) 12 (23) 201 1,381 — 9 CLO 521 — 2 42 — 565 — 2 ABS 10,580 28 75 (874) — 9,809 7 73 Trading securities 719 — — (100) — 619 (1) — Equity securities 247 10 — — — 257 10 — Mortgage loans 1,320 39 — (14) — 1,345 (43) — Investment funds 1,066 40 — — — 1,106 40 — Funds withheld at interest – embedded derivative (717) 187 — — — (530) — — Other investments 335 13 — — — 348 13 — Reinsurance recoverable 1,518 99 — 93 — 1,710 — — Assets of consolidated VIEs Trading securities 1,876 82 — 34 (54) 1,938 82 — Mortgage loans 2,120 51 — 55 — 2,226 51 — Investment funds 913 (1) — 338 (432) 818 (1) — Other investments 113 4 — 37 — 154 4 — Total Level 3 assets $ 89,074 $ 2,358 $ 480 $ 7,654 $ (493) $ 99,073 $ 1,400 $ 482 Liabilities Interest sensitive contract liabilities Embedded derivative $ (11,234) $ (275) $ — $ (487) $ — $ (11,996) $ — $ — Universal life benefits (769) (51) — — — (820) — — Future policy benefits AmerUs Closed Block (1,120) (46) — — — (1,166) — — ILICO Closed Block and life benefits (529) (16) — — — (545) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (253) (86) — 2 — (337) — — Total Level 3 liabilities $ (13,906) $ (474) $ — $ (485) $ — $ (14,865) $ — $ — 1 Related to instruments held at end of period. Three months ended September 30, 2023 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 48 $ — $ (2) $ — $ — $ 46 $ — $ (2) Corporate 2,460 (8) (25) (26) (20) 2,381 — (27) ABS 5,305 — 14 (255) (438) 4,626 — 4 CMBS 12 — — — — 12 — — RMBS 6 — — 261 (4) 263 — — Trading securities 38 (1) — (5) — 32 (1) — Equity securities 67 7 — — — 74 7 — Mortgage loans 34,668 (850) — 4,160 — 37,978 (850) — Funds withheld at interest – embedded derivative (4,356) (625) — — — (4,981) — — Short-term investments 30 — (1) 100 — 129 — (1) Other investments 337 (5) — 145 — 477 (5) — Investments in related parties AFS securities Corporate 1,171 1 (10) 24 — 1,186 — (10) CLO 495 — 8 — — 503 — 8 ABS 7,742 (2) (11) 110 — 7,839 (6) (14) Trading securities 867 4 — — — 871 3 — Equity securities 252 (7) — — — 245 (7) — Mortgage loans 1,296 (61) — (1) — 1,234 (61) — Investment funds 1,061 (18) — — — 1,043 (18) — Funds withheld at interest – embedded derivative (1,297) 325 — — — (972) — — Other investments 343 (16) — — — 327 (16) — Reinsurance recoverable 1,436 (135) — — — 1,301 — — Assets of consolidated VIEs Trading securities 1,425 (48) — (45) 526 1,858 (48) — Mortgage loans 2,113 (73) — 2 — 2,042 (73) — Investment funds 1,351 (30) — 81 — 1,402 (30) — Other investments 99 5 — (12) — 92 5 — Total Level 3 assets $ 56,969 $ (1,537) $ (27) $ 4,539 $ 64 $ 60,008 $ (1,100) $ (42) Liabilities Interest sensitive contract liabilities Embedded derivative $ (8,198) $ 1,251 $ — $ (398) $ — $ (7,345) $ — $ — Universal life benefits (854) 115 — — — (739) — — Future policy benefits AmerUs Closed Block (1,159) 59 — — — (1,100) — — ILICO Closed Block and life benefits (571) 20 — — — (551) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (209) (4) — — — (213) — — Total Level 3 liabilities $ (10,992) $ 1,441 $ — $ (398) $ — $ (9,949) $ — $ — 1 Related to instruments held at end of period. Nine months ended September 30, 2024 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 40 $ — $ 1 $ (6) $ — $ 35 $ — $ 1 Corporate 2,525 3 87 2,387 (827) 4,175 — 110 ABS 6,943 (14) 314 8,371 1 15,615 — 298 CMBS 21 1 (5) — — 17 — (3) RMBS 265 5 3 72 (2) 343 — 2 Trading securities 28 1 — (6) 14 37 — — Equity securities 26 (1) — 1 — 26 — — Mortgage loans 44,115 825 — 13,647 — 58,587 965 — Funds withheld at interest – embedded derivative (3,379) 798 — — — (2,581) — — Derivative assets — — — — 1 1 — — Short-term investments 105 — — 142 (79) 168 — — Other investments 630 (6) — 280 — 904 (7) — Investments in related parties AFS securities Corporate 1,171 (2) 33 (22) 201 1,381 — 31 CLO 506 — 17 42 — 565 — 18 ABS 7,826 46 22 1,915 — 9,809 2 20 Trading securities 838 (1) — (218) — 619 (2) — Equity securities 255 2 — — — 257 2 — Mortgage loans 1,281 41 — 23 — 1,345 (41) — Investment funds 1,082 24 — — — 1,106 24 — Funds withheld at interest – embedded derivative (721) 191 — — — (530) — — Other investments 343 5 — — — 348 5 — Reinsurance recoverable 1,367 51 — 292 — 1,710 — — Assets of consolidated VIEs Trading securities 1,852 31 — 103 (48) 1,938 30 — Mortgage loans 2,173 2 — 51 — 2,226 2 — Investment funds 977 (66) — 339 (432) 818 (66) — Other investments 101 — — 53 — 154 1 — Total Level 3 assets $ 70,370 $ 1,936 $ 472 $ 27,466 $ (1,171) $ 99,073 $ 915 $ 477 Liabilities Interest sensitive contract liabilities Embedded derivative $ (9,059) $ (1,270) $ — $ (1,667) $ — $ (11,996) $ — $ — Universal life benefits (834) 14 — — — (820) — — Future policy benefits AmerUs Closed Block (1,178) 12 — — — (1,166) — — ILICO Closed Block and life benefits (522) (23) — — — (545) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (330) (123) — 52 64 (337) — — Total Level 3 liabilities $ (11,924) $ (1,390) $ — $ (1,615) $ 64 $ (14,865) $ — $ — 1 Related to instruments held at end of period. Nine months ended September 30, 2023 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 1 $ — $ (2) $ 47 $ — $ 46 $ — $ (2) Corporate 1,665 (9) (1) 1,170 (444) 2,381 — (7) ABS 4,867 — (36) 794 (999) 4,626 — (49) CMBS — — — — 12 12 — (1) RMBS 232 6 2 258 (235) 263 — — Trading securities 53 2 — (12) (11) 32 — — Equity securities 92 (5) — — (13) 74 (5) — Mortgage loans 27,454 (794) — 11,318 — 37,978 (792) — Funds withheld at interest – embedded derivative (4,847) (134) — — — (4,981) — — Short-term investments 36 — (3) 70 26 129 — (1) Other investments 441 (5) — 41 — 477 (7) — Investments in related parties AFS securities Corporate 812 2 (18) 175 215 1,186 — (18) CLO 303 — 15 185 — 503 — 15 ABS 5,542 7 38 1,968 284 7,839 (2) 32 Trading securities 878 6 — (13) — 871 3 — Equity securities 279 (2) — (32) — 245 (3) — Mortgage loans 1,302 (44) — (24) — 1,234 (44) — Investment funds 959 52 — 32 — 1,043 53 — Funds withheld at interest – embedded derivative (1,425) 453 — — — (972) — — Other investments 303 (18) — 42 — 327 (19) — Reinsurance recoverable 1,388 (87) — — — 1,301 — — Assets of consolidated VIEs Trading securities 622 (40) — (55) 1,331 1,858 (40) — Mortgage loans 2,055 (71) — 58 — 2,042 (71) — Investment funds 2,471 (7) — 73 (1,135) 1,402 (7) — Other investments 99 7 — (14) — 92 7 — Total Level 3 assets $ 45,582 $ (681) $ (5) $ 16,081 $ (969) $ 60,008 $ (927) $ (31) Liabilities Interest sensitive contract liabilities Embedded derivative $ (5,841) $ (277) $ — $ (1,227) $ — $ (7,345) $ — $ — Universal life benefits (829) 90 — — — (739) — — Future policy benefits AmerUs Closed Block (1,164) 64 — — — (1,100) — — ILICO Closed Block and life benefits (548) (3) — — — (551) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (142) (71) — — — (213) — — Total Level 3 liabilities $ (8,525) $ (197) $ — $ (1,227) $ — $ (9,949) $ — $ — 1 Related to instruments held at end of period.
Gross Components of Purchases, Sales, Issuances and Settlements, net	The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above: Three months ended September 30, 2024 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Corporate $ 912 $ — $ (16) $ (121) $ 775 $ 68 $ (4,868) $ (4,800) ABS 3,004 — (351) (451) 2,202 4,897 (218) 4,679 RMBS 81 — — (3) 78 — — — Trading securities — — — (1) (1) — — — Equity securities — — — — — — (9) (9) Mortgage loans 7,518 — — (2,672) 4,846 — — — Short-term investments 168 — — (2) 166 — (78) (78) Investments in related parties AFS securities Corporate 45 — (65) (3) (23) 201 — 201 CLO 42 — — — 42 — — — ABS 1,193 — — (2,067) (874) — — — Trading securities — — — (100) (100) — — — Mortgage loans — — — (14) (14) — — — Reinsurance recoverable — 94 — (1) 93 — — — Assets of consolidated VIEs Trading securities 38 — (4) — 34 34 (88) (54) Mortgage loans 70 — — (15) 55 — — — Investment funds 338 — — — 338 — (432) (432) Other investments 37 — — — 37 — — — Total Level 3 assets $ 13,446 $ 94 $ (436) $ (5,450) $ 7,654 $ 5,200 $ (5,693) $ (493) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (750) $ — $ 263 $ (487) $ — $ — $ — Other liabilities — — — 2 2 — — — Total Level 3 liabilities $ — $ (750) $ — $ 265 $ (485) $ — $ — $ — Three months ended September 30, 2023 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Corporate $ 26 $ — $ — $ (52) $ (26) $ — $ (20) $ (20) ABS 221 — (13) (463) (255) 357 (795) (438) RMBS 261 — — — 261 — (4) (4) Trading securities — — — (5) (5) — — — Mortgage loans 5,696 — (285) (1,251) 4,160 — — — Short-term investments 100 — — — 100 — — — Other investments 145 — — — 145 — — — Investments in related parties AFS securities Corporate 27 — — (3) 24 — — — ABS 426 — — (316) 110 — — — Trading securities 1 — (1) — — — — — Mortgage loans — — — (1) (1) — — — Assets of consolidated VIEs Trading securities 6 — (51) — (45) 526 — 526 Mortgage loans 4 — — (2) 2 — — — Investment funds 113 — (32) — 81 — — — Other investments 2 — (14) — (12) — — — Total Level 3 assets $ 7,028 $ — $ (396) $ (2,093) $ 4,539 $ 883 $ (819) $ 64 Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (573) $ — $ 175 $ (398) $ — $ — $ — Total Level 3 liabilities $ — $ (573) $ — $ 175 $ (398) $ — $ — $ —
Summary of the Unobservable Inputs for the Embedded Derivative of Fixed Indexed Annuities	The following summarizes the unobservable inputs for AFS, trading and equity securities, mortgage loans, investment funds and the embedded derivatives of fixed indexed annuities, including those of consolidated VIEs: September 30, 2024 (In millions, except percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 27,344 Discounted cash flow Discount rate 4.3 % 17.7 % 6.9 % 1 Decrease Mortgage loans 62,158 Discounted cash flow Discount rate 1.0 % 36.5 % 7.4 % 1 Decrease Investment funds 1,623 Discounted cash flow Discount rate 6.3 % 13.5 % 11.3 % 1 Decrease Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 11,996 Discounted cash flow Nonperformance risk 0.5 % 1.2 % 0.8 % 2 Decrease Option budget 0.5 % 6.0 % 2.7 % 3 Increase Surrender rate 6.2 % 14.0 % 8.7 % 3 Decrease December 31, 2023 (In millions, except percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 14,247 Discounted cash flow Discount rate 2.3 % 18.1 % 7.0 % 1 Decrease Mortgage loans 47,569 Discounted cash flow Discount rate 2.5 % 20.6 % 6.8 % 1 Decrease Investment funds 1,574 Discounted cash flow Discount rate 6.3 % 13.5 % 11.2 % 1 Decrease 483 Net tangible asset values Implied multiple 1.14x 1.14x 1.14x Increase Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 9,059 Discounted cash flow Nonperformance risk 0.4 % 1.4 % 0.9 % 2 Decrease Option budget 0.5 % 6.0 % 2.3 % 3 Increase Surrender rate 6.0 % 13.4 % 8.7 % 3 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities or loans. 2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative. 3 The option budget and surrender rate weighted averages are calculated based on projected account values. The following summarizes the unobservable inputs for market risk benefits: September 30, 2024 (In millions, except percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 4,089 Discounted cash flow Nonperformance risk 0.5 % 1.2 % 1.1 % 1 Decrease Option budget 0.5 % 6.0 % 2.2 % 2 Decrease Surrender rate 3.3 % 7.0 % 4.5 % 2 Decrease Utilization rate 28.6 % 95.0 % 84.7 % 3 Increase September 30, 2023 (In millions, except percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 2,590 Discounted cash flow Nonperformance risk 0.6 % 1.6 % 1.4 % 1 Decrease Option budget 0.5 % 5.9 % 1.9 % 2 Decrease Surrender rate 3.4 % 6.5 % 4.6 % 2 Decrease Utilization rate 28.6 % 95.0 % 83.2 % 3 Increase 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. 2 The option budget and surrender rate weighted averages are calculated based on projected account values. 3 The utilization of GLWB withdrawals represents the estimated percentage of policyholders that are expected to use their income rider over the duration of the contract, with the weighted average based on current account values.
Summary of Financial Instruments Not Carried at Fair Value on the Balance Sheet	The following represents our financial instruments not carried at fair value on the condensed consolidated balance sheets: September 30, 2024 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Investment funds $ 107 $ 107 $ 107 $ — $ — $ — Policy loans 320 320 — — 320 — Funds withheld at interest 23,812 23,812 — — — 23,812 Short-term investments 205 205 — — — 205 Other investments 17 28 — — — 28 Investments in related parties Investment funds 498 498 498 — — — Funds withheld at interest 5,974 5,974 — — — 5,974 Short-term investments 812 812 — — 812 — Total financial assets not carried at fair value $ 31,745 $ 31,756 $ 605 $ — $ 1,132 $ 30,019 Financial liabilities Interest sensitive contract liabilities $ 191,137 $ 187,554 $ — $ — $ — $ 187,554 Debt 5,725 5,448 — 591 4,857 — Securities to repurchase 2,666 2,666 — — 2,666 — Funds withheld liability 3,416 3,416 — — — 3,416 Total financial liabilities not carried at fair value $ 202,944 $ 199,084 $ — $ 591 $ 7,523 $ 190,970 December 31, 2023 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Investment funds $ 109 $ 109 $ 109 $ — $ — $ — Policy loans 334 334 — — 334 — Funds withheld at interest 27,738 27,738 — — — 27,738 Other investments 46 52 — — — 52 Investments in related parties Investment funds 550 550 550 — — — Funds withheld at interest 7,195 7,195 — — — 7,195 Short-term investments 947 947 — — 947 — Total financial assets not carried at fair value $ 36,919 $ 36,925 $ 659 $ — $ 1,281 $ 34,985 Financial liabilities Interest sensitive contract liabilities $ 154,095 $ 146,038 $ — $ — $ — $ 146,038 Debt 4,209 3,660 — — 3,660 — Securities to repurchase 3,853 3,853 — — 3,853 — Funds withheld liability 350 350 — — 350 — Total financial liabilities not carried at fair value $ 162,507 $ 153,901 $ — $ — $ 7,863 $ 146,038

Deferred Acquisition Costs, D_2

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Deferred Acquisition Costs	The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 7 – Long-duration Contracts for more information on our products. Nine months ended September 30, 2024 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2023 $ 890 $ 1,517 $ 10 $ 11 $ 970 $ 2,581 $ 5,979 Additions 404 751 36 — 479 — 1,670 Amortization (176) (131) (8) (1) (88) (274) (678) Balance at September 30, 2024 $ 1,118 $ 2,137 $ 38 $ 10 $ 1,361 $ 2,307 $ 6,971 Nine months ended September 30, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 426 609 2 3 447 — 1,487 Amortization (74) (69) (3) (1) (40) (315) (502) Other — — — — — (3) (3) Balance at September 30, 2023 $ 656 $ 1,295 $ 10 $ 11 $ 806 $ 2,670 $ 5,448
Deferred Sales Inducements	The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 7 – Long-duration Contracts for more information on our products. Nine months ended September 30, 2024 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2023 $ 890 $ 1,517 $ 10 $ 11 $ 970 $ 2,581 $ 5,979 Additions 404 751 36 — 479 — 1,670 Amortization (176) (131) (8) (1) (88) (274) (678) Balance at September 30, 2024 $ 1,118 $ 2,137 $ 38 $ 10 $ 1,361 $ 2,307 $ 6,971 Nine months ended September 30, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 426 609 2 3 447 — 1,487 Amortization (74) (69) (3) (1) (40) (315) (502) Other — — — — — (3) (3) Balance at September 30, 2023 $ 656 $ 1,295 $ 10 $ 11 $ 806 $ 2,670 $ 5,448

Long-duration Contracts (Tables

Long-duration Contracts (Tables)	9 Months Ended
Long-duration Contracts (Tables)	Sep. 30, 2024
Insurance [Abstract]
Policyholder Account Balance	The following represents a rollforward of the policyholder account balance by product within interest sensitive contract liabilities. Where explicit policyholder account balances do not exist, the disaggregated rollforward represents the recorded reserve. Nine months ended September 30, 2024 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at December 31, 2023 $ 64,763 $ 93,147 $ 32,350 $ 7,629 $ 197,889 Deposits 19,786 12,761 24,083 933 57,563 Policy charges (2) (522) — — (524) Surrenders and withdrawals (3,691) (9,724) — (63) (13,478) Benefit payments (830) (1,204) (7,746) (173) (9,953) Interest credited 2,323 2,313 1,173 152 5,961 Foreign exchange (1) 1 116 (56) 60 Other — — 421 (74) 347 Balance at September 30, 2024 $ 82,348 $ 96,772 $ 50,397 $ 8,348 $ 237,865 Weighted average crediting rate 4.3 % 2.6 % 4.5 % 2.6 % Net amount at risk $ 427 $ 15,221 $ — $ 65 Cash surrender value 78,049 89,378 — 7,112 Nine months ended September 30, 2023 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at December 31, 2022 $ 43,518 $ 92,660 $ 27,439 $ 4,722 $ 168,339 Deposits 18,011 8,960 4,893 3,760 35,624 Policy charges (2) (481) — — (483) Surrenders and withdrawals (8,207) (8,292) (110) (25) (16,634) Benefit payments (738) (1,216) (2,264) (223) (4,441) Interest credited 1,284 802 628 110 2,824 Foreign exchange (77) (1) (26) (344) (448) Other 1 63 77 (46) (1,419) (1,325) Balance at September 30, 2023 $ 53,852 $ 92,509 $ 30,514 $ 6,581 $ 183,456 Weighted average crediting rate 3.7 % 2.3 % 3.1 % 2.7 % Net amount at risk $ 425 $ 14,438 $ — $ 104 Cash surrender value 50,352 84,052 — 5,335 1 Other includes $1,371 million reduction of reserves related to the Venerable Insurance and Annuity Company (VIAC) recapture agreement. See Note 11 – Related Parties for further information.
Policyholder Account Balance and Liability for Unpaid Claims and Claims Adjustment Expense	The following is a reconciliation of interest sensitive contract liabilities to the condensed consolidated balance sheets: September 30, (In millions) 2024 2023 Traditional deferred annuities $ 82,348 $ 53,852 Indexed annuities 96,772 92,509 Funding agreements 50,397 30,514 Other investment-type 8,348 6,581 Reconciling items 1 7,571 5,609 Interest sensitive contract liabilities $ 245,436 $ 189,065 1 Reconciling items primarily include embedded derivatives in indexed annuities, unaccreted host contract adjustments on indexed annuities, negative VOBA, sales inducement liabilities, and wholly ceded universal life insurance contracts. The following is a reconciliation of future policy benefits to the condensed consolidated balance sheets: September 30, (In millions) 2024 2023 Payout annuities with life contingencies $ 44,705 $ 40,840 Whole life 2,219 — Reconciling items 1 6,038 5,832 Future policy benefits $ 52,962 $ 46,672 1 Reconciling items primarily include the deferred profit liability and negative VOBA associated with the liability for future policy benefits. Additionally, it includes term life reserves, fully ceded whole life reserves, and reserves for immaterial lines of business including accident and health and disability, as well as other insurance benefit reserves for no-lapse guarantees with universal life contracts, all of which are fully ceded.
Policyholder Account Balance, Guaranteed Minimum Crediting Rate	The following represents policyholder account balances by range of guaranteed minimum crediting rates, as well as the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums: September 30, 2024 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 28,488 $ 15,531 $ 126,352 $ 170,371 2.0% – < 4.0% 23,576 1,787 1,927 27,290 4.0% – < 6.0% 28,764 75 1 28,840 6.0% and greater 11,364 — — 11,364 Total $ 92,192 $ 17,393 $ 128,280 $ 237,865 September 30, 2023 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 28,564 $ 19,709 $ 90,121 $ 138,394 2.0% – < 4.0% 28,838 1,128 541 30,507 4.0% – < 6.0% 11,433 9 1 11,443 6.0% and greater 3,112 — — 3,112 Total $ 71,947 $ 20,846 $ 90,663 $ 183,456
Liability for Future Policy Benefit, Activity	The following is a rollforward by product within future policy benefits: Nine months ended September 30, 2024 (In millions, except percentages and years) Payout annuities with life contingencies Whole life Total Present value of expected net premiums Beginning balance $ — $ 1,182 $ 1,182 Effect of changes in discount rate assumptions — (45) (45) Effect of foreign exchange on the change in discount rate assumptions — (2) (2) Beginning balance at original discount rate — 1,135 1,135 Effect of actual to expected experience — (4) (4) Adjusted balance — 1,131 1,131 Interest accrual — 17 17 Net premium collected — (144) (144) Foreign exchange — (28) (28) Ending balance at original discount rate — 976 976 Effect of changes in discount rate assumptions — 41 41 Effect of foreign exchange on the change in discount rate assumptions — 1 1 Ending balance $ — $ 1,018 $ 1,018 Present value of expected future policy benefits Beginning balance $ 45,001 $ 3,371 $ 48,372 Effect of changes in discount rate assumptions 6,233 (89) 6,144 Effect of foreign exchange on the change in discount rate assumptions 1 (6) (5) Beginning balance at original discount rate 51,235 3,276 54,511 Effect of changes in cash flow assumptions (104) — (104) Effect of actual to expected experience (89) (4) (93) Adjusted balance 51,042 3,272 54,314 Issuances 1,010 — 1,010 Interest accrual 1,353 52 1,405 Benefit payments (3,355) (66) (3,421) Foreign exchange 33 (64) (31) Ending balance at original discount rate 50,083 3,194 53,277 Effect of changes in discount rate assumptions (5,362) 46 (5,316) Effect of foreign exchange on the change in discount rate assumptions (16) (3) (19) Ending balance $ 44,705 $ 3,237 $ 47,942 Net future policy benefits $ 44,705 $ 2,219 $ 46,924 Weighted-average liability duration (in years) 9.4 31.3 Weighted-average interest accretion rate 3.7 % 4.8 % Weighted-average current discount rate 5.0 % 4.0 % Expected future gross premiums, undiscounted $ — $ 1,255 Expected future gross premiums, discounted 1 — 1,064 Expected future benefit payments, undiscounted 73,523 10,235 1 Discounted at the original discount rate. The following is a reconciliation of premiums and interest expense relating to future policy benefits to the condensed consolidated statements of income: Premiums Interest expense Nine months ended September 30, Nine months ended September 30, (In millions) 2024 2023 2024 2023 Payout annuities with life contingencies $ 985 $ 9,142 $ 1,353 $ 1,194 Whole life 154 — 35 — Reconciling items 1 24 21 — — Total $ 1,163 $ 9,163 $ 1,388 $ 1,194 1 Reconciling items primarily relate to immaterial lines of business including term life, fully ceded whole life, and accident and health and disability.
Additional Liability, Long-Duration Insurance	The following is a summary of remeasurement gains (losses) included within future policy and other policy benefits on the condensed consolidated statements of income: Nine months ended September 30, (In millions) 2024 2023 Reserves $ 193 $ 333 Deferred profit liability (37) (243) Negative VOBA (52) (54) Total remeasurement gains (losses) $ 104 $ 36
Market Risk Benefit, Activity	The following is a rollfoward of net market risk benefit liabilities by product: Nine months ended September 30, 2024 (In millions, except years) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2023 $ 192 $ 3,181 $ 3,373 Effect of changes in instrument-specific credit risk 2 (10) (8) Balance, beginning of period, before changes in instrument-specific credit risk 194 3,171 3,365 Issuances — 270 270 Interest accrual 8 143 151 Attributed fees collected 1 265 266 Benefit payments (3) (39) (42) Effect of changes in interest rates (2) (34) (36) Effect of changes in equity — (115) (115) Effect of actual policyholder behavior compared to expected behavior 5 64 69 Effect of changes in future expected policyholder behavior (3) 88 85 Effect of changes in other future expected assumptions — (19) (19) Balance, end of period, before changes in instrument-specific credit risk 200 3,794 3,994 Effect of changes in instrument-specific credit risk 1 94 95 Balance at September 30, 2024 201 3,888 4,089 Less: Reinsurance recoverable — (40) (40) Balance at September 30, 2024, net of reinsurance $ 201 $ 3,848 $ 4,049 Net amount at risk $ 427 $ 15,221 Weighted-average attained age of contract holders (in years) 76 69 Nine months ended September 30, 2023 (In millions, except years) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2022 $ 170 $ 2,319 $ 2,489 Effect of changes in instrument-specific credit risk 13 353 366 Balance, beginning of period, before changes in instrument specific credit risk 183 2,672 2,855 Issuances — 47 47 Interest accrual 7 108 115 Attributed fees collected 2 250 252 Benefit payments (1) (24) (25) Effect of changes in interest rates (18) (591) (609) Effect of changes in equity — (26) (26) Effect of actual policyholder behavior compared to expected behavior 4 42 46 Effect of changes in future expected policyholder behavior (3) 78 75 Effect of changes in other future expected assumptions — 6 6 Balance, end of period, before changes in instrument-specific credit risk 174 2,562 2,736 Effect of changes in instrument-specific credit risk (7) (139) (146) Balance at September 30, 2023 $ 167 $ 2,423 $ 2,590 Net amount at risk $ 425 $ 14,438 Weighted-average attained age of contract holders (in years) 75 69 The following is a reconciliation of market risk benefits to the condensed consolidated balance sheets. Market risk benefit assets are included in other assets on the condensed consolidated balance sheets. September 30, 2024 September 30, 2023 (In millions) Asset Liability Net liability Asset Liability Net liability Traditional deferred annuities $ — $ 201 $ 201 $ — $ 167 $ 167 Indexed annuities 313 4,201 3,888 431 2,854 2,423 Total $ 313 $ 4,402 $ 4,089 $ 431 $ 3,021 $ 2,590
Summary of the Unobservable Inputs for the Embedded Derivative of Fixed Indexed Annuities	The following summarizes the unobservable inputs for AFS, trading and equity securities, mortgage loans, investment funds and the embedded derivatives of fixed indexed annuities, including those of consolidated VIEs: September 30, 2024 (In millions, except percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 27,344 Discounted cash flow Discount rate 4.3 % 17.7 % 6.9 % 1 Decrease Mortgage loans 62,158 Discounted cash flow Discount rate 1.0 % 36.5 % 7.4 % 1 Decrease Investment funds 1,623 Discounted cash flow Discount rate 6.3 % 13.5 % 11.3 % 1 Decrease Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 11,996 Discounted cash flow Nonperformance risk 0.5 % 1.2 % 0.8 % 2 Decrease Option budget 0.5 % 6.0 % 2.7 % 3 Increase Surrender rate 6.2 % 14.0 % 8.7 % 3 Decrease December 31, 2023 (In millions, except percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 14,247 Discounted cash flow Discount rate 2.3 % 18.1 % 7.0 % 1 Decrease Mortgage loans 47,569 Discounted cash flow Discount rate 2.5 % 20.6 % 6.8 % 1 Decrease Investment funds 1,574 Discounted cash flow Discount rate 6.3 % 13.5 % 11.2 % 1 Decrease 483 Net tangible asset values Implied multiple 1.14x 1.14x 1.14x Increase Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 9,059 Discounted cash flow Nonperformance risk 0.4 % 1.4 % 0.9 % 2 Decrease Option budget 0.5 % 6.0 % 2.3 % 3 Increase Surrender rate 6.0 % 13.4 % 8.7 % 3 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities or loans. 2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative. 3 The option budget and surrender rate weighted averages are calculated based on projected account values. The following summarizes the unobservable inputs for market risk benefits: September 30, 2024 (In millions, except percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 4,089 Discounted cash flow Nonperformance risk 0.5 % 1.2 % 1.1 % 1 Decrease Option budget 0.5 % 6.0 % 2.2 % 2 Decrease Surrender rate 3.3 % 7.0 % 4.5 % 2 Decrease Utilization rate 28.6 % 95.0 % 84.7 % 3 Increase September 30, 2023 (In millions, except percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 2,590 Discounted cash flow Nonperformance risk 0.6 % 1.6 % 1.4 % 1 Decrease Option budget 0.5 % 5.9 % 1.9 % 2 Decrease Surrender rate 3.4 % 6.5 % 4.6 % 2 Decrease Utilization rate 28.6 % 95.0 % 83.2 % 3 Increase 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. 2 The option budget and surrender rate weighted averages are calculated based on projected account values. 3 The utilization of GLWB withdrawals represents the estimated percentage of policyholders that are expected to use their income rider over the duration of the contract, with the weighted average based on current account values.

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following is a summary of our debt: Outstanding Balance (In millions, except percentages) Issue Date Maturity Date Principal Balance September 30, 2024 December 31, 2023 4.125% 2028 Senior Notes January 12, 2018 January 12, 2028 $ 1,000 $ 1,054 $ 1,066 6.150% 2030 Senior Notes April 3, 2020 April 3, 2030 500 582 593 3.500% 2031 Senior Notes October 8, 2020 January 15, 2031 500 521 523 6.650% 2033 Senior Notes November 21, 2022 February 1, 2033 400 395 395 5.875% 2034 Senior Notes December 12, 2023 January 15, 2034 600 584 583 3.950% 2051 Senior Notes May 25, 2021 May 25, 2051 500 545 545 3.450% 2052 Senior Notes December 13, 2021 May 15, 2052 500 504 504 6.250% 2054 Senior Notes March 22, 2024 April 1, 2054 1,000 982 — 7.250% 2064 Subordinated Notes March 7, 2024 March 30, 2064 575 558 — Total debt $ 5,575 $ 5,725 $ 4,209

Equity (Tables)

Equity (Tables)	9 Months Ended
Equity (Tables)	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income	The following provides the details and changes in AOCI: (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at June 30, 2024 $ (9,670) $ (277) $ (83) $ 4,218 $ 5 $ (2) $ (5,809) Other comprehensive income (loss) before reclassifications 5,142 (22) 225 (2,263) (93) 36 3,025 Less: Reclassification adjustments for gains (losses) realized in net income 1 (348) (8) 4 — — — (352) Less: Income tax expense (benefit) 1,122 (3) 47 (472) (20) 6 680 Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax 886 7 60 (596) (9) 7 355 Balance at September 30, 2024 $ (6,188) $ (295) $ 31 $ 3,023 $ (59) $ 21 $ (3,467) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at June 30, 2023 $ (11,049) $ (378) $ 26 $ 4,708 $ 312 $ 5 $ (6,376) Other comprehensive income (loss) before reclassifications (3,199) 33 (192) 1,317 (254) (21) (2,316) Less: Reclassification adjustments for gains (losses) realized in net income 1 (11) — 21 — — — 10 Less: Income tax expense (benefit) (654) 6 (46) 273 (52) (3) (476) Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax (577) (3) (26) 471 (8) (4) (147) Balance at September 30, 2023 $ (13,006) $ (348) $ (115) $ 5,281 $ 118 $ (9) $ (8,079) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2023 $ (8,672) $ (289) $ (82) $ 3,458 $ 3 $ 13 $ (5,569) Other comprehensive income (loss) before reclassifications 3,528 (19) 264 (832) (87) 15 2,869 Less: Reclassification adjustments for gains (losses) realized in net income 1 (237) (14) 35 — — — (216) Less: Income tax expense (benefit) 776 (1) 49 (176) (18) 2 632 Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax 505 2 67 (221) (7) 5 351 Balance at September 30, 2024 $ (6,188) $ (295) $ 31 $ 3,023 $ (59) $ 21 $ (3,467) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2022 $ (12,565) $ (334) $ 47 $ 5,256 $ 285 $ (10) $ (7,321) Other comprehensive income (loss) before reclassifications (1,841) (31) (214) 1,328 (220) 6 (972) Less: Reclassification adjustments for gains (losses) realized in net income 1 (105) — 66 — — — (39) Less: Income tax expense (benefit) (828) (12) (68) 777 (46) 2 (175) Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax (467) (5) (50) 526 (7) 3 — Balance at September 30, 2023 $ (13,006) $ (348) $ (115) $ 5,281 $ 118 $ (9) $ (8,079) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income.

Related Parties (Tables)

Related Parties (Tables)	9 Months Ended
Related Parties (Tables)	Sep. 30, 2024
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following table summarizes our investments in Athora: (In millions) September 30, 2024 December 31, 2023 Investment fund $ 1,106 $ 1,082 Non-redeemable preferred equity and corporate debt securities 296 249 Total investment in Athora $ 1,402 $ 1,331

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Restricted Pledged Assets and Funds in Trust	The total restricted assets included on the condensed consolidated balance sheets are as follows: (In millions) September 30, 2024 December 31, 2023 AFS securities $ 42,446 $ 32,458 Trading securities 1,777 139 Equity securities 304 80 Mortgage loans 23,171 14,257 Investment funds 777 409 Derivative assets 68 73 Short-term investments 14 153 Other investments 623 313 Restricted cash 974 1,761 Total restricted assets $ 70,154 $ 49,643

Investments - Schedule of AFS S

Investments - Schedule of AFS Securities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	$ 192,382		$ 162,016
AFS securities allowance for credit losses	(678)	$ (671)	(591)	$ (579)	$ (522)	$ (459)
Gross Unrealized Gains	2,914		1,709
Gross Unrealized Losses	(12,036)		(14,787)
Available-for-sale securities	$ 182,582		$ 148,347
Carrying Amount, Assets, Percent of Total	100%		100%
Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	$ 174,252		$ 147,561
AFS securities allowance for credit losses	(677)	(670)	(590)	(578)	(521)	(458)
Gross Unrealized Gains	2,826		1,653
Gross Unrealized Losses	(11,716)		(14,286)
Available-for-sale securities	164,685		134,338
Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	18,130		14,455
AFS securities allowance for credit losses	(1)		(1)	(1)		(1)
Gross Unrealized Gains	88		56
Gross Unrealized Losses	(320)		(501)
Available-for-sale securities	$ 17,897		$ 14,009
Carrying Amount, Assets, Percent of Total	8.50%		9.20%
U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	$ 7,501		$ 6,161
AFS securities allowance for credit losses	0		0
Gross Unrealized Gains	84		67
Gross Unrealized Losses	(824)		(829)
Available-for-sale securities	6,761		5,399
US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	1,175		1,296
AFS securities allowance for credit losses	0		0
Gross Unrealized Gains	2		0
Gross Unrealized Losses	(200)		(250)
Available-for-sale securities	977		1,046
Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	2,088		2,083
AFS securities allowance for credit losses	0		0	(27)	(27)	(27)
Gross Unrealized Gains	44		71
Gross Unrealized Losses	(374)		(255)
Available-for-sale securities	1,758		1,899
Corporate \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	95,432		88,343
AFS securities allowance for credit losses	(168)	(168)	(129)	(140)	(73)	(61)
Gross Unrealized Gains	1,309		830
Gross Unrealized Losses	(8,963)		(10,798)
Available-for-sale securities	87,610		78,246
Corporate \| Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	1,642		1,423
AFS securities allowance for credit losses	0		0
Gross Unrealized Gains	7		1
Gross Unrealized Losses	(35)		(72)
Available-for-sale securities	1,614		1,352
CLO \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	27,362		20,506
AFS securities allowance for credit losses	(1)	0	(2)	(3)	(3)	(7)
Gross Unrealized Gains	437		261
Gross Unrealized Losses	(188)		(558)
Available-for-sale securities	27,610		20,207
CLO \| Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	5,763		4,367
AFS securities allowance for credit losses	0		0	0		(1)
Gross Unrealized Gains	41		21
Gross Unrealized Losses	(24)		(120)
Available-for-sale securities	5,780		4,268
ABS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	22,488		13,942
AFS securities allowance for credit losses	(74)	(67)	(49)	(30)	(35)	(29)
Gross Unrealized Gains	500		120
Gross Unrealized Losses	(444)		(630)
Available-for-sale securities	22,470		13,383
ABS \| Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	10,725		8,665
AFS securities allowance for credit losses	(1)	(1)	(1)	(1)	(1)	0
Gross Unrealized Gains	40		34
Gross Unrealized Losses	(261)		(309)
Available-for-sale securities	10,503		8,389
CMBS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	9,704		7,070
AFS securities allowance for credit losses	(57)	(57)	(29)	(7)	(6)	(5)
Gross Unrealized Gains	112		52
Gross Unrealized Losses	(395)		(502)
Available-for-sale securities	9,364		6,591
RMBS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	8,502		8,160
AFS securities allowance for credit losses	(377)	$ (378)	(381)	$ (371)	$ (377)	$ (329)
Gross Unrealized Gains	338		252
Gross Unrealized Losses	(328)		(464)
Available-for-sale securities	$ 8,135		$ 7,567

Investments - Maturities of AFS

Investments - Maturities of AFS Securities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Amortized Cost
Amortized Cost	$ 192,382	$ 162,016
Fair Value
Total AFS fixed maturity securities	182,582	148,347
Consolidated Entity, excluding Affiliated Entity
Amortized Cost
Due in one year or less	2,407
Due after one year through five years	19,358
Due after five years through ten years	27,393
Due after ten years	57,038
CLO, ABS, CMBS and RMBS	68,056
Amortized Cost	174,252	147,561
Fair Value
Due in one year or less	2,394
Due after one year through five years	19,138
Due after five years through ten years	26,016
Due after ten years	49,558
CLO, ABS, CMBS and RMBS	67,579
Total AFS fixed maturity securities	164,685	134,338
Related Party
Amortized Cost
Due after one year through five years	1,028
Due after five years through ten years	43
Due after ten years	571
CLO, ABS, CMBS and RMBS	16,488
Amortized Cost	18,130	14,455
Fair Value
Due after one year through five years	1,024
Due after five years through ten years	45
Due after ten years	545
CLO, ABS, CMBS and RMBS	16,283
Total AFS fixed maturity securities	$ 17,897	$ 14,009

Investments - Unrealized Losses

Investments - Unrealized Losses on AFS Securities (Details) $ in Millions	Sep. 30, 2024 USD ($) security	Dec. 31, 2023 USD ($)
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	$ 18,408	$ 17,675
Fair Value, 12 months or greater	65,707	79,813
Total	84,115	97,488
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(611)	(801)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(10,967)	(13,567)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(11,578)	(14,368)
Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	15,114	14,722
Fair Value, 12 months or greater	61,251	74,046
Total	76,365	88,768
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(564)	(684)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(10,711)	(13,203)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ (11,275)	(13,887)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions \| security	6,167
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions \| security	7,058
Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	$ 3,294	2,953
Fair Value, 12 months or greater	4,456	5,767
Total	7,750	8,720
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(47)	(117)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(256)	(364)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ (303)	(481)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions \| security	62
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions \| security	139
U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	$ 1,031	2,013
Fair Value, 12 months or greater	3,795	2,389
Total	4,826	4,402
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(6)	(94)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(818)	(735)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(824)	(829)
US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	22	123
Fair Value, 12 months or greater	893	888
Total	915	1,011
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(1)	(5)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(198)	(245)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(199)	(250)
Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	886	690
Fair Value, 12 months or greater	737	760
Total	1,623	1,450
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(134)	(13)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(239)	(242)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(373)	(255)
Corporate \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	7,810	7,752
Fair Value, 12 months or greater	45,086	50,028
Total	52,896	57,780
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(314)	(474)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(8,624)	(10,311)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(8,938)	(10,785)
Corporate \| Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	211	548
Fair Value, 12 months or greater	368	382
Total	579	930
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(12)	(35)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(23)	(37)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(35)	(72)
CLO \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	3,742	689
Fair Value, 12 months or greater	3,146	11,579
Total	6,888	12,268
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(7)	(2)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(131)	(543)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(138)	(545)
CLO \| Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	680	397
Fair Value, 12 months or greater	690	2,592
Total	1,370	2,989
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(1)	(16)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(20)	(102)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(21)	(118)
ABS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	435	2,129
Fair Value, 12 months or greater	4,319	4,378
Total	4,754	6,507
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(93)	(75)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(258)	(458)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(351)	(533)
ABS \| Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	2,403	2,008
Fair Value, 12 months or greater	3,398	2,793
Total	5,801	4,801
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(34)	(66)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(213)	(225)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(247)	(291)
CMBS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	918	859
Fair Value, 12 months or greater	2,074	1,967
Total	2,992	2,826
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(5)	(12)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(341)	(406)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(346)	(418)
RMBS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	270	467
Fair Value, 12 months or greater	1,201	2,057
Total	1,471	2,524
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(4)	(9)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(102)	(263)
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ (106)	$ (272)

Investments - Allowance for Cre

Investments - Allowance for Credit Losses Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	$ 671	$ 522	$ 591	$ 459
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	20	73	111	111
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	1	0	40
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(18)	(11)	(37)	(25)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	5	(6)	13	(6)
Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	670	521	590	458
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	20	73	111	110
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	1	0	40
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(18)	(11)	(37)	(25)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	5	(6)	13	(5)
Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance			1	1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded				1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase				0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold				0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)				(1)
Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance		27	0	27
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		0		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		0		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		0		0
Corporate \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	168	73	129	61
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	0	67	48	88
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	(2)	(8)	(8)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	2	(1)	(1)
Corporate \| Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance			0
CLO \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	0	3	2	7
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	1	0	1	1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	0	(2)	(5)
CLO \| Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance			0	1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded				0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase				0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold				0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)				(1)
ABS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	67	35	49	29
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	13	1	25	2
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(14)	(4)	(15)	(4)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	8	(2)	15	3
ABS \| Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	1	1	1	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	0	0	0	1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	0	0	0
CMBS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	57	6	29	5
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	1	1	27	4
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	(1)	0	1	(2)
RMBS \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	378	377	381	329
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	5	4	10	15
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	1	0	40
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(4)	(5)	(14)	(13)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	$ (2)	$ (6)	0	$ 0
U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance			0
US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance			$ 0

Investments - Net Investment In

Investments - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Net Investment Income [Line Items]
Investment funds	$ 18,846		$ 18,846		$ 17,668
Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	4,125	$ 3,214	11,556	$ 8,811
Investment expenses	(348)	(286)	(978)	(759)
Net investment income	3,777	2,928	10,578	8,052
AFS securities \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	2,520	1,822	6,997	4,940
Trading securities \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	40	49	125	135
Equity securities \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	19	14	65	54
Mortgage loans \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	1,007	642	2,711	1,632
Investment funds \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment expenses	42	(13)	36	59
Funds withheld at interest \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	279	486	1,001	1,368
Other \| Consolidated Entity Excluding Variable Interest Entities (VIE)
Net Investment Income [Line Items]
Investment revenue	$ 218	$ 214	$ 621	$ 623

Investments - Investment Relate

Investments - Investment Related Gains (Losses) (Details) - Consolidated Entity Excluding Variable Interest Entities (VIE) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Gain (Loss) on Securities [Line Items]
Gross realized gains on investment activity	$ 744	$ 55	$ 936	$ 379
Gross realized losses on investment activity	(237)	(431)	(802)	(647)
Net realized investment gains (losses) on AFS securities	507	(376)	134	(268)
Net recognized investment gains (losses) on trading securities	119	(137)	21	(105)
Net recognized investment gains (losses) on equity securities	38	(3)	65	(34)
Investment related gains (losses)	1,539	(2,624)	3,082	(1,193)
Derivative gains (losses)	1,608	(1,480)	2,486	(66)
Provision for Loan, Lease, and Other Losses	(14)	(60)	(114)	(237)
Other gains (losses)	(1,858)	343	(384)	355
Mortgage loans
Gain (Loss) on Securities [Line Items]
Investment related gains (losses)	$ 1,139	$ (911)	$ 874	$ (838)

Investments - Unrealized gains

Investments - Unrealized gains (losses) recognized in income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Gain (Loss) on Securities [Line Items]
Proceeds from Sale of Debt Securities, Available-for-sale	$ 8,539	$ 724	$ 19,305	$ 3,918
Consolidated Entity, excluding Affiliated Entity
Gain (Loss) on Securities [Line Items]
Debt Securities, Trading, Unrealized Gain (Loss)	83	(75)	42	(35)
Equity Securities, FV-NI, Unrealized Gain (Loss)	28	6	56	9
Related Party
Gain (Loss) on Securities [Line Items]
Debt Securities, Trading, Unrealized Gain (Loss)	(1)	3	(2)	3
Equity Securities, FV-NI, Unrealized Gain (Loss)	$ 10	$ (9)	$ 2	$ (16)

Investments - Mortgage Loans, N

Investments - Mortgage Loans, Net (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans	$ 62,158	$ 47,569
Mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mark to fair value	(2,246)	(3,183)
Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	31,862	26,612
Mark to fair value	(1,926)	(2,246)
Investment Owned, Balance, Principal Amount	33,788	28,858
Commercial mortgage loans \| Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Investment Owned, Balance, Principal Amount	32,066	27,630
Commercial mortgage loans \| Commercial mortgage loans under development
Loans and Leases Receivable Disclosure [Line Items]
Investment Owned, Balance, Principal Amount	1,722	1,228
Residential mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	30,296	20,957
Mark to fair value	(320)	(937)
Investment Owned, Balance, Principal Amount	$ 30,616	$ 21,894

Investments - Mortgage Loans,_2

Investments - Mortgage Loans, Net by Property Type and Geographic Region (Details) - Commercial mortgage loans - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 31,862	$ 26,612
Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	100%	100%
Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	100%	100%
Total U.S. Region
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 26,380	$ 22,598
Total U.S. Region \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	82.80%	85%
East North Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,494	$ 1,517
East North Central \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	4.70%	5.70%
East South Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 443	$ 523
East South Central \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	1.30%	2%
Middle Atlantic
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 8,497	$ 7,147
Middle Atlantic \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	26.70%	26.90%
Mountain
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,335	$ 1,196
Mountain \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	4.20%	4.50%
New England
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,126	$ 1,295
New England \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	3.50%	4.90%
Pacific
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 5,788	$ 4,860
Pacific \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	18.20%	18.30%
South Atlantic
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 5,504	$ 4,583
South Atlantic \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	17.30%	17.20%
West North Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 228	$ 249
West North Central \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	0.70%	0.90%
West South Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,965	$ 1,228
West South Central \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	6.20%	4.60%
UNITED KINGDOM
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 2,638	$ 2,343
UNITED KINGDOM \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	8.30%	8.70%
Other
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 2,844	$ 1,671
Other \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	8.90%	6.30%
International
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 5,482	$ 4,014
International \| Geographic Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	17.20%	15%
Hotels
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 2,941	$ 2,913
Hotels \| Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	9.20%	11%
Retail
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 2,447	$ 2,158
Retail \| Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	7.70%	8.10%
Office building
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 4,140	$ 4,455
Office building \| Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	13%	16.70%
Industrial
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 6,144	$ 4,143
Industrial \| Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	19.30%	15.60%
Apartment
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 11,556	$ 9,591
Apartment \| Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	36.30%	36%
Other commercial
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 4,634	$ 3,352
Other commercial \| Property Type Concentration Risk \| Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	14.50%	12.60%

Investments - Mortgage Loans, R

Investments - Mortgage Loans, Residential by State (Details) - Geographic Concentration Risk - Residential mortgage loans - Mortgage Loans, Net	Sep. 30, 2024	Dec. 31, 2023
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	100%	100%
California
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	26.20%	27.60%
Florida
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	12.60%	12%
NEW YORK
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5.10%	5.90%
Other U.S. States
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	40.20%	39.40%
Total U.S. Region
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	91.10%	91%
UNITED KINGDOM
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5.10%	4%
Other
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	3.80%	5%
International
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	8.90%	9%
TEXAS
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	7%	6.10%

Investments - Investment Funds

Investments - Investment Funds (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 18,846	$ 17,668
Carrying Amount, Assets, Percent of Total	100%	100%
Consolidated Entity, excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 107	$ 109
Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 17,135	$ 15,927
Carrying Amount, Assets, Percent of Total	90.90%	90.20%
Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,604	$ 1,632
Carrying Amount, Assets, Percent of Total	8.50%	9.20%
Equity Funds \| Consolidated Entity, excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 107	$ 109
Carrying Amount, Assets, Percent of Total	0.60%	0.60%
Equity Funds \| Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 7,837	$ 7,032
Carrying Amount, Assets, Percent of Total	41.60%	39.80%
Equity Funds \| Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 264	$ 267
Carrying Amount, Assets, Percent of Total	1.40%	1.50%
Strategic Origination Platforms \| Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 5,519	$ 4,987
Carrying Amount, Assets, Percent of Total	29.30%	28.20%
Strategic Origination Platforms \| Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 28	$ 32
Carrying Amount, Assets, Percent of Total	0.20%	0.20%
Insurance Platforms \| Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 0	$ 483
Carrying Amount, Assets, Percent of Total	0%	2.70%
Insurance Platforms \| Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,287	$ 1,300
Carrying Amount, Assets, Percent of Total	6.80%	7.30%
Hybrid Funds \| Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 3,077	$ 2,852
Carrying Amount, Assets, Percent of Total	16.30%	16.20%
Hybrid Funds \| Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 16	$ 20
Carrying Amount, Assets, Percent of Total	0.10%	0.10%
Yield Fund \| Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 702	$ 573
Carrying Amount, Assets, Percent of Total	3.70%	3.30%
Yield Fund \| Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 9	$ 13
Carrying Amount, Assets, Percent of Total	0%	0.10%

Investments - Summary of Maximu

Investments - Summary of Maximum Loss Exposure (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Variable Interest Entity [Line Items]
Assets	$ 354,966	$ 300,579
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	117,530	92,042
Variable Interest Entity, Not Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Assets	103,995	79,636
Variable Interest Entity, Not Primary Beneficiary [Member] \| Investment funds
Variable Interest Entity [Line Items]
Assets	17,135	15,927
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	23,698	22,240
Variable Interest Entity, Not Primary Beneficiary, Consolidated Entity Exclude Affiliated \| Investment funds
Variable Interest Entity [Line Items]
Assets	107	109
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	862	876
Variable Interest Entity, Not Primary Beneficiary, Consolidated Entity Exclude Affiliated \| Fixed maturity securities
Variable Interest Entity [Line Items]
Assets	67,990	48,155
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	69,290	50,623
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity \| Investment funds
Variable Interest Entity [Line Items]
Assets	1,604	1,632
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	2,659	2,377
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity \| Fixed maturity securities
Variable Interest Entity [Line Items]
Assets	16,902	13,495
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	20,764	15,608
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity \| Equity securities
Variable Interest Entity [Line Items]
Assets	257	318
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 257	$ 318

Investments - Repurchase Agreem

Investments - Repurchase Agreements (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	$ 2,666	$ 3,853
Amortized Cost	3,109	4,659
Fair Value	2,810	4,071
Less than 30 days
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	0	686
91 days to 1 year
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	1,097	0
Greater than 1 year
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	1,569	3,167
Foreign governments
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	155	137
Fair Value	113	99
Corporate
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	1,770	2,735
Fair Value	1,549	2,307
Collateralized Loan Obligations
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	587	580
Fair Value	589	579
ABS
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	597	1,207
Fair Value	$ 559	$ 1,086

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Amounts loaned under reverse repurchase agreements	$ 1,017	$ 947
Fair value of collateral	$ 2,347	$ 1,504

Investments - Concentration of

Investments - Concentration of Equity (Details) - Stockholders' Equity, Total - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Wheels
Concentration Risk [Line Items]
Investments		$ 1,591
Atlas
Concentration Risk [Line Items]
Investments	$ 3,240
AP Grange Holdings, LLC
Concentration Risk [Line Items]
Investments	4,626
Fox Hedge L.P.
Concentration Risk [Line Items]
Investments	$ 3,050
AT&T Inc.
Concentration Risk [Line Items]
Investments		$ 1,526

Derivative Instruments - Summar

Derivative Instruments - Summary of Notional and Fair Value of Derivative Assets and Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Derivative [Line Items]
Derivative assets, fair value	$ 7,529		$ 7,529		$ 5,298
Derivative liabilities, fair value	2,758		2,758		1,995
Total derivative liabilities	14,834		14,834		10,990
Derivative Asset, Including Embedded Derivatives	4,418		4,418		1,198
Derivatives designated as hedges
Derivative [Line Items]
Derivative assets, fair value	885		885		781
Derivative liabilities, fair value	$ 842		$ 842		$ 954
Derivatives designated as hedges \| Foreign currency swaps
Derivative [Line Items]
Notional Amount	15,119		15,119		9,034
Derivative assets, fair value	$ 503		$ 503		$ 477
Derivative liabilities, fair value	$ 345		$ 345		$ 230
Derivatives designated as hedges \| Interest rate swaps
Derivative [Line Items]
Notional Amount	21,079		21,079		10,031
Derivative assets, fair value	$ 131		$ 131		$ 29
Derivative liabilities, fair value	$ 40		$ 40		$ 95
Derivatives designated as hedges \| Foreign currency forwards
Derivative [Line Items]
Notional Amount	3,691		3,691		6,294
Derivative assets, fair value	$ 195		$ 195		$ 275
Derivative liabilities, fair value	$ 36		$ 36		$ 102
Derivatives designated as hedges \| Cross Currency Interest Rate Contract
Derivative [Line Items]
Notional Amount	4,506		4,506		4,468
Derivative assets, fair value	$ 56		$ 56		$ 0
Derivative liabilities, fair value	418		418		521
Derivatives not designated as hedges
Derivative [Line Items]
Total derivative liabilities	13,992		13,992		10,036
Derivative Asset, Including Embedded Derivatives	$ 3,533		$ 3,533		$ 417
Derivatives not designated as hedges \| Foreign currency swaps
Derivative [Line Items]
Notional Amount	13,706		13,706		8,072
Derivative assets, fair value	$ 223		$ 223		$ 230
Derivative liabilities, fair value	$ 354		$ 354		$ 244
Derivatives not designated as hedges \| Interest rate swaps
Derivative [Line Items]
Notional Amount	1,870		1,870		3,499
Derivative assets, fair value	$ 76		$ 76		$ 81
Derivative liabilities, fair value	$ 1		$ 1		$ 9
Derivatives not designated as hedges \| Equity options
Derivative [Line Items]
Notional Amount	82,762		82,762		73,881
Derivative assets, fair value	$ 5,820		$ 5,820		$ 3,809
Derivative liabilities, fair value	$ 127		$ 127		$ 102
Derivatives not designated as hedges \| Futures
Derivative [Line Items]
Notional Amount	44		44		35
Derivative assets, fair value	$ 119		$ 119		$ 72
Derivative liabilities, fair value	$ 0		$ 0		$ 0
Derivatives not designated as hedges \| Foreign currency forwards
Derivative [Line Items]
Notional Amount	40,174		40,174		28,236
Derivative assets, fair value	$ 394		$ 394		$ 286
Derivative liabilities, fair value	1,433		1,433		685
Derivatives not designated as hedges \| Embedded derivatives \| Funds withheld
Derivative [Line Items]
Embedded derivative assets, fair value	(3,111)		(3,111)		(4,100)
Embedded derivative liabilities, fair value	80		80		(64)
Derivatives not designated as hedges \| Embedded derivatives \| Interest Sensitive Contracts
Derivative [Line Items]
Embedded derivative assets, fair value	0		0		0
Embedded derivative liabilities, fair value	$ 11,996		$ 11,996		$ 9,059
Derivatives not designated as hedges \| Other swaps
Derivative [Line Items]
Notional Amount	2,591		2,591		2,588
Derivative assets, fair value	$ 12		$ 12		$ 39
Derivative liabilities, fair value	$ 1		$ 1		$ 1
Net Investment Hedging \| Derivatives designated as hedges \| Foreign currency forwards
Derivative [Line Items]
Notional Amount	218		218		219
Derivative assets, fair value	$ 0		$ 0		$ 0
Derivative liabilities, fair value	3		3		$ 6
Fair Value Hedging \| Derivatives designated as hedges \| Foreign currency swaps
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	56	$ (239)	82	$ (182)
Fair Value Hedging \| Derivatives designated as hedges \| Foreign currency swaps \| Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(313)	161	(158)	59
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	282	(166)	144	(57)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(31)	(5)	(14)	2
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Interest rate swaps \| Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	382	(74)	267	(92)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(386)	63	(310)	79
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(4)	(11)	(43)	(13)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Foreign currency forwards
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	13	(65)	(2)	(63)
Fair Value Hedging \| Derivatives designated as hedges \| Foreign currency forwards \| Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	8	5	14	12
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(180)	179	(1)	74
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	184	(187)	1	(77)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	4	(8)	0	(3)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	4	21	35	66
Fair Value Hedging \| Derivatives designated as hedges \| Cross Currency Interest Rate Contract \| Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	255	(90)	132	(5)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(258)	95	(135)	15
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(3)	5	(3)	10
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Cross Currency Interest Rate Contract \| Interest sensitive contract benefits
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	26	16	66	44
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(25)	(14)	(64)	(44)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	1	2	2	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	$ 0	$ 0	$ 0	$ 0

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
Derivative Instruments - Narrative (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Derivative [Line Items]
Other Comprehensive Income (Loss), before Tax	$ 3,377,000,000	$ (2,326,000,000)	$ 3,085,000,000	$ (933,000,000)
Derivatives used in Net Investment Hedge, Net of Tax	15,000,000		15,000,000		$ 26,000,000
Amount of Ineffectiveness on Net Investment Hedges	0	0	0	0
Cash flow hedges \| Derivatives designated as hedges \| Interest rate swaps
Derivative [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	152,000,000	91,000,000	149,000,000	(35,000,000)
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months			0
Cash flow hedges \| Derivatives designated as hedges \| Foreign currency swaps
Derivative [Line Items]
Gain (Loss) on Foreign Currency Cash Flow Hedge Ineffectiveness	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Net Investment Hedging
Derivative [Line Items]
Other Comprehensive Income (Loss), before Tax	$ (14,000,000)	$ 13,000,000	$ (11,000,000)	$ 5,000,000

Derivative Instruments - Offset

Derivative Instruments - Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative assets
Gross amount recognized	$ 7,529	$ 5,298
Financial instruments	(1,739)	(1,497)
Collateral (received)/pledged	(5,272)	(3,676)
Net amount	518	125
Off-balance sheet securities collateral	0	0
Net amount after securities collateral	518	125
Derivative liabilities
Gross amount recognized	(2,758)	(1,995)
Financial instruments	1,739	1,497
Collateral (received)/pledged	1,091	848
Net amount	72	350
Off-balance sheet securities collateral	1	0
Net amount after securities collateral	73	350
Derivatives designated as hedges
Derivative assets
Gross amount recognized	885	781
Derivative liabilities
Gross amount recognized	(842)	(954)
Foreign currency forwards \| Derivatives designated as hedges
Derivative assets
Gross amount recognized	195	275
Derivative liabilities
Gross amount recognized	(36)	(102)
Foreign currency swaps \| Derivatives designated as hedges
Derivative assets
Gross amount recognized	503	477
Derivative liabilities
Gross amount recognized	(345)	(230)
Cross Currency Interest Rate Contract \| Derivatives designated as hedges
Derivative assets
Gross amount recognized	56	0
Derivative liabilities
Gross amount recognized	(418)	(521)
Interest rate swaps \| Derivatives designated as hedges
Derivative assets
Gross amount recognized	131	29
Derivative liabilities
Gross amount recognized	(40)	(95)
Fixed maturity securities \| Foreign currency forwards \| Fair Value Hedging \| Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	3,851	4,883
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	(13)	(15)
Fixed maturity securities \| Foreign currency swaps \| Fair Value Hedging \| Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	11,588	6,820
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	71	(141)
Interest Sensitive Contracts \| Foreign currency swaps \| Fair Value Hedging \| Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	2,507	1,438
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	(44)	19
Interest Sensitive Contracts \| Cross Currency Interest Rate Contract \| Fair Value Hedging \| Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	4,220	4,010
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	205	363
Interest Sensitive Contracts \| Interest rate swaps \| Fair Value Hedging \| Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	17,483	6,910
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	$ (121)	$ 189

Derivative Instruments - Gains

Derivative Instruments - Gains (Losses) on Derivatives Not Designated as Hedging (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	$ 1,177	$ (431)	$ 927	$ (457)
Investment related gains (losses)
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	1,452	(1,682)	2,197	(180)
Investment related gains (losses) \| Equity options
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	596	(951)	2,298	390
Investment related gains (losses) \| Futures
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	26	(73)	152	22
Investment related gains (losses) \| Swaps
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	(126)	(24)	(156)	38
Investment related gains (losses) \| Foreign currency forwards
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	209	146	(657)	(191)
Investment related gains (losses) \| Embedded derivatives
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	747	(780)	560	(439)
Interest sensitive contract benefits \| Embedded derivatives
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	(275)	1,251	(1,270)	(277)
Fair Value Hedging \| Derivatives designated as hedges \| Investment related gains (losses) \| Foreign currency swaps
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(313)	161	(158)	59
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	282	(166)	144	(57)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(31)	(5)	(14)	2
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Investment related gains (losses) \| Interest rate swaps
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	382	(74)	267	(92)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(386)	63	(310)	79
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(4)	(11)	(43)	(13)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Investment related gains (losses) \| Foreign currency forwards
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(180)	179	(1)	74
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	184	(187)	1	(77)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	4	(8)	0	(3)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	4	21	35	66
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	8	5	14	12
Fair Value Hedging \| Derivatives designated as hedges \| Investment related gains (losses) \| Cross Currency Interest Rate Contract
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	255	(90)	132	(5)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(258)	95	(135)	15
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(3)	5	(3)	10
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Fair Value Hedging \| Derivatives designated as hedges \| Interest sensitive contract benefits \| Cross Currency Interest Rate Contract
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	26	16	66	44
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(25)	(14)	(64)	(44)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	1	2	2	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	$ 0	$ 0	$ 0	$ 0

Variable Interest Entities (Det

Variable Interest Entities (Details) - Variable Interest Entities - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Variable Interest Entity [Line Items]
Net Investment Income	$ 77	$ 75	$ 210	$ 210
Investment related gains (losses)	469	250	1,109	744
Other gains (losses)	2	(1)	(7)	(29)
Mortgage loans
Variable Interest Entity [Line Items]
Investment related gains (losses)	24	(25)	(4)	(45)
Investment funds
Variable Interest Entity [Line Items]
Investment related gains (losses)	414	292	1,099	833
Mortgage loans
Variable Interest Entity [Line Items]
Investment revenue	(30)	(29)	(91)	(83)
Investment funds
Variable Interest Entity [Line Items]
Investment expenses	22	20	43	55
Other
Variable Interest Entity [Line Items]
Investment expenses	(14)	(2)	(28)	(7)
Trading securities
Variable Interest Entity [Line Items]
Investment revenue	(39)	(28)	(104)	(79)
Investment related gains (losses)	$ 29	$ (16)	$ 21	$ (15)

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Assets
Available-for-sale securities	$ 182,582	$ 148,347
Investment funds	18,846	17,668
Derivative assets	7,529	5,298
Restricted cash	964
Reinsurance recoverable	7,454	4,154
Other assets (related party: 2024 – $207 and 2023 – $189)	10,726	10,179
Liabilities
Interest sensitive contract liabilities	245,436	204,670	$ 189,065
Future policy benefits	52,962	53,287	46,672
Market Risk Benefits	4,402	3,751	$ 3,021
Derivative liabilities	2,758	1,995
Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	164,685	134,338
Trading securities, at fair value	1,684	1,706
Mortgage loans	58,587	44,115
Investment funds	107	109
Funds withheld at interest	(21,231)	(24,359)
Derivative assets	7,529	5,298
Short-term investments	614	341
Other investments	1,727	1,206
Related Party
Assets
Available-for-sale securities	17,897	14,009
Trading securities, at fair value	619	838
Equity securities, at fair value	257	318
Mortgage loans	1,345	1,281
Investment funds	1,604	1,632
Funds withheld at interest	(5,444)	(6,474)
Short-term investments	812	947
Other investments	348	343
Reinsurance recoverable	3,372	0
Other assets (related party: 2024 – $207 and 2023 – $189)	207	189
Liabilities
Interest sensitive contract liabilities	7,085	8,599
Future policy benefits	23	9
Market Risk Benefits	257	227
Variable Interest Entities
Assets
Trading securities, at fair value	2,379	2,136
Mortgage loans	2,226	2,173
Investment funds	17,135	15,927
Other investments	159	103
Restricted cash	10	0
Other assets (related party: 2024 – $207 and 2023 – $189)	192	110
U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,761	5,399
US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	977	1,046
Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	1,758	1,899
Corporate \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	87,610	78,246
Corporate \| Related Party
Assets
Available-for-sale securities	1,614	1,352
CLO \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	27,610	20,207
CLO \| Related Party
Assets
Available-for-sale securities	5,780	4,268
ABS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	22,470	13,383
ABS \| Related Party
Assets
Available-for-sale securities	10,503	8,389
CMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	9,364	6,591
RMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	8,135	7,567
Level 3
Assets
Mortgage loans	62,158	47,569
Recurring \| Level 1
Assets
Cash and cash equivalents	13,587	13,020
Restricted cash	964	1,761
Reinsurance recoverable	0
Other assets (related party: 2024 – $207 and 2023 – $189)	0	0
Total assets measured at fair value	22,964	21,581
Liabilities
Market Risk Benefits	0	0
Derivative liabilities	1	17
Other liabilities	0	0
Total liabilities measured at fair value	1	17
Recurring \| Level 1 \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	7,527	6,297
Trading securities, at fair value	24	24
Equity securities, at fair value	207	210
Mortgage loans	0	0
Derivative assets	143	108
Short-term investments	202	0
Other investments	0	0
Recurring \| Level 1 \| Related Party
Assets
Available-for-sale securities	0	0
Trading securities, at fair value	0	0
Equity securities, at fair value	0	63
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Reinsurance recoverable		0
Recurring \| Level 1 \| Variable Interest Entities
Assets
Trading securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	0	0
Other investments	5	0
Cash and cash equivalents	305	98
Recurring \| Level 1 \| Universal life
Liabilities
Interest sensitive contract liabilities	0	0
Recurring \| Level 1 \| AmerUs Closed Block
Liabilities
Future policy benefits	0	0
Recurring \| Level 1 \| ILICO Closed Block and life benefits
Liabilities
Future policy benefits	0	0
Recurring \| Level 1 \| Embedded derivatives
Liabilities
Interest sensitive contract liabilities	0	0
Recurring \| Level 1 \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		0
Recurring \| Level 1 \| Embedded derivatives \| Related Party
Assets
Funds withheld at interest		0
Recurring \| Level 1 \| U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,759	5,392
Recurring \| Level 1 \| US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	756	895
Recurring \| Level 1 \| Corporate \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	12	10
Recurring \| Level 1 \| Corporate \| Related Party
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| CLO \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| CLO \| Related Party
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| ABS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| ABS \| Related Party
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| CMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 1 \| RMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 2
Assets
Cash and cash equivalents	0	0
Restricted cash	0	0
Reinsurance recoverable	0
Other assets (related party: 2024 – $207 and 2023 – $189)	0	0
Total assets measured at fair value	154,265	131,131
Liabilities
Market Risk Benefits	0	0
Derivative liabilities	2,756	1,977
Other liabilities	0	(64)
Total liabilities measured at fair value	2,756	1,913
Recurring \| Level 2 \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	136,973	118,247
Trading securities, at fair value	1,623	1,654
Equity securities, at fair value	1,059	699
Mortgage loans	0	0
Derivative assets	7,385	5,190
Short-term investments	39	236
Other investments	603	313
Recurring \| Level 2 \| Related Party
Assets
Available-for-sale securities	6,142	4,506
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Reinsurance recoverable		0
Recurring \| Level 2 \| Variable Interest Entities
Assets
Trading securities, at fair value	441	284
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	2
Cash and cash equivalents	0	0
Recurring \| Level 2 \| Universal life
Liabilities
Interest sensitive contract liabilities	0	0
Recurring \| Level 2 \| AmerUs Closed Block
Liabilities
Future policy benefits	0	0
Recurring \| Level 2 \| ILICO Closed Block and life benefits
Liabilities
Future policy benefits	0	0
Recurring \| Level 2 \| Embedded derivatives
Liabilities
Interest sensitive contract liabilities	0	0
Recurring \| Level 2 \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		0
Recurring \| Level 2 \| Embedded derivatives \| Related Party
Assets
Funds withheld at interest		0
Recurring \| Level 2 \| U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	2	7
Recurring \| Level 2 \| US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	977	1,046
Recurring \| Level 2 \| Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	967	964
Recurring \| Level 2 \| Corporate \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	83,423	75,711
Recurring \| Level 2 \| Corporate \| Related Party
Assets
Available-for-sale securities	233	181
Recurring \| Level 2 \| CLO \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	27,610	20,207
Recurring \| Level 2 \| CLO \| Related Party
Assets
Available-for-sale securities	5,215	3,762
Recurring \| Level 2 \| ABS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,855	6,440
Recurring \| Level 2 \| ABS \| Related Party
Assets
Available-for-sale securities	694	563
Recurring \| Level 2 \| CMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	9,347	6,570
Recurring \| Level 2 \| RMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	7,792	7,302
Recurring \| Level 3
Assets
Cash and cash equivalents	0	0
Restricted cash	0	0
Reinsurance recoverable	1,710
Other assets (related party: 2024 – $207 and 2023 – $189)	313	378
Total assets measured at fair value	99,386	70,748
Liabilities
Market Risk Benefits	4,402	3,751
Derivative liabilities	1	1
Other liabilities	337	330
Total liabilities measured at fair value	19,267	15,675
Recurring \| Level 3 \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	20,185	9,794
Trading securities, at fair value	37	28
Equity securities, at fair value	26	26
Mortgage loans	58,587	44,115
Derivative assets	1	0
Short-term investments	168	105
Other investments	904	630
Recurring \| Level 3 \| Related Party
Assets
Available-for-sale securities	11,755	9,503
Trading securities, at fair value	619	838
Equity securities, at fair value	257	255
Mortgage loans	1,345	1,281
Investment funds	1,106	1,082
Other investments	348	343
Reinsurance recoverable		1,367
Recurring \| Level 3 \| Variable Interest Entities
Assets
Trading securities, at fair value	1,938	1,852
Mortgage loans	2,226	2,173
Investment funds	818	977
Other investments	154	101
Cash and cash equivalents	0	0
Recurring \| Level 3 \| Universal life
Liabilities
Interest sensitive contract liabilities	820	834
Recurring \| Level 3 \| AmerUs Closed Block
Liabilities
Future policy benefits	1,166	1,178
Recurring \| Level 3 \| ILICO Closed Block and life benefits
Liabilities
Future policy benefits	545	522
Recurring \| Level 3 \| Embedded derivatives
Liabilities
Interest sensitive contract liabilities	11,996	9,059
Recurring \| Level 3 \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		3,379
Recurring \| Level 3 \| Embedded derivatives \| Related Party
Assets
Funds withheld at interest		(721)
Recurring \| Level 3 \| U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 3 \| US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 3 \| Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	35	40
Recurring \| Level 3 \| Corporate \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	4,175	2,525
Recurring \| Level 3 \| Corporate \| Related Party
Assets
Available-for-sale securities	1,381	1,171
Recurring \| Level 3 \| CLO \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| Level 3 \| CLO \| Related Party
Assets
Available-for-sale securities	565	506
Recurring \| Level 3 \| ABS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	15,615	6,943
Recurring \| Level 3 \| ABS \| Related Party
Assets
Available-for-sale securities	9,809	7,826
Recurring \| Level 3 \| CMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	17	21
Recurring \| Level 3 \| RMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	343	265
Recurring \| NAV
Assets
Cash and cash equivalents	0	0
Restricted cash	0	0
Reinsurance recoverable	0
Other assets (related party: 2024 – $207 and 2023 – $189)	0	0
Total assets measured at fair value	16,317	14,950
Liabilities
Market Risk Benefits	0	0
Derivative liabilities	0	0
Other liabilities	0	0
Total liabilities measured at fair value	0	0
Recurring \| NAV \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Derivative assets	0	0
Short-term investments	0	0
Other investments	0	0
Recurring \| NAV \| Related Party
Assets
Available-for-sale securities	0	0
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Reinsurance recoverable		0
Recurring \| NAV \| Variable Interest Entities
Assets
Trading securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	16,317	14,950
Other investments	0	0
Cash and cash equivalents	0	0
Recurring \| NAV \| Universal life
Liabilities
Interest sensitive contract liabilities	0	0
Recurring \| NAV \| AmerUs Closed Block
Liabilities
Future policy benefits	0	0
Recurring \| NAV \| ILICO Closed Block and life benefits
Liabilities
Future policy benefits	0	0
Recurring \| NAV \| Embedded derivatives
Liabilities
Interest sensitive contract liabilities	0	0
Recurring \| NAV \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		0
Recurring \| NAV \| Embedded derivatives \| Related Party
Assets
Funds withheld at interest		0
Recurring \| NAV \| U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| Corporate \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| Corporate \| Related Party
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| CLO \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| CLO \| Related Party
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| ABS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| ABS \| Related Party
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| CMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring \| NAV \| RMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Fair Value
Assets
Total assets measured at fair value	31,756	36,925
Liabilities
Interest sensitive contract liabilities	187,554	146,038
Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	107	109
Funds withheld at interest	(23,812)	(27,738)
Short-term investments	205
Other investments	28	52
Fair Value \| Related Party
Assets
Investment funds	498	550
Funds withheld at interest	(5,974)	(7,195)
Short-term investments	812	947
Fair Value \| Level 1
Assets
Total assets measured at fair value	0	0
Liabilities
Interest sensitive contract liabilities	0	0
Fair Value \| Level 1 \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0
Other investments	0	0
Fair Value \| Level 1 \| Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0	0
Fair Value \| Level 2
Assets
Total assets measured at fair value	1,132	1,281
Liabilities
Interest sensitive contract liabilities	0	0
Fair Value \| Level 2 \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0
Other investments	0	0
Fair Value \| Level 2 \| Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	812	947
Fair Value \| Level 3
Assets
Total assets measured at fair value	30,019	34,985
Liabilities
Interest sensitive contract liabilities	187,554	146,038
Fair Value \| Level 3 \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Funds withheld at interest	(23,812)	(27,738)
Short-term investments	205
Other investments	28	52
Fair Value \| Level 3 \| Related Party
Assets
Investment funds	0	0
Funds withheld at interest	(5,974)	(7,195)
Short-term investments	0	0
Fair Value \| NAV
Assets
Total assets measured at fair value	605	659
Liabilities
Interest sensitive contract liabilities	0	0
Fair Value \| NAV \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	107	109
Funds withheld at interest	0	0
Short-term investments	0
Other investments	0	0
Fair Value \| NAV \| Related Party
Assets
Investment funds	498	550
Funds withheld at interest	0	0
Short-term investments	0	0
Fair Value \| Recurring
Assets
Cash and cash equivalents	13,587	13,020
Restricted cash	964	1,761
Reinsurance recoverable	1,710	1,367
Other assets (related party: 2024 – $207 and 2023 – $189)	313	378
Total assets measured at fair value	292,932	238,410
Liabilities
Interest sensitive contract liabilities	12,816	9,893
Future policy benefits	1,711	1,700
Market Risk Benefits	4,402	3,751
Derivative liabilities	2,758	1,995
Other liabilities	337	266
Total liabilities measured at fair value	22,024	17,605
Fair Value \| Recurring \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	164,685	134,338
Trading securities, at fair value	1,684	1,706
Equity securities, at fair value	1,292	935
Mortgage loans	58,587	44,115
Embedded derivative assets, fair value	(2,581)	(3,379)
Derivative assets	7,529	5,298
Short-term investments	409	341
Other investments	1,507	943
Fair Value \| Recurring \| Related Party
Assets
Available-for-sale securities	17,897	14,009
Trading securities, at fair value	619	838
Equity securities, at fair value	257	318
Mortgage loans	1,345	1,281
Investment funds	1,106	1,082
Embedded derivative assets, fair value	(530)	(721)
Other investments	348	343
Reinsurance recoverable		1,367
Fair Value \| Recurring \| Variable Interest Entities
Assets
Trading securities, at fair value	2,379	2,136
Mortgage loans	2,226	2,173
Investment funds	17,135	15,927
Other investments	159	103
Cash and cash equivalents	305	98
Fair Value \| Recurring \| Universal life
Liabilities
Interest sensitive contract liabilities	820	834
Fair Value \| Recurring \| AmerUs Closed Block
Liabilities
Future policy benefits	1,166	1,178
Fair Value \| Recurring \| ILICO Closed Block and life benefits
Liabilities
Future policy benefits	545	522
Fair Value \| Recurring \| Embedded derivatives
Liabilities
Interest sensitive contract liabilities	11,996	9,059
Fair Value \| Recurring \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		3,379
Fair Value \| Recurring \| Embedded derivatives \| Related Party
Assets
Funds withheld at interest		(721)
Fair Value \| Recurring \| U.S. government and agencies \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,761	5,399
Fair Value \| Recurring \| US States and Political Subdivisions Debt Securities \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	977	1,046
Fair Value \| Recurring \| Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	1,758	1,899
Fair Value \| Recurring \| Corporate \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	87,610	78,246
Fair Value \| Recurring \| Corporate \| Related Party
Assets
Available-for-sale securities	1,614	1,352
Fair Value \| Recurring \| CLO \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	27,610	20,207
Fair Value \| Recurring \| CLO \| Related Party
Assets
Available-for-sale securities	5,780	4,268
Fair Value \| Recurring \| ABS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	22,470	13,383
Fair Value \| Recurring \| ABS \| Related Party
Assets
Available-for-sale securities	10,503	8,389
Fair Value \| Recurring \| CMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	9,364	6,591
Fair Value \| Recurring \| RMBS \| Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	8,135	$ 7,567
Funds withheld at interest \| Recurring \| Level 1 \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest \| Recurring \| Level 1 \| Embedded derivatives \| Related Party
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest \| Recurring \| Level 2 \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest \| Recurring \| Level 2 \| Embedded derivatives \| Related Party
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest \| Recurring \| Level 3 \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	(2,581)
Funds withheld at interest \| Recurring \| Level 3 \| Embedded derivatives \| Related Party
Assets
Embedded derivative assets, fair value	(530)
Funds withheld at interest \| Recurring \| NAV \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest \| Recurring \| NAV \| Embedded derivatives \| Related Party
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest \| Fair Value \| Recurring \| Embedded derivatives \| Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	(2,581)
Funds withheld at interest \| Fair Value \| Recurring \| Embedded derivatives \| Related Party
Assets
Embedded derivative assets, fair value	$ (530)

Fair Value - Fair Value Option

Fair Value - Fair Value Option (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	$ 1,313	$ (1,132)	$ 938	$ (996)
Mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	1,186	(984)	868	(909)
Unpaid principal balance	64,404		64,404		$ 50,752
Mark to fair value	(2,246)		(2,246)		(3,183)
Fair value	62,158		62,158		47,569
Fair Value, Option, Credit Risk, Gains (Losses) on Assets	(19)	(20)	(49)	(31)
Residential mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value option, loans, 90 days or more past due	776		776		479
Fair Value, Option, Loans Held as Assets, Aggregate Amount in Nonaccrual Status	679		679		355
Unpaid principal balance	850		850		528
Fair value	776		776		479
Fair Value, Option, Loans Held as Assets, Aggregate Difference	(74)		(74)		(49)
Residential mortgage loans \| Loans Insured or Guaranteed by US Government Authorities
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value option, loans, 90 days or more past due	97		97		124
Fair Value Option, Other Eligible Items
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	5	(4)	9	(71)
Commercial mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value option, loans, 90 days or more past due	254		254		64
Fair Value, Option, Loans Held as Assets, Aggregate Amount in Nonaccrual Status	316		316		147
Unpaid principal balance	507		507		221
Fair value	316		316		147
Fair Value, Option, Loans Held as Assets, Aggregate Difference	(191)		(191)		$ (74)
Investment related gains (losses) \| Trading securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	131	(137)	31	(105)
Net investment income \| Investment funds
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	37	(66)	18	25
Future policy and other policy benefits \| Future policy benefits
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	$ (46)	$ 59	$ 12	$ 64

Fair Value - Reconciliation of

Fair Value - Reconciliation of Level 3 Financial Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 89,074	$ 56,969	$ 70,370	$ 45,582
Total realized and unrealized gains (losses) included in income	2,358	(1,537)	1,936	(681)
Total realized and unrealized gains (losses) included in OCI	480	(27)	472	(5)
Purchases, issuances, sales and settlements, net	7,654	4,539	27,466	16,081
Transfers in	(493)	64	(1,171)	(969)
Transfers (out)	5,693	819	2,350	4,077
Ending balance	99,073	60,008	99,073	60,008
Total gains (losses) included in earnings1	1,400	(1,100)	915	(927)
Total gains (losses) included in OCI1	482	(42)	477	(31)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(13,906)	(10,992)	(11,924)	(8,525)
Total realized and unrealized gains (losses) included in income	(474)	1,441	(1,390)	(197)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	485	398	1,615	1,227
Transfers in	0	0	64	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	5,200	883	1,179	3,108
Purchases	13,446	7,028	38,703	21,958
Issuances	94	0	294	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	(436)	(396)	(1,138)	(723)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(5,450)	(2,093)	(10,393)	(5,154)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	0	64	0
Ending balance	(14,865)	(9,949)	(14,865)	(9,949)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0	0	0
Reinsurance recoverable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,518	1,436	1,367	1,388
Total realized and unrealized gains (losses) included in income	99	(135)	51	(87)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	93	0	292	0
Transfers in	0	0	0	0
Transfers (out)	0		0
Ending balance	1,710	1,301	1,710	1,301
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0		0
Purchases	0		0
Issuances	94		294
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(1)		(2)
Short-term investments \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	80	30	105	36
Total realized and unrealized gains (losses) included in income	0	0	0	0
Total realized and unrealized gains (losses) included in OCI	0	(1)	0	(3)
Purchases, issuances, sales and settlements, net	166	100	142	70
Transfers in	(78)	0	(79)	26
Ending balance	168	129	168	129
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	0	(1)	0	(1)
Short-term investments \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	166	100	142	70
Transfers in	(78)	0	(79)	26
Transfers (out)	78	0	79	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	26
Purchases	168	100	171	100
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	(6)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(2)	0	(23)	(30)
Equity securities \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	36	67	26	92
Total realized and unrealized gains (losses) included in income	(1)	7	(1)	(5)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	1	0
Transfers in	(9)	0	0	(13)
Ending balance	26	74	26	74
Total gains (losses) included in earnings1	0	7	0	(5)
Total gains (losses) included in OCI1	0	0	0	0
Equity securities \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	247	252	255	279
Total realized and unrealized gains (losses) included in income	10	(7)	2	(2)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	(32)
Transfers in	0	0	0	0
Transfers (out)				0
Ending balance	257	245	257	245
Total gains (losses) included in earnings1	10	(7)	2	(3)
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Purchases				0
Issuances				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements				(32)
Equity securities \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	0		1	0
Transfers in	(9)		0	(13)
Transfers (out)	9		9	13
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0		9	0
Purchases	0		2	0
Issuances	0		0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0		(1)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	0		0	0
Mortgage loans \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	52,645	34,668	44,115	27,454
Total realized and unrealized gains (losses) included in income	1,096	(850)	825	(794)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	4,846	4,160	13,647	11,318
Transfers in	0	0	0	0
Ending balance	58,587	37,978	58,587	37,978
Total gains (losses) included in earnings1	1,236	(850)	965	(792)
Total gains (losses) included in OCI1	0	0	0	0
Mortgage loans \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,320	1,296	1,281	1,302
Total realized and unrealized gains (losses) included in income	39	(61)	41	(44)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	(14)	(1)	23	(24)
Transfers in	0	0	0	0
Transfers (out)	0	0	0	0
Ending balance	1,345	1,234	1,345	1,234
Total gains (losses) included in earnings1	(43)	(61)	(41)	(44)
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Purchases	0	0	87	0
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(14)	(1)	(64)	(24)
Mortgage loans \| Variable Interest Entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	2,120	2,113	2,173	2,055
Total realized and unrealized gains (losses) included in income	51	(73)	2	(71)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	55	2	51	58
Transfers in	0	0	0	0
Transfers (out)	0	0	0	0
Ending balance	2,226	2,042	2,226	2,042
Total gains (losses) included in earnings1	51	(73)	2	(71)
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Purchases	70	4	125	63
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(15)	(2)	(74)	(5)
Mortgage loans \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	4,846	4,160	13,647	11,318
Transfers in	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Purchases	7,518	5,696	19,226	14,361
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	(285)	(26)	(348)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(2,672)	(1,251)	(5,553)	(2,695)
Investment funds \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,066	1,061	1,082	959
Total realized and unrealized gains (losses) included in income	40	(18)	24	52
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	32
Transfers in	0	0	0	0
Transfers (out)				0
Ending balance	1,106	1,043	1,106	1,043
Total gains (losses) included in earnings1	40	(18)	24	53
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Purchases				32
Issuances				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements				0
Investment funds \| Variable Interest Entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	913	1,351	977	2,471
Total realized and unrealized gains (losses) included in income	(1)	(30)	(66)	(7)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	338	81	339	73
Transfers in	(432)	0	(432)	(1,135)
Transfers (out)	432	0	432	1,610
Ending balance	818	1,402	818	1,402
Total gains (losses) included in earnings1	(1)	(30)	(66)	(7)
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	475
Purchases	338	113	339	113
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	(32)	0	(40)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	0	0	0	0
Other \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	904	337	630	441
Total realized and unrealized gains (losses) included in income	0	(5)	(6)	(5)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	145	280	41
Transfers in	0	0	0	0
Ending balance	904	477	904	477
Total gains (losses) included in earnings1	(1)	(5)	(7)	(7)
Total gains (losses) included in OCI1	0	0	0	0
Other \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	335	343	343	303
Total realized and unrealized gains (losses) included in income	13	(16)	5	(18)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	42
Transfers in	0	0	0	0
Transfers (out)				0
Ending balance	348	327	348	327
Total gains (losses) included in earnings1	13	(16)	5	(19)
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Purchases				42
Issuances				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements				0
Other \| Variable Interest Entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	113	99	101	99
Total realized and unrealized gains (losses) included in income	4	5	0	7
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	37	(12)	53	(14)
Transfers in	0	0	0	0
Transfers (out)	0	0	0	0
Ending balance	154	92	154	92
Total gains (losses) included in earnings1	4	5	1	7
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Purchases	37	2	56	7
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	(14)	(3)	(21)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	0	0	0	0
Other \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net		145	280	41
Transfers in		0	0	0
Transfers (out)		0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0	0	0
Purchases		145	280	472
Issuances		0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales		0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements		0	0	(431)
Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	34	48	40	1
Total realized and unrealized gains (losses) included in income	0	0	0	0
Total realized and unrealized gains (losses) included in OCI	1	(2)	1	(2)
Purchases, issuances, sales and settlements, net	0	0	(6)	47
Transfers in	0	0	0	0
Ending balance	35	46	35	46
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	0	(2)	1	(2)
Foreign governments \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net				47
Transfers in				0
Transfers (out)				0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Purchases				53
Issuances				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements				(6)
Corporate \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	8,114	2,460	2,525	1,665
Total realized and unrealized gains (losses) included in income	6	(8)	3	(9)
Total realized and unrealized gains (losses) included in OCI	80	(25)	87	(1)
Purchases, issuances, sales and settlements, net	775	(26)	2,387	1,170
Transfers in	(4,800)	(20)	(827)	(444)
Ending balance	4,175	2,381	4,175	2,381
Total gains (losses) included in earnings1	2	0	0	0
Total gains (losses) included in OCI1	98	(27)	110	(7)
Corporate \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,194	1,171	1,171	812
Total realized and unrealized gains (losses) included in income	(3)	1	(2)	2
Total realized and unrealized gains (losses) included in OCI	12	(10)	33	(18)
Purchases, issuances, sales and settlements, net	(23)	24	(22)	175
Transfers in	201	0	201	215
Transfers (out)	0	0	0	0
Ending balance	1,381	1,186	1,381	1,186
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	9	(10)	31	(18)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	201	0	201	215
Purchases	45	27	51	184
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	(65)	0	(66)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(3)	(3)	(7)	(9)
Corporate \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	775	(26)	2,387	1,170
Transfers in	(4,800)	(20)	(827)	(444)
Transfers (out)	4,868	20	993	473
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	68	0	166	29
Purchases	912	26	2,623	1,338
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	(16)	0	(18)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(121)	(52)	(218)	(168)
Collateralized Loan Obligations \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance			506
Total realized and unrealized gains (losses) included in income			0
Total realized and unrealized gains (losses) included in OCI			17
Purchases, issuances, sales and settlements, net			42
Transfers in			0
Ending balance	565		565
Total gains (losses) included in earnings1			0
Total gains (losses) included in OCI1			18
ABS \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	8,420	5,305	6,943	4,867
Total realized and unrealized gains (losses) included in income	1	0	(14)	0
Total realized and unrealized gains (losses) included in OCI	313	14	314	(36)
Purchases, issuances, sales and settlements, net	2,202	(255)	8,371	794
Transfers in	4,679	(438)	1	(999)
Ending balance	15,615	4,626	15,615	4,626
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	301	4	298	(49)
ABS \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	10,580	7,742	7,826	5,542
Total realized and unrealized gains (losses) included in income	28	(2)	46	7
Total realized and unrealized gains (losses) included in OCI	75	(11)	22	38
Purchases, issuances, sales and settlements, net	(874)	110	1,915	1,968
Transfers in	0	0	0	284
Transfers (out)	0	0	0	0
Ending balance	9,809	7,839	9,809	7,839
Total gains (losses) included in earnings1	7	(6)	2	(2)
Total gains (losses) included in OCI1	73	(14)	20	32
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	284
Purchases	1,193	426	5,780	3,132
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	(504)	(162)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(2,067)	(316)	(3,361)	(1,002)
ABS \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	2,202	(255)	8,371	794
Transfers in	4,679	(438)	1	(999)
Transfers (out)	218	795	747	1,694
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	4,897	357	748	695
Purchases	3,004	221	9,635	1,552
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	(351)	(13)	(423)	(33)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(451)	(463)	(841)	(725)
CMBS \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	20	12	21	0
Total realized and unrealized gains (losses) included in income	2	0	1	0
Total realized and unrealized gains (losses) included in OCI	(5)	0	(5)	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	12
Ending balance	17	12	17	12
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	(3)	0	(3)	(1)
CMBS \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net				0
Transfers in				12
Transfers (out)				0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				12
Purchases				0
Issuances				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements				0
RMBS \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	261	6	265	232
Total realized and unrealized gains (losses) included in income	2	0	5	6
Total realized and unrealized gains (losses) included in OCI	2	0	3	2
Purchases, issuances, sales and settlements, net	78	261	72	258
Transfers in	0	(4)	(2)	(235)
Ending balance	343	263	343	263
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	2	0	2	0
RMBS \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	78	261	72	258
Transfers in	0	(4)	(2)	(235)
Transfers (out)	0	4	2	240
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	5
Purchases	81	261	81	262
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(3)	0	(9)	(4)
Trading securities \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	37	38	28	53
Total realized and unrealized gains (losses) included in income	1	(1)	1	2
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	(1)	(5)	(6)	(12)
Transfers in	0	0	14	(11)
Ending balance	37	32	37	32
Total gains (losses) included in earnings1	1	(1)	0	0
Total gains (losses) included in OCI1	0	0	0	0
Trading securities \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	719	867	838	878
Total realized and unrealized gains (losses) included in income	0	4	(1)	6
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	(100)	0	(218)	(13)
Transfers in	0	0	0	0
Transfers (out)	0	0	0	0
Ending balance	619	871	619	871
Total gains (losses) included in earnings1	(1)	3	(2)	3
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Purchases	0	1	4	28
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	(1)	0	(38)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(100)	0	(222)	(3)
Trading securities \| Variable Interest Entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,876	1,425	1,852	622
Total realized and unrealized gains (losses) included in income	82	(48)	31	(40)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	34	(45)	103	(55)
Transfers in	(54)	526	(48)	1,331
Transfers (out)	88	0	88	31
Ending balance	1,938	1,858	1,938	1,858
Total gains (losses) included in earnings1	82	(48)	30	(40)
Total gains (losses) included in OCI1	0	0	0	0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	34	526	40	1,362
Purchases	38	6	201	26
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	(4)	(51)	(91)	(81)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	0	0	(7)	0
Trading securities \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net	(1)	(5)	(6)	(12)
Transfers in	0	0	14	(11)
Transfers (out)	0	0	0	16
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	14	5
Purchases	0	0	0	8
Issuances	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(1)	(5)	(6)	(20)
CLO \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	521	495		303
Total realized and unrealized gains (losses) included in income	0	0		0
Total realized and unrealized gains (losses) included in OCI	2	8		15
Purchases, issuances, sales and settlements, net	42	0	42	185
Transfers in	0	0	0	0
Transfers (out)	0		0	0
Ending balance	565	503	565	503
Total gains (losses) included in earnings1	0	0		0
Total gains (losses) included in OCI1	2	8		15
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0		0	0
Purchases	42		42	185
Issuances	0		0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	0		0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	0		0	0
Derivative assets \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1		0
Total realized and unrealized gains (losses) included in income	0		0
Total realized and unrealized gains (losses) included in OCI	0		0
Purchases, issuances, sales and settlements, net	0		0
Transfers in	0		1
Ending balance	1		1
Total gains (losses) included in earnings1	0		0
Total gains (losses) included in OCI1	0		0
Derivative assets \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases, issuances, sales and settlements, net			0
Transfers in			1
Transfers (out)			0
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3			1
Purchases			0
Issuances			0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales			0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements			0
Embedded derivatives \| Funds withheld at interest \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(3,283)	(4,356)	(3,379)	(4,847)
Total realized and unrealized gains (losses) included in income	702	(625)	798	(134)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	0
Ending balance	(2,581)	(4,981)	(2,581)	(4,981)
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	0	0	0	0
Embedded derivatives \| Funds withheld at interest \| Related Party
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(717)	(1,297)	(721)	(1,425)
Total realized and unrealized gains (losses) included in income	187	325	191	453
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	0
Ending balance	(530)	(972)	(530)	(972)
Total gains (losses) included in earnings1	0	0	0	0
Total gains (losses) included in OCI1	0	0	0	0
Derivative Financial Instruments, Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(1)	(1)	(1)	(1)
Total realized and unrealized gains (losses) included in income	0	0	0	0
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	0
Ending balance	(1)	(1)	(1)	(1)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0	0	0
Interest Sensitive Contracts \| Embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(11,234)	(8,198)	(9,059)	(5,841)
Total realized and unrealized gains (losses) included in income	(275)	1,251	(1,270)	(277)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	487	398	1,667	1,227
Transfers in	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	0	0	0
Ending balance	(11,996)	(7,345)	(11,996)	(7,345)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0	0	0
Other Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(253)	(209)	(330)	(142)
Total realized and unrealized gains (losses) included in income	(86)	(4)	(123)	(71)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	(2)	0	(52)	0
Transfers in	0	0	64	0
Transfers (out)	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0		64
Ending balance	(337)	(213)	(337)	(213)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0	0	0
Universal life \| Interest Sensitive Contracts
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(769)	(854)	(834)	(829)
Total realized and unrealized gains (losses) included in income	(51)	115	14	90
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	0
Ending balance	(820)	(739)	(820)	(739)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0	0	0
AmerUs Closed Block \| Future Policy Benefits
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(1,120)	(1,159)	(1,178)	(1,164)
Total realized and unrealized gains (losses) included in income	(46)	59	12	64
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	0
Ending balance	(1,166)	(1,100)	(1,166)	(1,100)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	0	0	0	0
ILICO Closed Block and life benefits \| Future Policy Benefits
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(529)	(571)	(522)	(548)
Total realized and unrealized gains (losses) included in income	(16)	20	(23)	(3)
Total realized and unrealized gains (losses) included in OCI	0	0	0	0
Purchases, issuances, sales and settlements, net	0	0	0	0
Transfers in	0	0	0	0
Ending balance	(545)	(551)	(545)	(551)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	0	0	0	0
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI	$ 0	$ 0	$ 0	$ 0

Fair Value - Gross Components o

Fair Value - Gross Components of Purchases, Sales, Issuances and Settlements, net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	$ 13,446	$ 7,028	$ 38,703	$ 21,958
Issuances	94	0	294	0
Sales	(436)	(396)	(1,138)	(723)
Settlements	(5,450)	(2,093)	(10,393)	(5,154)
Purchases, (Sales), Issuances, (Settlements)	7,654	4,539	27,466	16,081
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	5,200	883	1,179	3,108
Transfers (out)	(5,693)	(819)	(2,350)	(4,077)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(493)	64	(1,171)	(969)
Purchases	0	0	0	0
Issuances	(750)	(573)	(2,408)	(1,708)
Sales	0	0	0	0
Settlements	265	175	793	481
Purchases, (Sales), Issuances, (Settlements), Liabilities	(485)	(398)	(1,615)	(1,227)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	0	64	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	64	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	99,073	60,008	99,073	60,008	$ 89,074	$ 70,370	$ 56,969	$ 45,582
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	14,865	9,949	14,865	9,949	13,906	11,924	10,992	8,525
Mortgage loans \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	4,846	4,160	13,647	11,318
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	58,587	37,978	58,587	37,978	52,645	44,115	34,668	27,454
Mortgage loans \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0	87	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	(14)	(1)	(64)	(24)
Purchases, (Sales), Issuances, (Settlements)	(14)	(1)	23	(24)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,345	1,234	1,345	1,234	1,320	1,281	1,296	1,302
Mortgage loans \| Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	70	4	125	63
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	(15)	(2)	(74)	(5)
Purchases, (Sales), Issuances, (Settlements)	55	2	51	58
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	2,226	2,042	2,226	2,042	2,120	2,173	2,113	2,055
Mortgage loans \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	7,518	5,696	19,226	14,361
Issuances	0	0	0	0
Sales	0	(285)	(26)	(348)
Settlements	(2,672)	(1,251)	(5,553)	(2,695)
Purchases, (Sales), Issuances, (Settlements)	4,846	4,160	13,647	11,318
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Short-term investments \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	166	100	142	70
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(78)	0	(79)	26
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	168	129	168	129	80	105	30	36
Short-term investments \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	168	100	171	100
Issuances	0	0	0	0
Sales	0	0	(6)	0
Settlements	(2)	0	(23)	(30)
Purchases, (Sales), Issuances, (Settlements)	166	100	142	70
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	26
Transfers (out)	(78)	0	(79)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(78)	0	(79)	26
Investment funds \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases				32
Issuances				0
Sales				0
Settlements				0
Purchases, (Sales), Issuances, (Settlements)	0	0	0	32
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Transfers (out)				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,106	1,043	1,106	1,043	1,066	1,082	1,061	959
Investment funds \| Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	338	113	339	113
Issuances	0	0	0	0
Sales	0	(32)	0	(40)
Settlements	0	0	0	0
Purchases, (Sales), Issuances, (Settlements)	338	81	339	73
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	475
Transfers (out)	(432)	0	(432)	(1,610)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(432)	0	(432)	(1,135)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	818	1,402	818	1,402	913	977	1,351	2,471
Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0		0
Issuances	94		294
Sales	0		0
Settlements	(1)		(2)
Purchases, (Sales), Issuances, (Settlements)	93	0	292	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0		0
Transfers (out)	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,710	1,301	1,710	1,301	1,518	1,367	1,436	1,388
Trading securities \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	(1)	(5)	(6)	(12)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	14	(11)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	37	32	37	32	37	28	38	53
Trading securities \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	1	4	28
Issuances	0	0	0	0
Sales	0	(1)	0	(38)
Settlements	(100)	0	(222)	(3)
Purchases, (Sales), Issuances, (Settlements)	(100)	0	(218)	(13)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	619	871	619	871	719	838	867	878
Trading securities \| Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	38	6	201	26
Issuances	0	0	0	0
Sales	(4)	(51)	(91)	(81)
Settlements	0	0	(7)	0
Purchases, (Sales), Issuances, (Settlements)	34	(45)	103	(55)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	34	526	40	1,362
Transfers (out)	(88)	0	(88)	(31)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(54)	526	(48)	1,331
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,938	1,858	1,938	1,858	1,876	1,852	1,425	622
Trading securities \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0	0	8
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	(1)	(5)	(6)	(20)
Purchases, (Sales), Issuances, (Settlements)	(1)	(5)	(6)	(12)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	14	5
Transfers (out)	0	0	0	(16)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	14	(11)
Other \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	145	280	41
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	904	477	904	477	904	630	337	441
Other \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases				42
Issuances				0
Sales				0
Settlements				0
Purchases, (Sales), Issuances, (Settlements)	0	0	0	42
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Transfers (out)				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	348	327	348	327	335	343	343	303
Other \| Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	37	2	56	7
Issuances	0	0	0	0
Sales	0	(14)	(3)	(21)
Settlements	0	0	0	0
Purchases, (Sales), Issuances, (Settlements)	37	(12)	53	(14)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	154	92	154	92	113	101	99	99
Other \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		145	280	472
Issuances		0	0	0
Sales		0	0	0
Settlements		0	0	(431)
Purchases, (Sales), Issuances, (Settlements)		145	280	41
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0	0	0
Transfers (out)		0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0	0	0
Corporate \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	775	(26)	2,387	1,170
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(4,800)	(20)	(827)	(444)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	4,175	2,381	4,175	2,381	8,114	2,525	2,460	1,665
Corporate \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	45	27	51	184
Issuances	0	0	0	0
Sales	(65)	0	(66)	0
Settlements	(3)	(3)	(7)	(9)
Purchases, (Sales), Issuances, (Settlements)	(23)	24	(22)	175
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	201	0	201	215
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	201	0	201	215
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,381	1,186	1,381	1,186	1,194	1,171	1,171	812
Corporate \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	912	26	2,623	1,338
Issuances	0	0	0	0
Sales	(16)	0	(18)	0
Settlements	(121)	(52)	(218)	(168)
Purchases, (Sales), Issuances, (Settlements)	775	(26)	2,387	1,170
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	68	0	166	29
Transfers (out)	(4,868)	(20)	(993)	(473)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(4,800)	(20)	(827)	(444)
CLO \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	42		42	185
Issuances	0		0	0
Sales	0		0	0
Settlements	0		0	0
Purchases, (Sales), Issuances, (Settlements)	42	0	42	185
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0		0	0
Transfers (out)	0		0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	565	503	565	503	521		495	303
Equity securities \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0	1	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(9)	0	0	(13)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	26	74	26	74	36	26	67	92
Equity securities \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases				0
Issuances				0
Sales				0
Settlements				(32)
Purchases, (Sales), Issuances, (Settlements)	0	0	0	(32)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Transfers (out)				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	257	245	257	245	247	255	252	279
Equity securities \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0		2	0
Issuances	0		0	0
Sales	0		(1)	0
Settlements	0		0	0
Purchases, (Sales), Issuances, (Settlements)	0		1	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0		9	0
Transfers (out)	(9)		(9)	(13)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(9)		0	(13)
ABS \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	2,202	(255)	8,371	794
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	4,679	(438)	1	(999)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	15,615	4,626	15,615	4,626	8,420	6,943	5,305	4,867
ABS \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	1,193	426	5,780	3,132
Issuances	0	0	0	0
Sales	0	0	(504)	(162)
Settlements	(2,067)	(316)	(3,361)	(1,002)
Purchases, (Sales), Issuances, (Settlements)	(874)	110	1,915	1,968
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	284
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	284
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	9,809	7,839	9,809	7,839	10,580	7,826	7,742	5,542
ABS \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	3,004	221	9,635	1,552
Issuances	0	0	0	0
Sales	(351)	(13)	(423)	(33)
Settlements	(451)	(463)	(841)	(725)
Purchases, (Sales), Issuances, (Settlements)	2,202	(255)	8,371	794
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	4,897	357	748	695
Transfers (out)	(218)	(795)	(747)	(1,694)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	4,679	(438)	1	(999)
RMBS \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	78	261	72	258
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(4)	(2)	(235)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	343	263	343	263	261	265	6	232
RMBS \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	81	261	81	262
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	(3)	0	(9)	(4)
Purchases, (Sales), Issuances, (Settlements)	78	261	72	258
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0	0	5
Transfers (out)	0	(4)	(2)	(240)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(4)	(2)	(235)
CMBS \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	12
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	17	12	17	12	20	21	12	0
CMBS \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases				0
Issuances				0
Sales				0
Settlements				0
Purchases, (Sales), Issuances, (Settlements)				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				12
Transfers (out)				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net				12
Derivative assets \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0		1
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1		1		1	0
Derivative assets \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases			0
Issuances			0
Sales			0
Settlements			0
Purchases, (Sales), Issuances, (Settlements)			0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3			1
Transfers (out)			0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net			1
Foreign Government Debt \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases			0
Issuances			0
Sales			0
Settlements			(6)
Purchases, (Sales), Issuances, (Settlements)			(6)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3			0
Transfers (out)			0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net			0
Foreign governments \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0	(6)	47
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	35	46	35	46	34	40	48	1
Foreign governments \| Consolidated Entity, Excluding Variable Interest Entities (VIE) and Investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases				53
Issuances				0
Sales				0
Settlements				(6)
Purchases, (Sales), Issuances, (Settlements)				47
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3				0
Transfers (out)				0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net				0
Embedded derivatives \| Funds withheld at interest \| Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	(2,581)	(4,981)	(2,581)	(4,981)	(3,283)	(3,379)	(4,356)	(4,847)
Embedded derivatives \| Funds withheld at interest \| Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	(530)	(972)	(530)	(972)	(717)	(721)	(1,297)	(1,425)
Interest Sensitive Contracts \| Universal life
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	820	739	820	739	769	834	854	829
Interest Sensitive Contracts \| Embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0	0	0
Issuances	(750)	(573)	(2,408)	(1,708)
Sales	0	0	0	0
Settlements	263	175	741	481
Purchases, (Sales), Issuances, (Settlements), Liabilities	(487)	(398)	(1,667)	(1,227)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	0	0	0
Transfers (out)	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	11,996	7,345	11,996	7,345	11,234	9,059	8,198	5,841
Derivative Financial Instruments, Liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	1	1	1	1	1	1	1	1
Future Policy Benefits \| AmerUs Closed Block
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	1,166	1,100	1,166	1,100	1,120	1,178	1,159	1,164
Future Policy Benefits \| ILICO Closed Block and life benefits
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	545	551	545	551	529	522	571	548
Other Liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0		0
Issuances	0		0
Sales	0		0
Settlements	2		52
Purchases, (Sales), Issuances, (Settlements), Liabilities	2	0	52	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0		64
Transfers (out)	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0	64	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 337	$ 213	$ 337	$ 213	$ 253	$ 330	$ 209	$ 142

Fair Value - Summary of Unobser

Fair Value - Summary of Unobservable Inputs for the Embedded Derivatives of Interest Sensitive Contract Liabilities (Details) $ in Millions	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds	$ 18,846	$ 17,668
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-Sale Debt securities, Trading securities, and Equity securities	27,344	14,247
Mortgage loans, net of allowances	62,158	47,569
Level 3 \| Discounted cash flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds	$ 1,623	1,574
Level 3 \| Net tangible asset values
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds		$ 483
Nonperformance risk \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.005	0.004
Nonperformance risk \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.012	0.014
Nonperformance risk \| Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.008	0.009
Option budget \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.005	0.005
Option budget \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.060	0.060
Option budget \| Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.027	0.023
Surrender rate \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.062	0.060
Surrender rate \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.140	0.134
Surrender rate \| Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.087	0.087
Discount rate \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Mortgage loans, Measurement Input	0.010	0.025
Measurement Input for Available-for-Sale Debt securities, Trading securities, and Equity securities	0.043	0.023
Investment funds, measurement input	0.063	0.063
Discount rate \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Mortgage loans, Measurement Input	0.365	0.206
Measurement Input for Available-for-Sale Debt securities, Trading securities, and Equity securities	0.177	0.181
Investment funds, measurement input	0.135	0.135
Discount rate \| Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Mortgage loans, Measurement Input	0.074	0.068
Measurement Input for Available-for-Sale Debt securities, Trading securities, and Equity securities	0.069	0.070
Investment funds, measurement input	0.113	0.112
Implied multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input		1.14
Implied multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input		1.14
Implied multiple \| Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input		1.14
Embedded derivatives \| Interest Sensitive Contracts \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Total liabilities measured at fair value	$ 11,996	$ 9,059

Fair Value - Financial Instrume

Fair Value - Financial Instruments Not Carried at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Fair Value
Assets
Total assets measured at fair value	$ 31,756	$ 36,925
Liabilities
Interest sensitive contract liabilities	187,554	146,038
Debt	5,448	3,660
Securities Sold under Agreements to Repurchase	2,666	3,853
Funds withheld liability	3,416	350
Total liabilities not carried at fair value	199,084	153,901
Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	107	109
Policy loans	320	334
Funds withheld at interest	23,812	27,738
Other investments	28	52
Short-term investments	205
Fair Value \| Related Party
Assets
Investment funds	498	550
Funds withheld at interest	5,974	7,195
Short-term investments	812	947
Carrying Value
Assets
Total assets measured at fair value	31,745	36,919
Liabilities
Interest sensitive contract liabilities	191,137	154,095
Debt	5,725	4,209
Securities Sold under Agreements to Repurchase	2,666	3,853
Funds withheld liability	3,416	350
Total liabilities not carried at fair value	202,944	162,507
Carrying Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	107	109
Policy loans	320	334
Funds withheld at interest	23,812	27,738
Other investments	17	46
Short-term investments	205
Carrying Value \| Related Party
Assets
Investment funds	498	550
Funds withheld at interest	5,974	7,195
Short-term investments	812	947
Investment funds	18,846	17,668
Liabilities
Interest sensitive contract liabilities	245,436	204,670	$ 189,065
Debt	5,725	4,209
Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	107	109
Policy loans	320	334
Funds withheld at interest	21,231	24,359
Other investments	1,727	1,206
Short-term investments	614	341
Related Party
Assets
Investment funds	1,604	1,632
Funds withheld at interest	5,444	6,474
Other investments	348	343
Short-term investments	812	947
Liabilities
Interest sensitive contract liabilities	7,085	8,599
Variable Interest Entities
Assets
Investment funds	17,135	15,927
Other investments	159	103
Level 1 \| Fair Value
Assets
Total assets measured at fair value	0	0
Liabilities
Interest sensitive contract liabilities	0	0
Debt	591	0
Securities Sold under Agreements to Repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	591	0
Level 1 \| Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Policy loans	0	0
Funds withheld at interest	0	0
Other investments	0	0
Short-term investments	0
Level 1 \| Fair Value \| Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0	0
Level 3 \| Fair Value
Assets
Total assets measured at fair value	30,019	34,985
Liabilities
Interest sensitive contract liabilities	187,554	146,038
Debt	0	0
Securities Sold under Agreements to Repurchase	0	0
Funds withheld liability	3,416	0
Total liabilities not carried at fair value	190,970	146,038
Level 3 \| Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Policy loans	0	0
Funds withheld at interest	23,812	27,738
Other investments	28	52
Short-term investments	205
Level 3 \| Fair Value \| Related Party
Assets
Investment funds	0	0
Funds withheld at interest	5,974	7,195
Short-term investments	0	0
NAV \| Fair Value
Assets
Total assets measured at fair value	605	659
Liabilities
Interest sensitive contract liabilities	0	0
Debt	0	0
Securities Sold under Agreements to Repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	0	0
NAV \| Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	107	109
Policy loans	0	0
Funds withheld at interest	0	0
Other investments	0	0
Short-term investments	0
NAV \| Fair Value \| Related Party
Assets
Investment funds	498	550
Funds withheld at interest	0	0
Short-term investments	0	0
Level 2 \| Fair Value
Assets
Total assets measured at fair value	1,132	1,281
Liabilities
Interest sensitive contract liabilities	0	0
Debt	4,857	3,660
Securities Sold under Agreements to Repurchase	2,666	3,853
Funds withheld liability	0	350
Total liabilities not carried at fair value	7,523	7,863
Level 2 \| Fair Value \| Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Policy loans	320	334
Funds withheld at interest	0	0
Other investments	0	0
Short-term investments	0
Level 2 \| Fair Value \| Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	$ 812	$ 947

Fair Value - Narrative (Details

Fair Value - Narrative (Details) $ in Millions	Dec. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Carrying amount of equity securities	$ (358)
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount	$ 42

Deferred Acquisition Costs, D_3

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired - Roll Forward of DAC, DSI, and VOBA (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
DAC
Other		$ (3)
Deferred Policy Acquisition Costs, Deferred Sales Inducements, and Present Value of Future Profits, Foreign Currency Translation Gain (Loss) and Other		(3)
VOBA
Beginning balance	$ 2,581	2,988
Additions	0	0
Amortization	(274)	(315)
Ending balance	2,307	2,670
Total
Beginning balance	5,979	4,466
Additions	1,670	1,487
Amortization	(678)	(502)
Ending balance	6,971	5,448
Indexed annuities
DAC
Beginning balance	1,517	755
Additions	751	609
Amortization	(131)	(69)
Deferred Policy Acquisition Cost, Foreign Currency Translation Adjustment and Other		0
Deferred Sales Inducement Cost, Other Increase (Decrease)		0
Ending balance	2,137	1,295
DSI
Beginning balance	970	399
Additions	479	447
Amortization	(88)	(40)
Ending balance	1,361	806
Funding agreements
DAC
Beginning balance	10	11
Additions	36	2
Amortization	(8)	(3)
Deferred Policy Acquisition Cost, Foreign Currency Translation Adjustment and Other		0
Ending balance	38	10
Other investment-type
DAC
Beginning balance	11	9
Additions	0	3
Amortization	(1)	(1)
Deferred Policy Acquisition Cost, Foreign Currency Translation Adjustment and Other		0
Ending balance	10	11
Deferred Fixed Annuity
DAC
Beginning balance	890	304
Additions	404	426
Amortization	(176)	(74)
Deferred Policy Acquisition Cost, Foreign Currency Translation Adjustment and Other		0
Ending balance	$ 1,118	$ 656

Long-duration Contracts - Polic

Long-duration Contracts - Policyholder Account Balance Rollforward (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Policyholder Account Balance [Roll Forward]
Beginning balance	$ 197,889	$ 168,339
Deposits	57,563	35,624
Policy charges	(524)	(483)
Surrenders and withdrawals	(13,478)	(16,634)
Benefit payments	(9,953)	(4,441)
Interest credited	5,961	2,824
Foreign exchange	60	(448)
Other	347	(1,325)
Ending balance	237,865	183,456
Indexed annuities
Policyholder Account Balance [Roll Forward]
Beginning balance	93,147	92,660
Deposits	12,761	8,960
Policy charges	(522)	(481)
Surrenders and withdrawals	(9,724)	(8,292)
Benefit payments	(1,204)	(1,216)
Interest credited	2,313	802
Foreign exchange	1	(1)
Other	0	77
Ending balance	$ 96,772	$ 92,509
Weighted average crediting rate	2.60%	2.30%
Net amount at risk	$ 15,221	$ 14,438
Cash surrender value	89,378	84,052
Funding agreements
Policyholder Account Balance [Roll Forward]
Beginning balance	32,350	27,439
Deposits	24,083	4,893
Policy charges	0	0
Surrenders and withdrawals	0	(110)
Benefit payments	(7,746)	(2,264)
Interest credited	1,173	628
Foreign exchange	116	(26)
Other	421	(46)
Ending balance	$ 50,397	$ 30,514
Weighted average crediting rate	4.50%	3.10%
Net amount at risk	$ 0	$ 0
Cash surrender value	0	0
Other investment-type
Policyholder Account Balance [Roll Forward]
Beginning balance	7,629	4,722
Deposits	933	3,760
Policy charges	0	0
Surrenders and withdrawals	(63)	(25)
Benefit payments	(173)	(223)
Interest credited	152	110
Foreign exchange	(56)	(344)
Other	(74)	(1,419)
Ending balance	$ 8,348	$ 6,581
Weighted average crediting rate	2.60%	2.70%
Net amount at risk	$ 65	$ 104
Cash surrender value	7,112	5,335
Deferred Fixed Annuity
Policyholder Account Balance [Roll Forward]
Beginning balance	64,763	43,518
Deposits	19,786	18,011
Policy charges	(2)	(2)
Surrenders and withdrawals	(3,691)	(8,207)
Benefit payments	(830)	(738)
Interest credited	2,323	1,284
Foreign exchange	(1)	(77)
Other	0	63
Ending balance	$ 82,348	$ 53,852
Weighted average crediting rate	4.30%	3.70%
Net amount at risk	$ 427	$ 425
Cash surrender value	$ 78,049	$ 50,352

Long-duration Contracts - Recon

Long-duration Contracts - Reconciliation of Account Balance Within Interest Sensitive Contract Benefits (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	$ 245,436	$ 204,670	$ 189,065
Indexed annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	96,772		92,509
Funding agreements
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	50,397		30,514
Other investment-type
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	8,348		6,581
Reconciling items
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	7,571		5,609
Deferred Fixed Annuity
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	$ 82,348		$ 53,852

Long-duration Contracts - Accou

Long-duration Contracts - Account Balances by Guaranteed Minimum Interest Rates (Details) $ in Millions	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Policyholder Account Balance [Line Items]
Total	$ 237,865	$ 197,889	$ 183,456	$ 168,339
Less than 2.0%
Policyholder Account Balance [Line Items]
Total	$ 170,371		$ 138,394
Less than 2.0% \| Maximum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	2%		2%
2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	$ 27,290		$ 30,507
2.0% to 4.0% \| Maximum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	4%		4%
2.0% to 4.0% \| Minimum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	2%		2%
4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	$ 28,840		$ 11,443
Range of guaranteed minimum credit ratings (in percent)			6%
4.0% to 6.0% \| Maximum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	6%
4.0% to 6.0% \| Minimum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	4%		4%
6.0% and greater
Policyholder Account Balance [Line Items]
Total	$ 11,364		$ 3,112
6.0% and greater \| Minimum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	6%		6%
At guaranteed minimum
Policyholder Account Balance [Line Items]
Total	$ 92,192		$ 71,947
At guaranteed minimum \| Less than 2.0%
Policyholder Account Balance [Line Items]
Total	28,488		28,564
At guaranteed minimum \| 2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	23,576		28,838
At guaranteed minimum \| 4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	28,764		11,433
At guaranteed minimum \| 6.0% and greater
Policyholder Account Balance [Line Items]
Total	11,364		3,112
1 basis point – 100 basis points above guaranteed minimum
Policyholder Account Balance [Line Items]
Total	$ 17,393		$ 20,846
1 basis point – 100 basis points above guaranteed minimum \| Maximum
Policyholder Account Balance [Line Items]
Policyholder account balance above guaranteed minimum crediting rate	100		100
1 basis point – 100 basis points above guaranteed minimum \| Minimum
Policyholder Account Balance [Line Items]
Policyholder account balance above guaranteed minimum crediting rate	1		1
1 basis point – 100 basis points above guaranteed minimum \| Less than 2.0%
Policyholder Account Balance [Line Items]
Total	$ 15,531		$ 19,709
1 basis point – 100 basis points above guaranteed minimum \| 2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	1,787		1,128
1 basis point – 100 basis points above guaranteed minimum \| 4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	75		9
1 basis point – 100 basis points above guaranteed minimum \| 6.0% and greater
Policyholder Account Balance [Line Items]
Total	0		0
Greater than 100 basis points above guaranteed minimum
Policyholder Account Balance [Line Items]
Total	$ 128,280		$ 90,663
Greater than 100 basis points above guaranteed minimum \| Minimum
Policyholder Account Balance [Line Items]
Policyholder account balance above guaranteed minimum crediting rate	100		100
Greater than 100 basis points above guaranteed minimum \| Less than 2.0%
Policyholder Account Balance [Line Items]
Total	$ 126,352		$ 90,121
Greater than 100 basis points above guaranteed minimum \| 2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	1,927		541
Greater than 100 basis points above guaranteed minimum \| 4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	1		1
Greater than 100 basis points above guaranteed minimum \| 6.0% and greater
Policyholder Account Balance [Line Items]
Total	$ 0		$ 0

Long-duration Contracts - Balan

Long-duration Contracts - Balances of and Changes in Liability for Future Policy Benefits (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jul. 01, 2023	Dec. 31, 2022
Present value of expected future policy benefits
Beginning balance	$ 48,372	$ 36,422
Effect of changes in discount rate assumptions	5,316	9,753	$ 6,144		$ 8,425
Beginning balance at original discount rate	53,277	50,581	54,511		44,834
Effect of actual to expected experience	(93)
Adjusted balance	54,314
Issuances	1,010	9,120
Interest accrual	1,405	1,194
Benefit payments	(3,421)	(2,731)
Foreign exchange	(31)	6
Other		(1,509)
Ending balance at original discount rate	53,277	50,581
Ending balance	47,942	40,840
Effect of changes in discount rate assumptions	41		(45)
AOCI, Liability for Future Policy Benefit, Expected Net Premium, Foreign Exchange, before Tax	1		(2)
Beginning balance at original discount rate	1,018		1,182
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, Foreign Exchange, before Tax	(19)	12	(5)		(13)
Net future policy benefits	52,962	46,672	53,287
Beginning balance at original discount rate	976		1,135
Effect of actual to expected experience	(4)	(36)
Adjusted balance	1,131	44,501
Interest accrual	17
Net premium collected	(144)
Foreign exchange	(28)
Effect of changes in cash flow assumptions	(104)	(297)			(297)
Venerable \| Reinsurance agreement recapture
Present value of expected future policy benefits
Net future policy benefits				$ 2,700
Payout annuities with life contingencies
Present value of expected future policy benefits
Beginning balance	45,001	36,422
Effect of changes in discount rate assumptions	5,362	9,753	6,233		8,425
Beginning balance at original discount rate	50,083	50,581	51,235		44,834
Effect of actual to expected experience	(89)
Adjusted balance	51,042
Issuances	1,010
Interest accrual	1,353
Benefit payments	(3,355)
Foreign exchange	33	6
Ending balance at original discount rate	50,083	50,581
Ending balance	44,705	40,840
Effect of changes in discount rate assumptions	0		0
AOCI, Liability for Future Policy Benefit, Expected Net Premium, Foreign Exchange, before Tax	0		0
Beginning balance at original discount rate	0		0
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, Foreign Exchange, before Tax	$ (16)	$ 12	1		(13)
Liability for Future Policy Benefit, Weighted-Average Duration	9 years 4 months 24 days	9 years 7 months 6 days
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate	3.70%	3.60%
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate	5%	6.10%
Expected future benefit payments, Undiscounted	$ 73,523	$ 73,933
Expected future gross premiums, Undiscounted	0
Expected future gross premiums, Discounted	0
Net future policy benefits	44,705	40,840
Net future policy benefits, net of reinsurance recoverable		40,840
Beginning balance at original discount rate	0		0
Effect of actual to expected experience	0	(36)
Adjusted balance	0	44,501
Interest accrual	0
Net premium collected	0
Foreign exchange	0
Effect of changes in cash flow assumptions	(104)
Payout annuities with life contingencies \| Venerable \| Reinsurance agreement recapture
Present value of expected future policy benefits
Other		(1,509)
Whole Life Insurance
Present value of expected future policy benefits
Beginning balance	3,371	0
Effect of changes in discount rate assumptions	(46)	0	(89)		0
Beginning balance at original discount rate	3,194	0	3,276		0
Effect of actual to expected experience	(4)
Adjusted balance	3,272
Issuances	0	0
Interest accrual	52	0
Benefit payments	(66)	0
Foreign exchange	(64)	0
Other		0
Ending balance at original discount rate	3,194	0
Ending balance	3,237	0
Effect of changes in discount rate assumptions	41		(45)
AOCI, Liability for Future Policy Benefit, Expected Net Premium, Foreign Exchange, before Tax	1		(2)
Beginning balance at original discount rate	1,018		1,182
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, Foreign Exchange, before Tax	$ (3)	$ 0	(6)		0
Liability for Future Policy Benefit, Weighted-Average Duration	31 years 3 months 18 days	0 years
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate	4.80%	0%
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate	4%	0%
Expected future benefit payments, Undiscounted	$ 10,235	$ 0
Expected future gross premiums, Undiscounted	1,255
Expected future gross premiums, Discounted	1,064
Net future policy benefits	2,219	0
Net future policy benefits, net of reinsurance recoverable		0
Beginning balance at original discount rate	976		$ 1,135
Effect of actual to expected experience	(4)	0
Adjusted balance	1,131	0
Interest accrual	17
Net premium collected	(144)
Foreign exchange	(28)
Effect of changes in cash flow assumptions	0				$ 0
All products, excluding reconciling items
Present value of expected future policy benefits
Net future policy benefits	$ 46,924
Net future policy benefits, net of reinsurance recoverable		$ 40,840

Long-duration Contracts - Rec_2

Long-duration Contracts - Reconciliation of Future Policy Benefits (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	$ 52,962	$ 53,287	$ 46,672
Payout annuities with life contingencies
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	44,705		40,840
Reconciling items
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	6,038		5,832
Whole Life Insurance
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	$ 2,219		$ 0

Long-duration Contracts - Premi

Long-duration Contracts - Premium Reconciliation (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Total	$ 1,163	$ 9,163
Future policy benefit, interest expense	1,388	1,194
Payout annuities with life contingencies
Liability for Future Policy Benefit, Activity [Line Items]
Total	985	9,142
Future policy benefit, interest expense	1,353	1,194
Reconciling items
Liability for Future Policy Benefit, Activity [Line Items]
Total	24	21
Future policy benefit, interest expense	0	0
Whole Life Insurance
Liability for Future Policy Benefit, Activity [Line Items]
Total	154	0
Future policy benefit, interest expense	$ 35	$ 0

Long-duration Contracts - Narra

Long-duration Contracts - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Additional Liability, Long-Duration Insurance [Line Items]
Future policy benefit, interest expense			$ 1,388	$ 1,194
Favorable (unfavorable) movements			(430)	4,418
Benefit payments			(3,421)	(2,731)
Interest accrual			1,405	1,194
Issuances			1,010	9,120
Effect of changes in discount rate assumptions	$ 5,316	$ 9,753	5,316	9,753	$ 6,144	$ 8,425
Market risk benefit, period increase (decrease)			716	101
Effect of changes in interest rates			(36)	(609)
Effect of changes in instrument-specific credit risk	(95)	146	(95)	146	8	(366)
Interest accrual			151	115
Attributed fees collected			266	252
Effect of changes in equity			(115)	(26)
Liability for Future Policy Benefit, Adverse Development, Expense			15	110
Remeasurement gains (losses) on future policy benefits related to discount rate	(2,263)	1,317	(832)	1,328
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax And	(832)	1,328	(832)	1,328
Payout annuities with life contingencies
Additional Liability, Long-Duration Insurance [Line Items]
Future policy benefit, interest expense			1,353	1,194
Benefit payments			(3,355)
Interest accrual			1,353
Issuances			1,010
Effect of changes in discount rate assumptions	$ 5,362	$ 9,753	$ 5,362	$ 9,753	$ 6,233	$ 8,425

Long-duration Contracts - Weigh

Long-duration Contracts - Weighted Average Durations and Interest Rates (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Insurance [Abstract]
Beginning balance at original discount rate	$ 53,277	$ 50,581	$ 54,511	$ 44,834
Other		(1,509)
Effect of changes in cash flow assumptions	(104)	(297)		(297)
Effect of changes in discount rate assumptions	(5,316)	(9,753)	(6,144)	(8,425)
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, Foreign Exchange, before Tax	(19)	12	(5)	(13)
Effect of actual to expected experience	(4)	(36)
Adjusted balance	1,131	44,501
Issuances	1,010	9,120
Interest accrual	1,405	1,194
Benefit payments	(3,421)	(2,731)
Foreign exchange	(31)	6
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	$ 47,942	$ 40,840	$ 48,372	$ 36,422

Long-duration Contracts - Remea

Long-duration Contracts - Remeasurement Gain (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Insurance [Abstract]
Reserves			$ 193	$ 333
Deferred profit liability			(37)	(243)
Negative VOBA			(52)	(54)
Total remeasurement gains (losses)	$ 111	$ 30	$ 104	$ 36

Long-duration Contracts - Marke

Long-duration Contracts - Market Risk Benefits (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Market Risk Benefit [Roll Forward]
Beginning Balance	$ 3,365	$ 2,855
Effect of changes in instrument-specific credit risk	95	(146)	$ (8)	$ 366
Balance, beginning of period, before changes in instrument-specific credit risk	(3,373)	(2,489)
Issuances	270	47
Interest accrual	151	115
Attributed fees collected	266	252
Benefit payments	(42)	(25)
Effect of changes in interest rates	(36)	(609)
Effect of changes in equity	(115)	(26)
Effect of actual policyholder behavior compared to expected behavior	69	46
Balance at September 30, 2024	(4,089)	(2,590)
Less: Reinsurance recoverable	(40)
Balance at September 30, 2024, net of reinsurance	4,049
Ending Balance	3,994	2,736
Effect of changes in future expected policyholder behavior	85	75
Effect of changes in other future expected assumptions	(19)	6
Indexed annuities
Market Risk Benefit [Roll Forward]
Beginning Balance	3,171	2,672
Effect of changes in instrument-specific credit risk	94	(139)	(10)	353
Balance, beginning of period, before changes in instrument-specific credit risk	(3,181)	(2,319)
Issuances	270	47
Interest accrual	143	108
Attributed fees collected	265	250
Benefit payments	(39)	(24)
Effect of changes in interest rates	(34)	(591)
Effect of changes in equity	(115)	(26)
Effect of actual policyholder behavior compared to expected behavior	64	42
Balance at September 30, 2024	(3,888)	(2,423)
Less: Reinsurance recoverable	(40)
Balance at September 30, 2024, net of reinsurance	3,848
Ending Balance	3,794	2,562
Net amount at risk	$ 15,221	$ 14,438
Weighted-average attained age of contract holders (in years)	69 years	69 years
Effect of changes in future expected policyholder behavior	$ 88	$ 78
Effect of changes in other future expected assumptions	(19)	6
Deferred Fixed Annuity
Market Risk Benefit [Roll Forward]
Beginning Balance	194	183
Effect of changes in instrument-specific credit risk	1	(7)	$ 2	$ 13
Balance, beginning of period, before changes in instrument-specific credit risk	(192)	(170)
Issuances	0	0
Interest accrual	8	7
Attributed fees collected	1	2
Benefit payments	(3)	(1)
Effect of changes in interest rates	(2)	(18)
Effect of changes in equity	0	0
Effect of actual policyholder behavior compared to expected behavior	5	4
Balance at September 30, 2024	(201)	(167)
Less: Reinsurance recoverable	0
Balance at September 30, 2024, net of reinsurance	201
Ending Balance	200	174
Net amount at risk	$ 427	$ 425
Weighted-average attained age of contract holders (in years)	76 years	75 years
Effect of changes in future expected policyholder behavior	$ (3)	$ (3)
Effect of changes in other future expected assumptions	$ 0	$ 0

Long-duration Contracts - Mar_2

Long-duration Contracts - Market Risk Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Market Risk Benefit [Line Items]
Asset	$ 313		$ 431
Liability	4,402	$ 3,751	3,021
Net liability	4,089	3,373	2,590	$ 2,489
Indexed annuities
Market Risk Benefit [Line Items]
Asset	313		431
Liability	4,201		2,854
Net liability	3,888	3,181	2,423	2,319
Deferred Fixed Annuity
Market Risk Benefit [Line Items]
Asset	0		0
Liability	201		167
Net liability	$ 201	$ 192	$ 167	$ 170

Long-duration Contracts - Signi

Long-duration Contracts - Significant Inputs and Assumptions (Details) $ in Millions	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Market Risk Benefit [Line Items]
Net liability	$ 4,089	$ 3,373	$ 2,590	$ 2,489
Nonperformance risk \| Discounted cash flow \| Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.005		0.006
Nonperformance risk \| Discounted cash flow \| Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.012		0.016
Nonperformance risk \| Discounted cash flow \| Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.011		0.014
Option budget \| Discounted cash flow \| Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.005		0.005
Option budget \| Discounted cash flow \| Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.060		0.059
Option budget \| Discounted cash flow \| Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.022		0.019
Surrender rate \| Discounted cash flow \| Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.033		0.034
Surrender rate \| Discounted cash flow \| Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.070		0.065
Surrender rate \| Discounted cash flow \| Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.045		0.046
Measurement Input, Utilization Rate \| Discounted cash flow \| Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.286		0.286
Measurement Input, Utilization Rate \| Discounted cash flow \| Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.950		0.950
Measurement Input, Utilization Rate \| Discounted cash flow \| Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.847		0.832

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	3 Months Ended	9 Months Ended
Debt - Narrative (Details) - USD ($)	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Debt instrument, face amount		$ 5,575,000,000
Senior Notes due 2054
Line of Credit Facility [Line Items]
Debt instrument, face amount		$ 1,000,000,000
Debt instrument, interest rate, stated percentage		6.25%
Junior Subordinated Debt
Line of Credit Facility [Line Items]
Debt instrument, face amount		$ 575,000,000
Debt instrument, interest rate, stated percentage		7.25%
Debt instrument, basis spread on variable rate		2.986%
Period the interest payments may be deferred (in years)		5 years
Liquidity Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 3,100,000,000
Line of Credit Facility, Fair Value of Amount Outstanding		0	$ 0
Line of Credit Facility, Current Borrowing Capacity		2,600,000,000
Liquidity Facility \| Athene Life Re Ltd.
Line of Credit Facility [Line Items]
Line of Credit Facility, Covenant Terms, Consolidated Net Worth Requirement, Amount		$ 10,200,000,000
2054 Subordinated Notes \| Subsequent Event \| Subordinated Debt
Line of Credit Facility [Line Items]
Debt instrument, face amount	$ 600,000,000
Debt instrument, interest rate, stated percentage	6.625%
Debt instrument, basis spread on variable rate	2.607%

Debt - Senior Note Issuance (De

Debt - Senior Note Issuance (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Debt instrument, face amount	$ 5,575
Debt	$ 5,725	$ 4,209
Senior Notes due 2028
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Jan. 12, 2018
Debt instrument, face amount	$ 1,000
Debt instrument, interest rate, stated percentage	4.125%
Long-term Debt, Maturity Date	Jan. 12, 2028
Debt	$ 1,054	1,066
Senior Notes due 2030
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Apr. 03, 2020
Debt instrument, face amount	$ 500
Debt instrument, interest rate, stated percentage	6.15%
Long-term Debt, Maturity Date	Apr. 03, 2030
Debt	$ 582	593
Senior Notes due 2031
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Oct. 08, 2020
Debt instrument, face amount	$ 500
Debt instrument, interest rate, stated percentage	3.50%
Long-term Debt, Maturity Date	Jan. 15, 2031
Debt	$ 521	523
Senior Notes due 2033
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Nov. 21, 2022
Debt instrument, face amount	$ 400
Debt instrument, interest rate, stated percentage	6.65%
Long-term Debt, Maturity Date	Feb. 01, 2033
Debt	$ 395	395
Senior Notes due 2051
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	May 25, 2021
Debt instrument, face amount	$ 500
Debt instrument, interest rate, stated percentage	3.95%
Long-term Debt, Maturity Date	May 25, 2051
Debt	$ 545	545
Senior Notes due 2034
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Dec. 12, 2023
Debt instrument, face amount	$ 600
Debt instrument, interest rate, stated percentage	5.875%
Long-term Debt, Maturity Date	Jan. 15, 2034
Debt	$ 584	583
Senior Notes due 2052
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Dec. 13, 2021
Debt instrument, face amount	$ 500
Debt instrument, interest rate, stated percentage	3.45%
Long-term Debt, Maturity Date	May 15, 2052
Debt	$ 504	504
Senior Notes due 2054
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Mar. 22, 2024
Debt instrument, face amount	$ 1,000
Debt instrument, interest rate, stated percentage	6.25%
Long-term Debt, Maturity Date	Apr. 01, 2054
Debt	$ 982	0
Junior Subordinated Debt
Debt Instrument [Line Items]
Debt Instrument, Issuance Date	Mar. 07, 2024
Debt instrument, face amount	$ 575
Debt instrument, interest rate, stated percentage	7.25%
Long-term Debt, Maturity Date	Mar. 30, 2064
Debt	$ 558	$ 0

Equity - Narrative (Details)

Equity - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
Equity - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Class of Stock [Line Items]
Payments of Ordinary Dividends, Common Stock	$ 374	$ 750
Distribution of Marketable Securities to Stockholders as Dividends
Class of Stock [Line Items]
Payments of Ordinary Dividends, Common Stock	$ 499	$ 0

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (5,809)	$ (6,376)	$ (5,569)	$ (7,321)
Other comprehensive income (loss) before reclassifications	3,025	(2,316)	2,869	(972)
Less: Reclassification adjustments for gains (losses) realized	(352)	10	(216)	(39)
Less: Income tax expense (benefit)	680	(476)	632	(175)
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	355	(147)	351	0
Ending balance	(3,467)	(8,079)	(3,467)	(8,079)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	886	(577)	505	(467)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(277)	(378)	(289)	(334)
Ending balance	(295)	(348)	(295)	(348)
AOCI, Accumulated Gain (Loss), Debt Securities, with credit allowance, portion attributable to NCI
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	7	(3)	2	(5)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Including Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	5,142	(3,199)	3,528	(1,841)
Less: Reclassification adjustments for gains (losses) realized	(348)	(11)	(237)	(105)
Less: Income tax expense (benefit)	1,122	(654)	776	(828)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Including Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(22)	33	(19)	(31)
Less: Reclassification adjustments for gains (losses) realized	(8)	0	(14)	0
Less: Income tax expense (benefit)	(3)	6	(1)	(12)
AOCI, Liability for Future Policy Benefit, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	4,218	4,708	3,458	5,256
Ending balance	3,023	5,281	3,023	5,281
Remeasurement gains (losses) on market risk benefits related to credit risk
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	5	312	3	285
Ending balance	(59)	118	(59)	118
AOCI, Gain (Loss), Debt Securities, Available-for-Sale, without Allowance for Credit Loss, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(9,670)	(11,049)	(8,672)	(12,565)
Ending balance	(6,188)	(13,006)	(6,188)	(13,006)
AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(83)	26	(82)	47
Ending balance	31	(115)	31	(115)
Accumulated Foreign Currency Adjustment Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(2)	5	13	(10)
Ending balance	21	(9)	21	(9)
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	225	(192)	264	(214)
Less: Reclassification adjustments for gains (losses) realized	4	21	35	66
Less: Income tax expense (benefit)	47	(46)	49	(68)
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	36	(21)	15	6
Less: Reclassification adjustments for gains (losses) realized	0	0	0	0
Less: Income tax expense (benefit)	6	(3)	2	2
AOCI, Derivative Qualifying as Hedge, Excluded Component, Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	60	(26)	67	(50)
AOCI, Liability for Future Policy Benefit, Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	(596)	471	(221)	526
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	(9)	(8)	(7)	(7)
Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of subsidiary issuance of equity interests and tax	7	(4)	5	3
AOCI, Liability for Future Policy Benefit, Including portion attributable to Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(2,263)	1,317	(832)	1,328
Less: Reclassification adjustments for gains (losses) realized	0	0	0	0
Less: Income tax expense (benefit)	(472)	273	(176)	777
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Including
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(93)	(254)	(87)	(220)
Less: Reclassification adjustments for gains (losses) realized	0	0	0	0
Less: Income tax expense (benefit)	$ (20)	$ (52)	$ (18)	$ (46)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 191	$ 162	$ 659	$ 458
Effective income tax rate (percent)	11%	33%	15%	18%

Related Parties - Summary of In

Related Parties - Summary of Investments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Investment funds	$ 18,846	$ 17,668
Related Party
Related Party Transaction [Line Items]
Investment funds	1,604	1,632
Related Party \| Athora
Related Party Transaction [Line Items]
Investment funds	1,106	1,082
Equity Securities, FV-NI	296	249
Investments	$ 1,402	$ 1,331

Related Parties - Narrative (De

Related Parties - Narrative (Details)	3 Months Ended			9 Months Ended
Related Parties - Narrative (Details)	Sep. 30, 2024 USD ($) board_member	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) board_member	Sep. 30, 2023 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jul. 01, 2023 USD ($)	Feb. 08, 2023 USD ($)
Related Party Transaction [Line Items]
Backbook Value	$ 103,400,000,000			$ 103,400,000,000
Management Fee, Percent	0.0335			0.0335
Number of board of directors that are employees of Apollo \| board_member	5			5
Number of board of directors \| board_member	11			11
Investment funds	$ 18,846,000,000			$ 18,846,000,000			$ 17,668,000,000
Interest sensitive contract liabilities	245,436,000,000	$ 189,065,000,000		245,436,000,000	$ 189,065,000,000		204,670,000,000
Available-for-sale securities	182,582,000,000			182,582,000,000			148,347,000,000
Distributions to noncontrolling interests	(95,000,000)	(254,000,000)		(603,000,000)	(381,000,000)
Net future policy benefits	52,962,000,000	46,672,000,000		52,962,000,000	46,672,000,000		53,287,000,000
Contributions from noncontrolling interests	126,000,000	325,000,000		831,000,000	325,000,000
Reinsurance recoverable	7,454,000,000			7,454,000,000			4,154,000,000
Payments of Ordinary Dividends, Common Stock				374,000,000	750,000,000
Noncontrolling interests
Related Party Transaction [Line Items]
Distributions to noncontrolling interests	(95,000,000)	(254,000,000)		(603,000,000)	(381,000,000)
Contributions from noncontrolling interests	126,000,000	325,000,000		831,000,000	325,000,000
Related Party \| Management fees associated with investment funds
Related Party Transaction [Line Items]
Investment expenses	$ 327,000,000	249,000,000		$ 920,000,000	703,000,000
Related Party \| Performance Fee Target \| Minimum
Related Party Transaction [Line Items]
Performance Fee Target Percent	0			0
Related Party \| Performance Fee Target \| Maximum
Related Party Transaction [Line Items]
Performance Fee Target Percent	2			2
Contingent Investment Fees
Related Party Transaction [Line Items]
Other liabilities	$ 265,000,000			$ 265,000,000			213,000,000
Athora \| Related Party
Related Party Transaction [Line Items]
Day from receipt of notice of a cession	30 days			30 days
Athora \| Related Party \| Maximum
Related Party Transaction [Line Items]
Liabilities ceded (in percent)	0.50			0.50
Percentage of liabilities (in percent)	0.20			0.20
Percent of refusal to reinsure liabilities ceded from a third party (in percent)	0.20			0.20
Percent of fair market value of total assets of subsidiary (in percent)	0.03			0.03
Venerable \| Reinsurance agreement recapture
Related Party Transaction [Line Items]
Provision for Loan, Lease, and Other Losses			$ 104,000,000
Net future policy benefits								$ 2,700,000,000
Other Nonrecurring Gain		555,000,000
Investments
Related Party Transaction [Line Items]
Investment commitment	$ 27,200,000,000			$ 27,200,000,000
Private equity
Related Party Transaction [Line Items]
Management Fee, Percent	0.045			0.045
Related Party
Related Party Transaction [Line Items]
Investment commitment						$ 2,500,000,000			$ 3,300,000,000
Other investments	$ 348,000,000			$ 348,000,000			343,000,000
Investment funds	1,604,000,000			1,604,000,000			1,632,000,000
Interest sensitive contract liabilities	7,085,000,000			7,085,000,000			8,599,000,000
Available-for-sale securities	17,897,000,000			17,897,000,000			14,009,000,000
Other liabilities	3,938,000,000			3,938,000,000			774,000,000
Investment expenses	327,000,000	$ 249,000,000		920,000,000	$ 703,000,000
Net future policy benefits	23,000,000			23,000,000			9,000,000
Reinsurance recoverable	3,372,000,000			3,372,000,000			0
Related Party \| Catalina
Related Party Transaction [Line Items]
Reinsurance recoverable	3,372,000,000			3,372,000,000
Related Party \| Management fees associated with investment funds
Related Party Transaction [Line Items]
Other liabilities	142,000,000			142,000,000			101,000,000
Related Party \| MidCap affiliates
Related Party Transaction [Line Items]
Debt Securities	2,004,000,000			2,004,000,000			1,844,000,000
Related Party \| Performance Fee Target
Related Party Transaction [Line Items]
Investment expenses				$ 37,500,000
Related Party \| Apollo \| Sub-allocated assets
Related Party Transaction [Line Items]
Base Management Fee				0.225%
Incremental Fee				0.15%
Related Party \| Apollo \| Sub-allocated assets \| Minimum
Related Party Transaction [Line Items]
Sub-allocation Fee				0.065%
Related Party \| Apollo \| Sub-allocated assets \| Maximum
Related Party Transaction [Line Items]
Sub-allocation Fee				0.70%
Related Party \| Athora
Related Party Transaction [Line Items]
Investment funds	1,106,000,000			$ 1,106,000,000			1,082,000,000
Equity Securities, FV-NI	296,000,000			296,000,000			249,000,000
Investments	1,402,000,000			1,402,000,000			1,331,000,000
Related Party \| Venerable
Related Party Transaction [Line Items]
Equity investment method	$ 180,000,000			$ 180,000,000			181,000,000
Investment Interest Rate	6.257%			6.257%
Related Party \| Apollo Athene Strategic Partnership Advisors, LLC
Related Party Transaction [Line Items]
Investment funds	$ 1,894,000,000			$ 1,894,000,000			1,725,000,000
Strategic Partnership Capacity	2,875,000,000			2,875,000,000
Related Party \| PK AirFinance
Related Party Transaction [Line Items]
Available-for-sale securities	1,633,000,000			1,633,000,000			1,617,000,000
Related Party \| Catalina
Related Party Transaction [Line Items]
Investments	201,000,000			201,000,000
Other liabilities	257,000,000			257,000,000			330,000,000
Payments of Ordinary Dividends, Common Stock	141,000,000
Related Party \| Atlas
Related Party Transaction [Line Items]
Available-for-sale securities	2,449,000,000			2,449,000,000			1,008,000,000
Related Party \| Wheels
Related Party Transaction [Line Items]
Available-for-sale securities	928,000,000			928,000,000			981,000,000
Related Party \| Funding agreements \| Athora
Related Party Transaction [Line Items]
Interest sensitive contract liabilities	61,000,000			61,000,000			61,000,000
Related Party \| Investments \| Athora
Related Party Transaction [Line Items]
Investment commitment	540,000,000			540,000,000
Related Party \| Investments \| PK AirFinance
Related Party Transaction [Line Items]
Investment commitment	40,000,000			40,000,000
Related Party \| Investments \| Atlas
Related Party Transaction [Line Items]
Investment commitment	2,973,000,000			2,973,000,000
Related Party \| Investments \| Wheels
Related Party Transaction [Line Items]
Investment commitment	81,000,000			81,000,000
Related Party \| Private equity \| Venerable
Related Party Transaction [Line Items]
Other investments	348,000,000			348,000,000			343,000,000
Related Party \| Repurchase Agreements \| Atlas
Related Party Transaction [Line Items]
Investments	792,000,000			792,000,000			921,000,000
Parent Company \| Apollo Global Management , Inc.
Related Party Transaction [Line Items]
Maximum borrowing capacity	500,000,000			500,000,000
Long-Term Line of Credit	0			0			0
Parent Company \| Apollo Global Management , Inc. \| Revolving Credit Facility
Related Party Transaction [Line Items]
Revolving note receivable, borrowing capacity	500,000,000			500,000,000
Intercompany Note Receivable	$ 143,000,000			$ 143,000,000			$ 109,000,000
ACRA
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	63.45%			63.45%
Noncontrolling Interest, Ownership Percentage by Parent	36.55%			36.55%
Athene Co-Invest Reinsurance Affiliate 2A Ltd.
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	63%			63%
Noncontrolling Interest, Ownership Percentage by Parent	37%			37%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Feb. 08, 2023
Other Commitments [Line Items]
Investment period (in years)	5 years
Advances from FHLB	$ 13,000		$ 6,500
Letters of Credit Outstanding, Amount	1,306
Interest sensitive contract liabilities	245,436		204,670	$ 189,065
Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability	(177)
Loss Contingency Accrual, Insurance-related Assessment, Policy Surcharge Asset	5
Related Party
Other Commitments [Line Items]
Investment commitment		$ 2,500			$ 3,300
Interest sensitive contract liabilities	7,085		8,599
Other Commitment, to be Paid, Year Three					400
Other Commitment, to be Paid, Year Five					$ 2,900
Guarantor Obligations, Current Carrying Value	0
Investments
Other Commitments [Line Items]
Investment commitment	27,200
Secured Funding Agreements
Other Commitments [Line Items]
Interest sensitive contract liabilities	14,100		6,000
Athene Global Funding \| Funding agreements
Other Commitments [Line Items]
Maximum borrowing capacity	11,900
Interest sensitive contract liabilities	$ 23,000		$ 19,900

Commitments and Contingencies_2

Commitments and Contingencies - Pledged Assets and Funds in Trust (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Other Commitments [Line Items]
Investment funds	$ 18,846	$ 17,668
Derivative assets	7,529	5,298
Restricted cash	964
Total restricted assets	70,154	49,643
Asset Pledged as Collateral
Other Commitments [Line Items]
AFS securities	42,446	32,458
Debt Securities, Trading, Restricted	1,777	139
Equity securities	304	80
Mortgage loans, net of allowances	23,171	14,257
Investment funds	777	409
Derivative assets	68	73
Short-term Investments	14	153
Other investments	623	313
Restricted cash	$ 974	$ 1,761